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Abstract 
Neisseria meningitidis is the causative agent of fatal meningococcal sepsis in humans, 
characterised by high bacterial loads in blood, and collapse of the microcirculatory system. The 
organism is adapted to colonise the human nasopharynx, an environment which is oxygen poor 
but rich in nitric oxide (NO), a gas vital for the regulation of essential physiological processes 
such as vasorelaxation, antimicrobial and innate immune responses by the host. Furthermore, 
during sepsis caused by meningococcaemia, high concentrations of nitrite can be measured in 
the blood, derived from activated circulating monocytes and endothelial cells. Meningococci 
express a partial denitrification pathway comprising of a nitrite reductase (AniA) and a nitric 
oxide reductase (NorB) to survive and thrive in an oxygen deficient niche such as the 
nasopharynx. The aniA and norB genes are negatively regulated by an NO sensitive repressor, 
NsrR. Studies from our group have shown that NorB is critical for counteracting the 
antimicrobial and innate immune response of the host. As NO based regulation requires a 
tightly regulated equilibrium, this could have far reaching consequences on the NO mediated 
signalling processes, and is likely to be relevant to survival of the organism within NO-enriched 
nasopharyngeal mucosae and blood. 
Previously, it was shown that bacterial NO detoxification reduces the concentration of host-
cell S-nitrosothiol (SNO), a vital post-translational modification akin to phosphorylation, in 
murine macrophages in vitro. To investigate if similar meningococcal NO metabolism 
mediated SNO depletion persists in vivo, we established a murine model of early acute 
meningococcal sepsis. We showed that bacterial burden correlates positively with plasma SNO 
and hepatic NO2
- but negatively with hepatic NOx. However, bacterial NO metabolism did not 
differentially modulate SNO and other NO metabolite profile of murine blood and liver tissue. 
Since there is no information to date on the effect of multiple meningococcal denitrification 
genes (aniA and norB) on the cellular pathology of meningococcal sepsis, we constructed and 
characterised a combination of NO metabolising gene mutants (∆aniA/∆norB, ∆nsrR/∆norB, 
∆aniA/∆norB/∆nsrR) using the isocloning method.  
Differentiated human primary bronchial airway epithelial cells cultured at an air-liquid 
interface (HPEC-ALI) are polarised cells with tight junctions, possessing similar 
characteristics to the nasopharyngeal epithelial cells with which meningococci have to interact 
during colonisation and pathogenesis. HPEC-ALIs were infected with the newly created 
mutants (∆aniA/∆norB and ∆aniA/∆norB/∆nsrR) to examine the role of bacterial NO 
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metabolism on the barrier function and immune response, functions known to be modulated by 
high concentrations of NO present in the airway epithelium. We demonstrated bacterial burden 
inversely correlates with the barrier function (TER) but positively with the cytokine profile 
(IL-8, TNFα). However, meningococcal denitrification does not have any differential role in 
the regulation of barrier function and cytokine profile of the HPEC-ALIs in the experimental 
system we used. 
The role of meningococcal denitrification in biofilm formation in vitro was also investigated. 
Preliminary data showed when biofilm formation was induced by nutrient starvation, 
∆aniA/∆norB showed a significantly reduced biofilm forming ability compared to the Wt strain 
measured by the crystal violet staining. To investigate the role of aniA in differential regulation 
of biofilm formation, reverse complemented strains (∆aniA/aniAIPTG+ and ∆aniA/aniA+) were 
created. Characterisation data showed functional activation was restored in ∆aniA when aniA 
was complemented along with the upstream regulatory elements such as the endogenous 
promoter (∆aniA/aniA+) but not when aniA coding region was complemented under the control 
of an IPTG inducible lac promoter (∆aniA/aniAIPTG+). 
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1 Chapter 1: Introduction 
1.1 History and a brief overview of Neisseria meningitidis 
Disease similar to the meningococcal infection dates back to the 16th century. Vieusseux first 
described the disease in 1805 when an outbreak occurred in Geneva, Switzerland (Vieusseux, 
1805). In 1806 the disease was reported in Medfield, USA by physicians Lothario Danielson 
and Elias Mann (Danielson, 1806). Existence of the oval shaped micrococci in cerebrospinal 
fluid (CSF) was described by Italian pathologists Marchiafava and Celli in 1884 (Marchiafava, 
1884). Austrian bacteriologist, Anton Weichselbaum first isolated the bacterium from the CSF 
of a patient with meningitidis and termed it as ‘Diplococcus intracellularis’ (Weichselbaum, 
1887). Human lumbar puncture, a routinely used technique for culture based diagnosis of 
meningococcal infection was described in 1893 (Quincke, 1893). Kiefer grew meningococci 
from the nasopharynx of the patients suffering from meningococci and also from the people 
who were in close contact with the patients (Kiefer, 1896). Early investigators were perplexed 
by the presence of meningococci in the nasopharynx of the healthy people. However, this 
observation first confirmed the non-symptomatic carriage of the organism in nasopharynx. In 
1909, Dopter extracted an organism which had similar properties to the meningococci which 
failed to agglutinate to antibody made against other strains found in CSF. Subsequently these 
organisms were termed as parameningococci. Hence, Dopter is credited of having revealed the 
first example of meningococcal serogrouping (Dopter, 1909). Serum therapy was used to treat 
meningococcal infection (Flexner, 1913) until the introduction of sulphonamide in 1937 for 
treating asymptomatic carriage (Schwentker et al, 1984) . This reduced the mortality rate from 
70% to 30%. Sulphonamide resistant meningococci was reported within the Naval recruits at 
San Diego (Bristow et al, 1965). However, the first vaccine against meningococcal serogroup 
C was introduced in the 1960s due to the development of resistance against sulphonamides 
(Artenstein et al, 1970). Conjugate polysaccharide vaccines developed against the capsular 
component have provided good protection against serogroup A, C, W-135 and Y (Trotter & 
Ramsay, 2007). Development of vaccine against serogroup B meningococcal disease has been 
a challenge for a long time. This is due to the fact that polysaccharide of serogroup B 
meningococcal capsule closely mimics the human tissue antigen such as NCAM (neural cell 
adhesion molecule). Due to this molecular mimicry, the antibody against capsule in serogroup 
B is poorly immunogenic and does not induce a protective response (Finne et al, 1987; Nedelec 
et al, 1990). Multiple vaccine candidates were identified using the reverse vaccinology 
(Rappuoli, 2001) which involved the screening of whole genome sequence of serogroup B 
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meningococci for finding novel antigens other than the capsule (Pizza et al, 2000). After 
subsequent serological and immunological characterisation, novel surface exposed antigens 
were identified. Using these components, a novel vaccine was developed against serogroup B 
which is marketed as Bexsero (also known as 4CMenB). Bexsero consists of four main 
components, 1) Factor H binding protein (fHbp), 2) Neisseria heparin binding antigen 
(NHBA), 3) Neisserial adhesin A (NadA) 4) New Zealand MenB vaccine (MenZB) (Serruto 
et al, 2012). Other ingredients that make up the vaccine are aluminium hydroxide, histidine, 
sodium chloride, sucrose and water. The vaccine was licenced for use in Europe in January 
2013 (Bai et al, 2011). A formal decision to include Bexsero as part of the child immunisation 
scheme in UK was made in the late March 2015 (http://www.bbc.co.uk/news/health-
32101921) and became a part of the routine vaccination schedule in September 2015 
(http://www.bbc.co.uk/news/health-34084999). TRUMENBA, produced by Pfizer, a vaccine 
against serogroup B was approved by the Food and Drug Administration (FDA) authority in 
October 29, 2014 for use in USA (http://www.cdc.gov/meningococcal/outbreaks/vaccine-
serogroupb.html). It constitutes of two variants of the factor H binding protein (fHbp). After 
evaluating the global data from initial trials, Bexsero was approved in USA in January 2015 
(http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm431446.htm).
A recent study by our group demonstrated that inoculation of live Neisseria lactamica into 
young university student reduces the carriage and acquisition of N. meningitidis at a rate higher 
than the existing glycoconjugate vaccines (Deasy et al, 2015). This outcome could inform a 
new way of fighting meningococcal disease using bacterial medicine. Despite evidences of 
good protection, the efficacy of these novel vaccines/treatments have to be monitored over a 
large population and a long period of time given the plasticity of meningococcal genome have 
the potential to render these treatment regimes non-functional and obsolete in the long run 
(Deasy et al, 2015; Evans et al, 2011). 
The genus ‘Neisseria’ was first coined by bacteriologist Albert Neisser (Ligon, 2005). 
Although Nesseria spp are primarily human commensals, some species have been reported to 
be found in animals such as Neisseria ovis in sheep (Lindqvist, 1960), Neisseria dentiae in 
cows (Sneath & Barrett, 1996). Out of 14 Neisseria species that exclusively colonise human 
mucosal surfaces, N. gonorrhoeae and N. meningitidis are clinically important pathogens 
responsible for causing significant morbidity and mortality around the globe. In addition, 
harmless and non pathogenic commensal N. lactamica has also received significant medical 
attention as several studies have reported an inverse correlation between colonisation of N. 
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lactamica and pathogenic N. meningitidis. N. meningitidis (also known as ‘’the 
meningococcus’’) is a Gram negative heterotrophic bacterium belonging to the family of 
Neisseriaceae and is exclusively found in human nasopharynx which provides a stable 
ecological niche for the organism. It is predominantly diplococcus (Figure 1.1 A). At any given 
time the organism can colonise the nasopharynx of up to 35% of the healthy individuals and 
can be transmitted from one person to another by respiratory droplets (Caugant & Maiden, 
2009). By adopting yet undetermined mechanism the organism can enter the bloodstream and 
cause pathology in the forms of meningitidis and septicaemia (Figure 1.1 B). However, the 
occurrence of invasive disease is rare because it represents an evolutionary dead end for the 
bacteria which normally is a successful coloniser of the human nasopharynx. The organism is 
fastidious in nature and has a limited lifespan ex vivo. It is non motile, aerobic and catalase 
producing. Like other bacteria, it is surrounded by lipid containing outer membrane protein 
(OMP). It grows optimally at 37°C with 5% CO2 supplementation on various nutrient plates 
such as Columbia blood agar, Chocolate agar, GC agar and Mueller- Hinton agar (used in this 
study). The bacterium is an oxidase positive diplococcus (0.6 µm x 0.8 µm) which can be either 
encapsulated or unencapsulated (Rouphael & Stephens, 2012).  The cocci can be found as 
single cells, tetrads or pairs. Glucose and maltose are utilised by the bacterium as carbon 
sources (Beno et al, 1968; Exley et al, 2005). Antimicrobial susceptibility test is performed by 
using Etest strip, broth microdilution or by minimal inhibitory concentration (MIC) 
determination. Laboratory personnel dealing with the organism must work in a biological 
safety cabinet and have protective vaccination. Antibiotic resistance is not widespread in the 
organism with the exception of sulphonamide. However, emergence of ciprofloxacin resistant 
meningococci have been reported in North America (Wu et al, 2009). 
 
Figure 1.1 A) Image of diplococcus Neisseria meningitidis and B) Picture of a patient 
suffering from meningococcal infection 
 (http://bioweb.uwlax.edu/bio203/s2008/bingen_sama/shape%20of%20neisseria.jpg)  
(http://carrington.edu/blog/medical/vaccines/meningococcal-disease-and-meningococcal-
vaccine/)  
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1.2 Genetics of Neisseria meningitidis 
Possession of a plastic genome is one of the main evolutionary features of N. meningitidis. This 
property provides the organism an additional advantage over other pathogens to colonise the 
nasopharynx and cause pathology by evading or subverting immune response. To date a 
number of genome sequences of N. meningitidis strains have been unravelled, such as Z2491 
(Serogroup A, ST4, 2,184,406 bp length) (Parkhill et al, 2000), MC58 (Serogroup B, ST-32, 
2,272,351 bp length) (Tettelin et al, 2000), FAM18 (Serogroup C, ST-11, 2,194,961 bp length)  
(Bentley et al, 2007) and NMB-CDC (Serogroup B, ST-8). Genome sequences reveal that the 
chromosome length of N. meningitidis is around 2.0-2.2 megabases containing about 2000 
genes (Schoen et al, 2008). Apart from the IHT-A1 region which harbours the genes for capsule 
biosynthesis there is no defined core pathogenome for the organism. This might indicate that 
the virulence is clonal group dependent. Genetic islands coding for virulence factors and 
hypothetical surface proteins are present in the meningococcal genome. These islands are often 
acquired by horizontal transfer events between N. meningitidis, N. gonorrhoeae, commensal 
Neisseria spp and other bacterial species such as Haemophilus (Davidsen & Tonjum, 2006; 
Kroll et al, 1998; Linz et al, 2000). Presence of 2000 copies of uptake signal sequence in 
meningococcal genome facilitates the uptake of foreign DNA by transformation (Kroll et al, 
1998; Smith et al, 1999). Meningococci shares 90% sequence homology with N. lactamica and 
N. gonorrhoeae. Events of genetic recombination is evidenced by the presence of repetitive 
sequences, IS elements and polymorphic regions which make up about 10% of the genome.  
1.3 Classification of Neisseria meningitidis 
N. meningitidis is classified by serological typing and serogrouping (Frasch et al, 1985 ; 
Slaterus, 1961). Unlike N. gonorrhoeae, N. meningitidis is an organism with capsular 
polysaccharide. On the basis of immune reactivity and capsular structure, meningococci can 
be divided into 13 serogroups (A, B, C, E-29, H, I, K, L, W-135, X, Y, Z and Z’ (29E) 
(Branham, 1953). However, six serogroups (A, B, C, W-135, X, Y) account for more than 90% 
of the clinical cases of meningococcal disease (Pollard, 2004). Capsular structure of serogroup 
B, C, Y and W-135 consists of sialic acid linked to glucose or galactose (Bhattacharjee et al, 
1975) and N-acetyl mannosamine-1-phosphate is the main component of serogroup A capsule 
(Liu et al, 1971).  
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The most abundant outer membrane protein for meningococci is porin. The two porins  
expressed by the organism are PorA and PorB (PorB2, PorB3). PorB expression facilitates 
serotyping whereas variability in PorA gene helps serosubtyping (Frasch et al, 1985 ). Unlike 
lipopolysaccharides found in members of the other Gram negative bacterial family, 
meningococcal outer membrane consists of lipo-oligosaccharides (LOS). It is composed of 
lipid A and a short chain of 8-12 saccharide units but lacks multiple sugar residues of LPS. It 
is responsible for the endotoxin activity. Immunotyping of meningococci is performed by the 
antigen recognition of 12 different immunogroups by the variability of their LOS antigens 
(Scholten et al, 1994). Molecular typing has been the choice of method for identifying and 
categorising various meningococcal strains, clonal groups and meningococcal genomes. 
Several molecular methods are used for typing such as multilocus enzyme electrophoresis 
(MLEE) (Weis & Lind, 1998), pulse-field gel electrophoresis (PFGE) (Bevanger et al, 1998), 
PCR (Mothershed et al, 2004) and multilocus sequence typing (MLST). MLST is the most 
widely used and accepted modern technique for classifying various meningococcal strains into 
different sequence types. This is done on the basis of nucleotide sequence polymorphisms 
associated in the selected housekeeping genes (Maiden et al, 1998). Around 10000 sequence 
types are listed in the Neisseria Multi Locus Sequence Typing website 
(http://pubmlst.org/neisseria/) (Jolley & Maiden, 2010).  
1.4 Transmission, carriage and epidemiology of Neisseria meningitidis 
N. meningitidis can be transmitted from person to person by contacting respiratory droplets. 
Although the disease is most common in the infants, highest carriage of the organism is found 
in the young adults such as university students (Ala'aldeen et al, 2011). At any given time the 
bacteria can colonise 10% of the given population excluding situation such as epidemics 
(Caugant et al, 1994). Social behaviours such as kissing, bedroom-sharing, cigarette smoking 
and close contact environment such as the one encountered during Hajj pilgrimage can lead up 
to higher asymptomatic carriage of the organism in adolescents (Christensen et al, 2010; 
MacLennan et al, 2006; Soriano-Gabarro et al, 2011; Wilder-Smith et al, 2003).  
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There are around 1.2 million cases of meningococcal disease worldwide resulting in the death 
of 135000 people per annum (Rouphael & Stephens, 2012). Age group, population, 
geographical location and different bacterial serogroup play important roles in dictating the 
severity of meningococcal disease. A few genetically well defined clonal complexes are 
responsible for meningococcal disease (Maiden et al, 1998). About 90% of the disease 
worldwide is caused by serogroups A, B and C. In recent times, incidences of disease caused 
by serogroup A have been low in the developed world despite outbreaks in the early part of 
20th century in USA (Rosenstein et al, 2001). However, Serogroup A has been responsible for 
the largest outbreak of meningococcal disease in the sub-Saharan African region spanning 21 
countries from Ethiopia to Senegal also known as the ‘meningitis belt’ (Hart & Cuevas, 1997).  
This has caused the death of around 30000 people out of 300000 affected. In this region 
epidemic occurs every 8-10 years (Stephens et al, 2007). Although the reasons behind 
development of these outbreaks are poorly understood, environmental factors such as dust and 
excessive humidity could be responsible (Greenwood et al, 1984; Molesworth et al, 2003). 
Serogroup A meningococcal disease has also been reported in Asian countries such as China, 
India, Nepal and Russia (Stephens et al, 2007; Wang et al, 1992). Serogroup B accounts for 
the majority of endemics in the developed world, causing 80% of the disease in Europe and 
30%-40% in USA. In England and Wales, serogroup B has accounted for most of the laboratory 
confirmed meningococcal infection from 2004 – 2014 (Figure 1.2). There was a large outbreak 
of MenB in New Zealand in 1991 (Martin et al, 1998). In USA serogroup C has been 
responsible for the 30% of the disease (Jackson et al, 1995). Serogroup W epidemic was 
reported in the pilgrims returning from Hajj in 2001 (Wilder-Smith et al, 2003). In addition, 
emergence of pathology with serogroup W has also been reported in Latin America, Africa 
(Stephens et al, 2007). Although rare in other regions around 1300 cases of Serogroup X 
meningococcal disease has been found in African meningitis belt during 2006-2010 (Xie et al, 
2013). Due to waning maternal antibodies, the highest rate of MenB disease is prevalent in 
infants under the age of one (Cartwright et al, 2001).Worldwide data show that young children 
are the most vulnerable group for meningococcal infection but in endemics older children and 
adolescents are more prone to risk.  
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Figure 1.2 Epidemiology of the meningococcal disease  
A) Worldwide geographical distribution of pathogenic major serogroups (A, B, C, W-135, X 
and Y) of meningococci (http://www.meningitis.com/US/media/uploads/map_2.jpg)  
B) Prevalence of the laboratory confirmed meningococcal disease and their serogroups in 
England and Wales from 2004-2014. 
(https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/397913/hpr03
15_imd.pdf). 
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1.5   Clinical representation and diagnosis of meningococcal disease 
Meningococcal disease is a clinical emergency which can kill a person of any age within hours. 
A study from hospital emergency room reported that about one-third of the fatalities happen 
within the first 6 hours of admission and about two-thirds within the first 18 hours (van Deuren 
et al, 2000). The clinical spectrum of the disease is diverse. Sepsis and meningitis are the two 
most common forms of representation of the meningococcal disease. Acute pyogenic 
meningitis accounts for 75% of the patients for meningococcal disease (Brandtzaeg & van 
Deuren, 2012). It is caused by the inflammation of meninges. Approximately 40% of the 
patients suffering from meningitis would have bacteraemia. However, 10% of the patient 
would have bacteraemia without meningitis (Al-Tawfiq et al, 2010; Dankert, 2004). In rare 
circumstances, patients would have mild meningococcal bacteraemia which can be treated 
without using any antibiotic (Sullivan & LaScolea, 1987). Outcome of the meningococcal 
disease is dependent on multiple factors such as age of the patient and infecting clonal complex 
(Read et al, 2003). The most extreme outcome of meningococcal disease is purpura fulminas 
which is characterised by haemorrhagic infraction and intravascular thrombosis of the skin. 
Even after successful treatment patients may suffer from sequelae such as deafness. Sequelae 
from meningococcal disease usually results from sepsis and could lead to organ amputation in 
the long run (Baraff et al, 1993).   
In case of suspected meningococcal disease blood sample or CSF is collected. Samples are to 
be examined urgently as the treatment will differ on the basis of disease detection and severity. 
Samples are tested by blood culture, agglutination test or meningococcal PCR. For confirming 
meningitis, a lumber puncture is performed for isolating CSF. An advanced PCR technique 
combined with fluidic microarray (the Luminex xMAPTM technology) is also used for 
detecting bacteria in CSF in patients suspected with having meningitis. This is a robust method 
which uses PCR combined with flow cytometry, laser technology, digital signal processing, 
traditional chemistry and microspheres (Moller, 2012). Although gram staining is an efficient 
method for detecting meningococcal disease, the success of this process depends on the 
bacterial concentration present in the sample. Around 60%-90% of CSF specimen from 
meningococcal sample yield a positive result with gram staining (Dankert, 2004). Increased 
leukocytes (exceeding 1000 cells/mm3) and decreased glucose concentration in leukocytes 
(<40 mg/dl) are also indicators of meningococcal disease (Wilks, 2003).   
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1.6  Pathological events of meningococcal sepsis 
N. meningitidis reside in the nasopharynx of 5%-10% of the population without causing any 
pathological complications (Donovan & Blewitt, 2009). However, under unknown 
circumstances, the bacteria can penetrate through the nasopharyngeal mucosae and enter the 
bloodstream to cause meningococcal septicaemia and from there, traverse the endothelial 
blood-brain barrier and cause meningococcal meningitis. The overall mortality rate from 
meningococcal disease is around 8% (Rajapaksa & Starr, 2010).  Survivors of meningitis and 
septicaemia can often suffer from neurological and physical abnormalities. Sepsis is defined as 
a systemic respiratory response syndrome in response to infection showing multiple clinical 
manifestations such as abnormal body temperature (>38°C or < 36°C), high heart rates (> 90 
beats per minute), abnormal breathing (> 20 breaths/minute) or hyperventilation, abnormal 
leukocyte count (> 12000 cells/cubic mm or < 4000 cells/cubic mm or > 10% immature 
neutrophils) (Bone et al, 1992). The main pathological observation in septic patients is the 
perturbation of the tightly regulated microvasculature, in which Nitric oxide (NO) is a pivotal 
signalling molecule (Section 1.11.1) (Buerk, 2007). Increased vascular permeability, 
intravascular thrombosis and both the abnormal vasodilation and vasoconstriction can result in 
the failure of the circulatory system.   
1.6.1 Increased vascular permeability  
Early events in septicaemia are characterised by the increased vascular permeability in 
response to the exposure of meningococcal endotoxin and surface adhesion molecules. This 
results in an excessive activation of the innate immune system and subsequent recruitment of 
macrophages and neutrophils to the site of infection. Increased vascular permeability in 
response to meningococcal infection subsequently induces hypovolaemia, an event resulting 
from the aberrant loss of plasma albumin. Enzymatic degradation of the endothelial surface 
proteins such as glycosaminoglycans has been attributed for the capillary leakage by 
hypovolaemia (Klein et al, 1992; Oragui et al, 2000). This cascade of events subsequently 
results in respiratory failure, pulmonary oedema and a significant reduction in the cardiac 
output. 
1.6.2 Pathophysiological vasodilation and vasoconstriction 
To counteract respiratory failure mediated by hypovolaemia, compensatory vasoconstriction is 
induced to restore blood perfusion and cardiac output. This results in an initial restoration of 
homeostasis of microvasculature. However, in most of the severely affected patients intense 
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vasoconstriction persists. This results in the generation of pale, cold and ischaemic tissues, 
which can consequently lead to thrombosis and gangrene. In contrast, some of the patients 
experience an excessive vasodilation in response to the compensatory vasoconstriction 
following initial hypovolaemia. Consequently, hypotension is triggered with a marked drop in 
blood pressure. Excessive production of NO as encountered during sepsis due to high NOS 
activity could also contribute to excessive vasodilation leading to hypotension and 
inflammatory tissue damage (Kilbourn et al, 1997; Thiemermann, 1997). This could lead to 
multiple organ failure including kidneys, lungs, brain and heart.  
1.6.3 Intravascular thrombosis and coagulation 
One of the major characteristics of severe meningococcal sepsis is the development of purpura 
fulminas accompanied by intravascular thrombosis and haemorrhagic necrosis of skin and 
limbs (Brandtzaeg & van Deuren, 2012). Clot formation during normal vascular homeostasis 
is a process which requires spatiotemporal and precisely regulated coordination of three 
important pathways; the procoagulant, antithrombic and thrombolytic pathways. Severe 
disseminated thrombosis during meningococcal sepsis occurs as result of disruption in the 
regulation of these pathways. In response to endotoxin or inflammatory stimulus of 
meningococci, the procoagulant pathway is activated rapidly. The endothelium harbours 
various components of anticoagulation required for thromboresistance. For example NO and 
prostacyclin, inhibit platelet formation and heparin sulphate has antithrombic properties 
(Heyderman et al, 1992). However, the pathway for activating anticoagulating proteins such 
as antithrombin, protein C and protein S is severely impaired and down-regulated in the septic 
patients (Faust et al, 2001). Dysfunctional anticoagulating mechanism coupled with 
upregulation of tissue and procoagulating factors from monocytes and platelets result in 
widespread intravascular thrombosis. An impaired thrombolytic mechanism also contributes 
to this pathophysiology.  
1.6.4 Severe myocardial dysfunction 
Significant impairment in the activity of microvasculature following capillary leak and 
hypovolaemia, loss of circulating blood volume can subsequently lead to myocardial failure. 
Despite the compensatory vasoconstriction in order to restore the normal blood perfusion, 
persistent defect in myocardial contractility has been reported. Proinflammatory mediators 
such as TNFα, IL-1β, NO act as myocardial depressant factors (Kumar et al, 1999; Kumar et 
al, 1996). Other accompanying physiological events in sepsis such as acidosis, ischemia, 
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hypoglycaemia, hypocalcaemia and hypophosphataemia can also lead to the severe myocardial 
dysfunction (Pathan et al, 2003).  
1.7 Mechanisms of colonisation and cellular invasion by N. meningitidis 
Following acquisition by the inhalation of respiratory droplets, the meningococcus establishes 
contact with the mucosal epithelial cell of the nasopharynx (Figure 1.3). N. meningitidis has 
evolved a number of surface associated proteins and structures to facilitate its interaction with 
the host cell. These components play essential role in the colonisation process of meningococci. 
In addition, they also determine many important parameters in host-pathogen interaction such 
as tissue tropism and invasive versus carriage potential. Meningococcal adhesion to the host is 
a dynamic process involving complex interaction between the bacterial surface components 
and host receptors. The outcome of this interaction is dependent on the cooperation of multiple 
surface proteins (Figure 1.4) at different stages of infection and colonisation. 
Type IV pili (Tfp) are responsible for mediating the initial attachment of Neisseria to the 
epithelium. Adhesive properties of capsulated meningococci are governed by pili which extend 
several thousand nanometres beyond the polysaccharide capsular structure (Pinner et al, 1991; 
Virji et al, 1992a). Non piliated strains of meningococci do not efficiently bind to the host cell 
(Nassif, 1999; Virji et al, 1991). Tfp  is also important for facilitating the DNA uptake by N. 
meningitidis (Proft & Baker, 2009). It is a multimeric protein complex consisting of PilE 
protein. pilE deficient capsulated strains are incapable of binding to the host cell. Although 
CD46, a membrane bound cofactor protein, is considered to be the predominant receptor for 
Tfp binding (Kallstrom et al, 1997), CD46 independent binding of pili has also been reported 
(Kirchner et al, 2005). In N. meningitidis two types of PilC are found, PilC1 and PilC2. 
However, it is PilC1 which is essential for binding with epithelium as evidenced by the lack of 
binding by PilC1- isolates despite the expression of PilC2 (Nassif et al, 1994). Tfp is a dynamic 
structure which is being constantly remodelled. It can undergo posttranslational modification 
such as glycosylation. It has been suggested that meningococci can disseminate to a new 
location by detaching from the microcolony using glycosylated pili (Chamot-Rooke et al, 
2011).  
Porin is the predominant surface protein which is responsible for the diffusion of small 
metabolites such as ions through the pores. It can facilitate pathogenesis by modulating 
important processes such as immune stimulation, serum resistance and invasion (Massari et al, 
2003). Three types of porins are found (PorA, PorB2 and PorB3) of which PorA is cation 
selective and PorB2 and PorB3 are anion selective. Unlike N. gonorrhoeae (Bauer et al, 1999), 
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there is no evidence for a direct effect of meningococcal porin on invasion process. But it is 
postulated that it can indirectly affect Neisserial entry into cells by modulating the nucleation 
process. 
Sequencing has revealed a number of physiologically important novel surface structures such 
as autotransporters (App, MspA/AusI, NadA, NhhA), outer membrane proteins (Opa, Opc) 
(Figure 1.4) which have been implicated in the colonisation and invasion machinery of N. 
meningitidis. 
The outer membrane opacity proteins give an opaque type phenotype to N. meningitidis when 
grown on the agar plates. Two types of OM opa proteins (Opa and Opc) are expressed by both 
pathogenic and commensal meningococci. Eight transmembrane β-strands and four surface 
bound loops make up the structure of Opa protein. It is expressed by multiple genes and its 
regulation is subject to phase and antigenic variation (Callaghan et al, 2006). Opa binds to the 
multiple members of the CEACAM (Carcino-embryonic antigen related cell-adhesion 
molecule) receptor family (Dehio et al, 1998; Virji et al, 1996). Thus Opa facilitates the cellular 
attachment and invasion by interacting with the CEACAM receptors which are highly 
expressed during inflammation. Opc is only expressed by meningococci of all Neisseria spp 
and is encoded by a single gene. In non-capsulated meningococci Opc facilitates the adherence 
and invasion of endothelial cells independent of the activity of pili and Opa (Virji et al, 1993; 
Virji et al, 1992b; Virji et al, 1994). Both Opa and Opc can bind to HSPGs (Heparan sulfate 
proteoglycans) which are found on the cell surface (Virji et al, 1999; Virji et al, 1992b). 
Neisseria adhesin A (NadA) of N. meningitidis is one of the members of trimeric 
autotransporter protein family. In particular it belongs to the Oca (Oligomeric coiled-coil 
adhesion) family which represents a group of autotransporters responsible for mediating the 
oligomerisation process by the presence of a coiled-coil motif (Desvaux et al, 2004). It is found 
in about 50% of the N. meningitidis strains including hypervirulent lineages such as ET5, ET37, 
cluster 4 but absent in lineage III and also in N. gonorrhoeae, commensal species such as N. 
lactamica (Comanducci et al, 2002). However, it is only found in 5% of the healthy carriage 
population (Comanducci et al, 2004). In addition, it is well conserved, induces strong 
bactericidal antibody response and helps the meningococci to bind to the epithelial cell 
(Capecchi et al, 2005).  These observation supported the hypothesis that NadA is an important 
co-factor in the pathogenesis of group B meningococci and thus was incorporated as one of the 
four antigen components of the novel multicomponent Bexsero vaccine against the group B 
meningococci. 
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Neisseria hia homolog A (NhhA) is another member of the trimeric autotransporter family. It 
is composed of 590 amino acids and have been found in all meningococcal strains (Scarselli et 
al, 2006). It facilitates the adherence of meningococci to epithelial cells and protects the 
organism from phagocytosis and complement mediated killing (Sjölinder et al, 2008). By 
adopting these mechanisms, NhhA affects colonisation and invasion in vivo.  
Adhesion and penetration protein (App) is an autotransporter protein which is present in all 
Neisseria spp. It is homologous to the Hap adhesin of Haemophilus influenzae (St Geme et al, 
1994). It has autocatalytic serine protease activity and helps the meningococci to adhere to 
epithelial cell (Hadi et al, 2001; Serruto et al, 2003). It is suggested that App is involved in the 
early stage of colonisation until it is autocleaved and thereby could facilitate the dissemination 
of bacteria by promoting detachment. In addition, MspA/AusI and NaIP are other 
autotransporters with serine protease activity which have been shown to have adhesive 
properties during interaction with the epithelial cells (Turner et al, 2006; van Ulsen et al, 2006; 
van Ulsen et al, 2003).  
It is noteworthy that surface structures such as App, NadA and NhhA have been found to be 
expressed and functional in capsulated meningococcal strains (Capecchi et al, 2005; Scarselli 
et al, 2006; Serruto et al, 2003). Some of the meningococcal surface proteins such as App, 
NhhA were found while comparing with homologues from other colonisers of the upper 
respiratory tract such as Haemophilus influenzae, Bordetella pertussis. These homologue 
proteins also play important roles in colonisation and invasion process in other bacteria. First 
step in establishing meningococcal colonisation is the attachment of the bacterium to the 
nasopharyngeal epithelial cells. Given that pili is the primary factor determining the attachment 
step, the outer membrane proteins and adhesins can act as auxiliary factors facilitating the 
colonisation process. Antibodies directed against App, NadA and NhhA have been found from 
the sera of convalescent patients and carrier population of meningococcal disease. A screen for 
finding novel vaccine candidates showed that antibodies generated against these surface 
proteins elicit bactericidal response (Pizza et al, 2000). These observations further highlight 
the relevance of the meningococcal surface proteins in modulating the colonisation and 
invasion process. 
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Figure 1.3 Depiction of colonisation and invasion by N. meningitidis.  
Following acquisition by the inhalation of respiratory droplets, the meningococcus establishes 
contact with the mucosal epithelial cell of the nasopharynx. Apart from transcytosis, the 
meningococci can cross the epithelial barrier and enter bloodstream by disrupting the barrier 
function or by phagocytosis. However, bacteria are eliminated after crossing the epithelial 
barrier in asymptomatic carriage samples. Once in the bloodstream bacteria may thrive and 
multiply in the blood stream or disseminate throughout the body and the brain. Upon reaching 
brain it can cross the brain vascular endothelium and cause infection of the meninges and the 
CSF. Figure adapted from (Virji, 2009)  
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Figure 1.4 Outer membrane structures of N. meningitidis important for the bacterial 
interaction with the epithelial cells and pathogenesis.  
Porins (PorA, PorB), Pili (Type IV pili), Iron binding complex (consists of TbpA and TbpB 
proteins), Outer membrane opacity proteins (Opa, Opc), App- (Adhesion and penetration 
protein), MsPA/ AusI (Autotransporter protein), NaIP (Neisseria autotransporter lipoprotein), 
NhhA (Neisseria hia/hsf homologue), NadA (Neisseria adhesion A), MiP (Macrophage 
infectivity potentiator), fHBP (Factor H binding protein) 
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1.8 Nitric oxide: a brief history and overview 
English chemist Joseph Priestley first discovered NO in 1772 which he termed as ‘nitrous air’. 
The use of NO for treating critical heart conditions without the appreciation of NO as EDRF 
(endothelium derived relaxation factor) can be traced back to the late 18th century. Physician 
Lauder Brunton showed the physiological role of NO derived compound such as nitrite by 
treating a patient suffering from angina with amyl nitrite in 1876 (Marsh & Marsh, 2000). 
However, he was not aware of the specific role and mechanism by which NO from nitrite 
reduced chest pain.  
When prescribed GTN (also known as glyceryl trinitrate), a component of dynamite as 
treatment for angina pectoris, the  discoverer of dynamite, Alfred Nobel in a letter addressed 
to his assistant, Ragnar Sohlman, mentioned that ‘’My heart trouble will keep me here in Paris 
for another few days at least, until my doctors are in complete agreement about my immediate 
treatment. Isn't it the irony of fate that I have been prescribed GTN, to be taken internally! 
They call it Trinitrin, so as not to scare the chemist and the public’’ 
(http://www.nobelprize.org/alfred_nobel/biographical/articles/ringertz/). Although NO 
harbouring vasodilatory compounds such as nitroprusside and nitroglycerine were shown to 
activate the sGCs (Arnold et al, 1977; Schultz et al, 1977), any possibility of NO mediated 
sGC activation was ignored as NO at that time was considered being a carcinogenic, pungent-
smelling gas and an air pollutant (Fontijn et al, 1970). It was hard to accept for the scientific 
community that a harmful compound like NO would be pivotal for regulating an important 
physiological process such as vasodilation. The major breakthrough in unravelling the role of 
NO as EDRF came by two major discoveries. Firstly a substance from endothelium was found 
to be responsible for mediating vasorelaxation (Furchgott & Zawadzki, 1980). The substance 
was termed as EDRF. Secondly, NO was discovered independently by Ignarro and Moncada 
groups as the EDRF responsible for stimulating sGCs in smooth muscle cells to synthesise 
cGMP, thereby causing vasodilation  (Ignarro et al, 1987; Moncada et al, 1988; Palmer et al, 
1988). Their work was commended with the award of Nobel Prize in Physiology and Medicine 
in 1998. Since then NO has been proven to be an important molecule in physiology, 
microbiology, immunology, pharmacology and was declared as the ‘Molecule of the Year’ in 
1992 (Culotta & Koshland, 1992).  
NO is a colourless and simple diatomic gas consisting of one atom of nitrogen and one atom 
of oxygen. It is poorly soluble in water and does not undergo hydration reaction. NO is an 
uncharged molecule which can traverse the cellular boundary. Therefore, it can exert its 
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biological effect away from its origin. Due to the presence of an unpaired electron, it can act 
as a highly reactive free radical. It can interact with a diverse range of inorganic molecules 
such as transition metals, superoxide, oxygen, prosthetic groups such as heme or thiol groups 
of protein to form S-nitrosothiols (SNO), structural component of DNA such as pyrimidine 
bases, reaction with iron-sulphur cluster or zinc finger domains (Bogdan, 2001). Many of these  
target for NO reactions are important regulatory components such as transcription factors or 
parts of signalling cascades. Therefore, NO can affect heterogeneous and diverse range of 
biological processes (Murad, 2004). However, the biological chemistry of NO is complex and 
often controversial.  
It has been challenging for the researchers to link micro-environmental NO chemistry with the 
biological effects mediated by NO. In particular, defining the parameters of redox chemistry in 
the regulation of NO mediated biological responses has proven to be challenging. It is also 
questionable how such a ubiquitously expressed and short lived molecule can selectively 
regulate a vast number of important cellular processes including cell signalling. Many 
investigators referred to the post translational modification of thiol containing cysteine proteins 
by the formation of S-nitrosthiol (SNO) as an answer to this caveat. S-nitrosylation involves 
the formation of SNO following the reaction of NO with a thiol of cysteine residue of protein 
in presence of an oxidising agent (Section 1.9). It has been proven to regulate a diverse range 
of cellular responses such as apoptosis, neurotransmission, cell signalling and gene expression 
(Seth & Stamler, 2010; Stamler et al, 2001). The process of S-nitrosylation is spatiotemporally 
regulated, reversible in nature and stimulus evoked (Stamler et al, 2001). The realisation of the 
opposite process, denitrosylation, involving the release of NO moiety from SNO has been 
relatively recent (Tannenbaum & White, 2006). Thus, S-nitrosylation can be compared with 
other important posttranslational modifications processes such as phosphorylation and 
ubiquitylation. Increased S-nitrosylation has been implicated in Parkinson’s disease, 
neurotoxicity, cerebral ischemia (Foster et al, 2003; Lipton et al, 1998; Schonhoff et al, 2006). 
Denitrosylation is linked to clinical conditions such as asthma, vascular dysfunction, sickle cell 
diseases (Benhar et al, 2009). In addition, SNO homeostasis is also important in the 
pathogenesis of malignant hyperthermia, type 2 diabetes, haemorrhage (Foster et al, 2009; 
Sheng et al, 2010). 
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1.9 Formation of NO and S-nitrosothiol 
The majority of NO production in mammalian cells is driven by the activity of Nitric Oxide 
synthase (NOS) enzymes (Hogg, 2000). NOS catalyses the L-arginine to citrulline conversion 
in an oxygen and NADPH dependent manner and produces NO (Figure 1.5 A). In higher 
eukaryotes three types of NOS isoforms have been identified; constitutively expressed neuronal 
and endothelial NOSs (nNOS and eNOS, respectively) and the inducible NOS (iNOS) (Nathan 
& Xie, 1994). NOS exert its function as a dimer. Each NOS monomer contains a C-terminal 
reductase domain and an N-terminal oxygenase domain. The C-terminal domain harbours 
binding sites for NADPH, flavoproteins such as Flavin adenine dinucleotide (FAD) and Flavin 
mononucleotide (FMN). N-terminal oxygenase domain contains heme, tetrahydrobiopterin 
(BH4) and L-arginine binding site (Crane et al, 1997; Sennequier & Stuehr, 1996). The reaction 
of NO and citrulline production from L-arginine requires five electrons, co factors such as 
FAD, FMN, BH4, calmodulin (CAM), co-substrates such as NADPH and O2. In reductase 
domain electron from NADPH is transferred to flavoproteins FAD, FMN. Subsequently, CAM 
binding facilitates the transfer of electrons to heme group and O2 of oxygenase domain. For 
generation of one mole of NO from NOS, one mole of O2 and 1.5 NADPH molecules are 
required (Nathan & Xie, 1994) (Stuehr et al, 1991).  
Constitutively expressed, nNOS and eNOS are regulated by the intracellular concentration of 
calcium. They produce low levels of NO and are important for regulating vasorelaxation, cell 
growth and proliferation processes (Figure 1.6). In contrast, iNOS has been attributed to the 
production of high amounts of NO in response to stress and injury. Burst of NO induced by the 
iNOS (Figure 1.6) has been implicated to pathways relating to the cell cycle and apoptosis. 
NO reacts with O2 to form NO2
- in aqueous solution in the presence of oxygen. As NO reacts 
rapidly with metal centres to form Fe-nitrosyl complexes and superoxide radical (O2
-) (Figure 
1.6), the observed half life of the molecule in biological samples is only 3-5 seconds (Ignarro, 
1990).  Rapid reaction of NO with iron-containing proteins is one of the most prevalent 
interactions in the mammalian cells. The predominant oxidation product of NO is NO3
- owing 
to the reaction of NO with metal-oxygen complexes (e.g. formation of met-haemoglobin and 
NO3
- after reaction of NO with oxyhaemoglobin) (Ignarro et al, 1993). 
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Higher oxides of NO such as N2O3 react with thiol of cysteine protein to form SNO (Figure 
1.5 A). The process is termed as S-nitrosylation. It is very important to note the selective nature 
of S-nitrosylation given that only some cysteine containing proteins are s-nitrosylated where 
the others are not. The generic structure SNO is R-S-N=O and the bond is a covalent one.  In 
biological conditions, the kinetics of three main reactions can govern the formation and 
decomposition of RSNO: denitrosylation, transnitrosylation and thiolation (shown in Figure 
1.5).  Given that S-N bond dissociation energy is not favourable for the homolytic 
decomposition of RSNO (Bartberger et al, 2001), reversible reductive and enzymatic 
mechanisms are likely to be of more importance in SNO homeostasis.  The denitrosylation 
reaction involves the release of NO from SNOs. Temperature, light, metal ions such as iron, 
copper and other metal ion containing proteins can reduce RSNO by releasing NO (Lipton et 
al, 1998; Stamler et al, 1997b). Several enzymes such as GSNO reductase, thioredoxins are 
also capable of releasing NO from the RSNOs (Liu et al, 2004; Sengupta et al, 2007). 
Transnitrosylative reactions involve the transfer of NO from one thiol group of a SNO to 
another thiol group and the process is reversible (Figure 1.5 B). Biochemistry of 
transnitrosylation has received much attention due its role in the regulation of cell signalling 
pathways (Seth & Stamler, 2010). This reaction results in the formation of another SNO and 
thereby provides a mechanism for auto S-nitrosylation mediated posttranslational protein 
modification. Nucleophillic interaction of sulphur (thiol) on RSNO results in the production of 
a nitroxyl and disulphide anion and the reaction is termed as S-thiolation (Figure 1.5 D) (Hogg, 
2002).  Given the formation of strong disulphide bonds, S-thiolated modifications provide more 
stability compared to transnitrosylation.  It is postulated that SNO can act as NO, NO.and NO+ 
donor under physiological condition. However, the mechanism and mode of transfer or release 
of NO from SNO is debatable and often controversial (Tannenbaum & White, 2006). 
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Figure 1.5 Mechanisms of NO, SNO production and decomposition. 
A) NOS catalysed NO production from arginine leads to the production of higher NO oxides. 
N2O3 can induce S-nitrosylation reaction. B) Transnitrosylation involves the transfer of NO 
group from one SNO group to another. C) NO release reaction results in the liberation of NO 
and is governed by a reducing agent such as Copper (Cu) D) Thiolation is the nucleophilic 
interaction of thiols with NO of SNO-proteins. E) Light mediated photolysis of SNO results in 
the production of free radical NO. 
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Figure 1.6 Reaction and impact of NO at various concentrations in biology. 
At physiological concentrations (nM) (generated by eNOS/nNOS activity), NO reacts with 
heme proteins such as oxyhaemoglobin/haemoglobins, (HbO2/Hb), soluble guanylate cyclase 
(sGC) and cytochrome c oxidase (CcOx) which affect important processes such as 
vasorelaxation, neurotransmission, respiration. In the presence of high concentrations (µM) of 
NO (as encountered following the iNOS activity) in pathophysiological conditions, it reacts 
with superoxide anion radical (O2
-) and iron sulphur clusters [FeS] to exert biological effects 
such as immune response, respiration, apoptosis. Adapted from (Toledo & Augusto, 2012).  
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1.10 S-nitrosohaemoglobin: an important protein in vasodilation 
Haemoglobin is the tetrameric protein component of the RBC that transports oxygen (O2) from 
lungs to tissue. S-nitrosohaemoglobin (SNO-Hb) has been implicated directly in the SNO 
mediated hypoxic vasodilation (Stamler et al, 1997a). In oxygenated conditions, haemoglobin 
tetramer is endogenously s-nitrosylated by FeNO of haemoglobin at the cysβ93 position.  The 
oxygenated structure of Hb is termed as ‘R’ (relaxed, high O2 affinity). Following 
deoxygenation of haemoglobin, the NO group from SNO-Hb is released along with O2 
resulting in bioactive NO signal transduction leading to vasodilation. The deoxygenated Hb is 
termed as ‘T’ (tensed, low O2 affinity). Therefore after allosteric transition from R to T state, 
SNO-Hb from RBCs can transport NO to the compartments of low PO2 to increase O2 delivery 
coupled with NO dispension at microvascular sites (Allen & Piantadosi, 2006; Jia et al, 1996). 
S-nitrosylation driven allosteric regulation of haemoglobin has been validated by different 
biochemical methods such as photolysis, mass spectrometry and chemiluminescence (Jia et al., 
1996, Gow et al., 1998 and Lipton et al., 2001). However, Schimdt and co-workers (1996) 
argued against the principle of FeNO-SNO transfer in SNO-Hb where they used a triiodide 
based chemiluminescence for measuring SNO-Hb following cyanide pre-treatment (Schmidt 
et al, 1996). In another analysis Gaston et al (2003) questioned the credibility of technique 
pointing out that tri iodide based chemiluminescence is not suitable for SNO mediated 
allosteric regulation analysis. Given the redox based complexity of haemoglobin protein, the 
role of SNO-Hb in vascular regulation still remains a fertile area of research.   
1.11 Biological roles of NO 
1.11.1 NO as EDRF 
Soluble guanyl cyclase is the natural receptor for NO and only a small concentration of NO (5-
10 nM) can activate the enzyme. It is mainly found in two major isoforms, α1β1 and α2β1. The 
latter isoform is found in brain whereas α1β1 has a wider distribution across different tissues 
(Friebe & Koesling, 2003). Despite difference in spatial expression, there is no difference in 
their catalytic activity, substrate affinity for NO binding. Although homodimers (α1α1 and β1β1) 
of sGC has been identified, they are functionally inactive (Zabel et al, 1999). Therefore, only 
heterodimers can catalyse the formation of cGMP from GTP. The subunits are divided into 
three domains: a C terminal catalytic domain, a middle part and an N-terminal region. It’s the 
N-terminal region that harbours the prosthetic heme group. Presence of this heme group is 
mandatory for the activation of enzyme by NO. A histidine residue at His-105 position acts as 
the proximal ligand by binding with the heme. This is pivotal for the NO mediated activation 
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of the sGC as deletion of his-105 results in abrogation of NO induced activation. (Wedel et al, 
1994). The NO sensitive heme of sGC exhibits an absorbance maximum at 431 nm. This 
indicates the presence of a five coordinated ferrous heme group with a histidine acting as axial 
ligand at the fifth coordinating position (Stone & Marletta, 1994). NO binds to the sixth 
coordinating and form a NO-Fe2+- His complex. Subsequent breakdown of Fe2+- His complex 
results in formation of a five coordinated heme-nitrosyl complex with the following reaction 
of NO with heme. 
Fe (II) + NO → Fe (II) - NO 
The above cascade of events initiate a conformational change in the structure of sGC enzyme, 
thereby increasing the conversion of GTP to cGMP by approximately 200 fold (Humbert et al, 
1990). Studies from Marletta group has shown that sGCs belongs to a recently identified group 
of proteins termed as ‘heme nitric oxide/ oxygen binding protein’ (H-NOX) found in both 
prokaryotes and eukaryotes (Olea et al, 2010). The H-NOX domain of sGC is only selective 
for NO. Structural studies of prokaryotic O2 binding H-NOX domain have shown that the 
presence of a hydrogen bonding network in the distal pocket is essential for stable binding to 
O2. Sequential mutagenesis of distal pocket amino acids demonstrated that single tyrosine is 
required for O2 binding  and hydrogen bond formation (Boon et al, 2005). However, the 
mammalian sGCs lack such a tyrosine in its heme pocket, eliminating O2 as a ligand for heme. 
Thus in aerobic environment, sGCs can selectively use NO as a ligand to produce cGMP and 
regulate important biological processes such as vasorelaxation. cGMP stimulates a cGMP-
dependent protein kinase that activates myosin light chain phosphatase, the enzyme that 
dephosphorylates myosin light chains resulting in smooth muscle relaxation. 
1.11.2 NO in infection and as an antimicrobial agent 
Since NO entered the immunology field in the late 1980s, scientists have been perplexed by 
the dual role of the molecule in both inhibiting and stimulating immune response. It is produced 
by a large number of immune cells such as macrophages, T cells, B cells, natural Killer cells. 
There have been contradictory reports on the levels of iNOS expression in human macrophages 
(Bogdan, 2001; Schneemann & Schoedon, 2002). When measured by chemiluminescence in 
our laboratory, the amount of NO detected from MDM is low and it is subsequently converted 
to nitrite (Stevanin et al, 2005). However other studies have demonstrated the presence of iNOS 
protein and mRNA expression, from human macrophages (Fang, 1997; Weinberg et al, 1995). 
Presence of NO in MDM was also confirmed by the increased 4-amino-5-methylamino-2’7’-
 Bacterial nitric oxide metabolism in the pathogenesis of meningococcal sepsis 
41 
 
difluorofluorescein (DAF-FM) after infection with N. meningitidis (Tunbridge et al, 2006). 
Contrary to previous view that iNOS is the key mediator in immune response, other constitutive 
NOS such as nNOS, eNOS have been found to be produced by the immune cells during 
infection (Bogdan, 2001). The diffusible nature of NO means it can exert immune response 
away from its origin. Redox environment and other stimuli can also trigger NO generation in 
immune cells independent of the NOS mediated pathway. NO harbouring molecules such as 
low molecular weight SNO (GSNO) can act as long distance NO carriers (Gaston et al, 2003).  
NO can be liberated from GSNO spontaneously or following cleavage by ectoenzyme gamma-
glutamyl transpeptidase (GGT) present on the human T and B lymphocytes (Henson et al, 
1999). In acidic conditions present in phagocytes, stable product of NOS activity, NO2
- can be 
converted to NO. Hemeproteins such as cytochrome P450, peroxidases can oxidise N-hydroxy-
L-arginine present in the cells to citrulline and NO (Wu & Morris, 1998).  
NO at high concentration as such encountered in an infection situation is normally cytotoxic 
or inhibitory for microbes (De Groote & Fang, 1995). However, the extent of antimicrobial 
action depends on multiple factors such as spatiotemporal generation of NO, sensitivity of the 
organism to NO, ability to detoxify NO by organism. Molecular targets affected by NO include 
DNA, proteins and lipids. NO can reversibly inhibit cytochrome c oxidase, the terminal enzyme 
of mitochondrial respiratory chain, leading to the inhibition of cellular respiration (Cleeter et 
al, 1994). Zinc is an essential element of living organism and also a vital component of proteins 
such as NOS. In addition it helps to stabilise the protein structures. NO can displace zinc from 
the metallothionein of E.coli (Binet et al, 2002) and mobilise the zinc in Salmonella enterica 
(Schapiro et al, 2003). Most of the antimicrobial effects of NO result not from the direct effect 
of NO but by the activity of reactive nitrogen intermediates formed by the NO oxidation 
products.  Such examples include formation of peroxynitrite (OONO-) and SNO. Peroxynitrite 
(OONO-) is formed when NO rapidly reacts with the superoxide (O2
-). They are very reactive 
compounds which can interact with a variety of biological of targets. Peroxynitrite affects 
transcription after reacting with the DNA sugar phosphate backbone, cell membrane 
degradation after reacting with lipid, and cause cysteine oxidation and tyrosine nitration after 
reacting with the metal-centres and amino acid residues (Pacher et al, 2007). In aerobic 
condition, NO can deaminate DNA via the intermediate of SNO production N2O3 (Wink et al, 
1991) (Figure 1.5A). NO derived reactive nitrogen species inhibit essential microbial enzymes 
such as ribonucleotide reductase and aconitase by reacting with the iron group present in these 
enzymes (Burgner et al, 1999).  NO can exert lethal effects on microbes indirectly by its 
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immunomodulatory actions such as T-cell activation/inhibition, cytokine regulation, 
autoimmune response (McInnes & Liew, 2002). 
During sepsis high levels of NO from iNOS may contribute to hypotension and inflammatory 
tissue damage (Kilbourn et al, 1997). Indeed, decreased mortality and microvascular reactivity 
has been observed in iNOS deficient animal model or conditions where iNOS activity has been 
inhibited by commercial inhibitor or scavengers (Hollenberg et al, 2000; Kim & Greenburg, 
2002). In contrast, other groups have reported contradictory findings using similar approaches 
where a reduced iNOS activity resulted in unaltered or increased mortality in sepsis (Laubach 
et al, 1995; Lopez et al, 2004).  Therefore NO may play both detrimental and protective role 
during the course of sepsis. This implies any NO mediated observation in sepsis has to be 
interpreted from the context the experimental system used. 
1.12 Respiratory pathway of Neisseria meningitidis 
N. meningitidis is typically considered as an obligate aerobe. It utilises oxygen as the terminal 
electron acceptor. It is incapable of anaerobic growth which could be due to the possession of 
only the aerobic (class I) ribonucleotide reductase (Rock et al, 2005). It can grow 
microaerobically using the partial denitrification pathway (Anjum et al, 2002). This would 
make evolutionary sense as the only natural habitat of the organism, nasopharynx is oxygen 
poor but rich in NO (Lundberg et al, 1994; Lundberg & Weitzberg, 1999). Routine isolation 
of both aerobic and anaerobic bacteria further strengthens this argument (Brook, 2003).  
Denitrification is the step-wise reduction of nitrate (NO3
-) to dinitrogen (N2) gas. Conversion 
from NO3
- to N2 is split into four reactions, each catalysed by a specific metalloenzyme 
complex (Figure 1.7 A) (Tavares et al, 2006). Firstly NO3
- is converted to NO2
- catalysed by 
nitrate reductase. Subsequently NO2
- is reduced to NO by nitrite reductase. NO is converted to 
N2O by nitric oxide reductase and lastly nitrous oxide reductase converts N2O to N2. In 
denitrifying bacteria, denitrification pathway is linked to the respiratory chain. NO oxide 
substrates at each step serve as alternative sink for electrons and support bacterial growth by 
coupling with oxidative respiration (Zumft, 1997). In vivo, NO2
- is produced both by the 
activity of the nitrate reducing bacteria present in mouth, pharynx and also by oxidation of NO 
which is used as a signalling molecule (Lundberg et al, 2004; Rock et al, 2005).  
Unlike other full denitrifiers such as Paracoccus denitrificans, Pseudomonas aeruginosa, 
Ralstonia metallidaruns etc, N. meningitidis is classified as a partial denitrifier as it contains 
only two genes of the whole denitrification pathway (Figure 1.7 A). Whole genome sequence 
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of N. meningitidis has revealed the presence of two divergently transcribed genes coding for 
aniA, a copper containing nitrite reductase (Section 1.13.1), and norB, a nitric oxide reductase 
(Section 1.13.2) (Tettelin et al, 2000). These two genes are separated by having an intergenic 
region of 370 bp and are subject to complex regulation by multiple transcriptional activators, 
repressors (Figure 1.8).   
Homologues for respiratory complexes I, II and II are found in N. meningitidis. Therefore, 
electrons could enter the respiratory chain through a proton translocating NADH 
dehydrogenase or a succinate dehydrogenase. Subsequently these electrons could be 
transferred to the cytochrome bc1 complex by ubiquinone (Figure 1.7 B) (Rock & Moir, 2005). 
It is to be noted that N. meningitidis possess only one terminal reductase capable of utilising 
oxygen. The reductase is known as cytochrome cbb3 oxidase and was first identified in 
Bradyrhizobium japonicum. It is a membrane bound heme copper oxidase (Preisig et al, 1996). 
It has high affinity for oxygen and is involved with oxygen limited conditions (Pitcher & 
Watmough, 2004). This property enables N. meningitidis to adapt to microaerobic condition. 
However, meningococcal cbb3 active site can bind to both O2 and NO. This implies that during 
the denitrification process, the oxidase can be competitively inhibited by the generation of NO, 
intermediate product of denitrification. In presence of high NO and O2 concentrations, these 
two compounds can react to form peroxynitrite which can damage the cbb3 (Brown & Cooper, 
1994; Sharpe & Cooper, 1998).  
Respiration by oxygen reduction is preferable over nitrite as the redox potential of O2/H2O 
(+820 mV) is higher than that of NO2
-/NO (+348 mV) (Conrad, 1990). So, O2 has higher 
affinity for electron over NO2
-. In addition, higher energy is liberated by proton translocation 
by the flow of electrons towards oxidase physiologically in comparison to the reduction of 
NO2
-. The translocated protons are used for generating ATP for the organism. Hence both in 
presence of O2 and NO2
-, reduction of O2 is preferable in most of the cases due to the generation 
of more energy in the form of ATP. NADH is the major source of electrons for both the O2 and 
NO2
- mediated respiratory pathways. Ubiquinone is reduced to ubiquinol in quinone pool 
present in the inner membrane by receiving electrons from NADH. NorB enzyme or bc1 
complex directly oxidises ubiquinol by receiving electron and reducing NO to N2O in the 
process. A number of intermediate cytochromes transfer electrons from bc1 complex terminal 
oxidases to AniA and cbb3 (Figure 1.7 B).   
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Figure 1.7 Denitrification pathway and meningococcal respiratory chain 
A) Denitrification pathway- Gradual reduction of NO3
- to N2 where each step is catalysed by 
a denitrification enzyme. The enzymes encoded by N. meningitidis are highlighted in red. B) 
A cartoon summarising the respiratory chain of N. meningitidis- Respiratory substrates 
(NO2
-, NO, O2) are indicated in blue, corresponding thick blue arrays link them to the 
corresponding reducing enzymes in green gradient (AniA, NorB and cbb3). Electron 
transporters are highlighted in light orange gradient and electron flow is depicted by black 
arrows.  
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1.13 Essential enzymes and proteins of meningococcal respiratory pathway 
1.13.1 AniA (Nitrite reductase) 
AniA was identified as Pan1 (54 kDa), major protein expressed by N. gonorrhoeae in anaerobic 
conditions. The terminal electron acceptor supporting anaerobic growth was identified as nitrite 
in gonococcus (Knapp & Clark, 1984). Later using specific antibody, presence of Pan1 was 
confirmed in the patients suffering from gonorrhoea (Clark et al, 1987) and similar proteins 
were found in other Neisseria spp such as in N. meningitidis (Hoehn & Clark, 1990). Pan1 was 
renamed as AniA (anaerobically induced protein A) after cloning and sequencing (Hoehn & 
Clark, 1992a). Study by the same group also confirmed it as an outer membrane protein by 
identifying it as a lipoprotein (Hoehn & Clark, 1992b). Bacterial nitrite reductase can be of two 
types which are distinguishable by their prosthetic groups: the copper containing nitrite 
reductases (CuNIR) and the cytochrome cd1-type reductases containing two haem groups. Low 
level similarity of AniA to that of copper containing nitrite reductase was first reported in 1995 
(Berks et al, 1995). AniA was confirmed as the copper containing inducible nitrite reductase 
when an insertional mutation in the aniA gene rendered the anaerobic growth of gonococcus 
severely impaired (Mellies et al, 1997). Importance of aniA as gonococcal virulence factor was 
further realised when a study showed that overexpression of aniA can afford protection against 
the killing following exposure to human serum (Cardinale & Clark, 2000).  Crystal structure 
and sequence comparison of nitrite reductases from 15 other bacteria have revealed that AniA 
is a class II CuNIR sharing 45% sequence identity with the nitrite reductase from the 
archaebacterium Haloarcula marismortui (Boulanger & Murphy, 2002). Meningococcal AniA 
is coded by NMB1623 and is 1173 bp in length. It has been shown to be important for the 
bacterial growth in oxygen limited conditions (Rock & Moir, 2005). It can accept electrons 
from the c type cytochrome (C5) (Figure 1.7 B) (Deeudom et al, 2008). However studies from 
different groups have confirmed the presence of mutation in the catalytic domain of 
meningococcal aniA whereas it is conserved in other Neisseria spp. A study conducted by Barth 
and colleagues reported that 13 of 41 (32%) sequenced meningococcal genome contains a 
frameshift mutation in the aniA region and  the strain 053442 lacks aniA completely suggesting 
that the strain would be unable to perform denitrification (Barth et al, 2009). In addition, in N. 
gonorrhoeae and other related Neisseria spp., AniA can receive electrons from C5 and via a 
second route via the CcoP domain of cytochrome cbb3. However, AniA of N. meningitidis only 
receives electrons from cytochrome C5 as one of the CcoP domains is non functional due to a 
single nucleotide polymorphism (Aspholm et al, 2010). This is a meningococci specific 
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adaptation. All these strains retain functional norB (Section 1.13.2) providing the organism 
protection from the toxic effects of NO. Therefore, it has been suggested that N. meningitidis 
could be evolving towards becoming a NO tolerant aerobe from being a denitrifier (Moir, 
2011).  
AniA (reduced) + NO2- + 2H+ → AniA (oxidised) + NO + H2O 
1.13.2 NorB (Nitric oxide reductase) 
NO reductases (NOR) are of three types, the cNOR (cytochrome bc type complex), qNOR     
(the cytochrome b type complex lacking the cytochrome c component) and a qNOR-type 
reductase that also includes CuA (qCuANOR). cNOR type reductases accept electrons from 
soluble protein donors and qNOR receives electrons from quinol. Identification of nitrous oxide 
as the end product of anaerobic respiration on nitrite (Lissenden et al, 2000) led to the 
identification of qNOR in N. gonorrhoeae (Householder et al, 2000). The NOR in N. 
meningitidis is a qNOR-type reductase which is encoded by NMB1622 (Wasser et al, 2002). 
The first Neisserial 84.3 kDa NorB was identified in N. gonorrhoeae and it shares high 
sequence identity with the soil bacterium Ralstonia eutropha (Householder et al, 2000). It 
catalyses the conversion of NO to N2O by receiving electron from the quinone pool (Figure 
1.7 B). Accumulation of high concentration of NO as a result of NO2
- reduction by AniA has 
bactericidal activity as it inhibits aerobic respiration by binding to the cbb3 oxidase 
competitively. Therefore, this enzyme is critical for bacterial growth during microaerobic 
condition. It is highly conserved across all Neisseria species. Activity of NorB is 2.5 to 3 times 
higher in N. meningitidis (240-256 nmol NO reduced per minute per OD600 unit) compared to 
N. gonorrhoeae (88-155 nmol NO reduced per minute per OD600 unit) (Barth et al, 2009). It 
has been shown to be important for the survival of the organism inside human MDMs and 
nasopharyngeal mucosa (Stevanin et al, 2005). Furthermore, it is also essential for regulation 
of apoptosis (Tunbridge et al, 2006) and cytokine and chemokine response of human MDMs 
(Stevanin et al, 2007). 
NorB (reduced) + NO + 2H+ → NorB (oxidised) + N2O + H2O 
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1.13.3 NsrR (Nitrite sensing repressor protein) 
NsrR (Nitrite sensing repressor protein) is an NO sensing Rrf2 type transcriptional repressor 
protein. It was first discovered in Nitrosomonas europaea (Beaumont et al, 2004). Since then 
it  has been shown to be a mediator of expression of NO metabolising genes in different 
bacterial species such as E. coli (Bodenmiller & Spiro, 2006), Salmonella (Gilberthorpe et al, 
2007) , N. gonorrhoeae (Overton et al, 2006) and N. meningitidis (Heurlier et al, 2008; Rock 
et al, 2007) etc. The protein sequence is well conserved across all Neisseria spp (Barth et al, 
2009). Both N. gonorrhoeae and N. meningitidis use NsrR as a negative regulator of aniA and 
norB transcription (Overton et al, 2006; Rock et al, 2007). Binding site of NsrR is located 60 
bp upstream of the aniA promoter. Three conserved cysteine residues in NsrR are responsible 
for sensing NO by coordinating with [2Fe- 2S] cluster (Isabella et al, 2008). These residues are 
conserved in all the Neisseria species (Barth et al, 2009). E.coli has a large NsrR regulon where 
it regulates the expression of 39 genes (Filenko et al, 2007). In contrast, NsrR regulon is small 
in N. meningitidis where it regulates the expression of only 5 genes (aniA, norB, nirV, dnrN, 
mobA) (Heurlier et al, 2008). dnrN encodes for a protein involved in the repair of nitrosative 
damage to iron-sulfur clusters) and nirV (a putative nitrite reductase assembly protein). 
1.13.4 FNR- (Fumarate and nitrite reductase regulator)   
Expression of aniA is primarily mediated by O2 sensing FNR protein. FNR is a transcriptional 
activator and homologue of the fumarate and nitrate reductase repressor protein. It was first 
discovered in E. coli (Lambden & Guest, 1976) and is a member of FNR-CRP superfamily of 
transcriptional regulators (Korner et al, 2003).  
Structural prediction of FNR in comparison with similar transcriptional regulator such as CRP 
of E. coli (Weber & Steitz, 1987) reveal that it can be divided into three regions depending on 
the function; a C-terminal DNA binding domain, a helix responsible for facilitating the 
dimerization of the FNR monomer and an N-terminal domain harbouring an iron-sulphur (FeS) 
centre for oxygen sensing. The FeS centre is found as [4Fe – 4S] in anoxic condition but 
converted to [2Fe-2S] upon exposure to oxygen (Barth et al, 2009).  
FNR is termed as the master regulator of aniA expression. By binding directly with O2, FNR 
regulates the expression of nine transcriptional units in N. meningitidis (Bartolini et al, 2006). 
In closely related pathogen, N. gonorrhoeae it regulates the expression of fourteen genes but 
downregulate six genes (Whitehead et al, 2007). FNR regulated genes are involved in 
anaerobic respiration and carbon metabolism. Both in gonococcus and meningococci, FNR is 
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pivotal for AniA activity as evidenced by diminished NO2
- reduction by fnr mutants (Lissenden 
et al, 2000; Rock et al, 2005; Rock et al, 2007).   
In addition, N. meningitidis serogroup B fnr mutant strains are attenuated in mouse and rat 
models (Bartolini et al, 2006). Although normally regarded as an oxygen sensitive regulator of 
aniA, it can also be regulated by NO (Heurlier et al, 2008).  The [4Fe-4S]2+ cluster of FNR 
reacts with NO to form dinitrosyl-iron complexes (DNICs) which reduces the affinity of FNR 
to bind its DNA sequence (Cruz-Ramos et al, 2002). Unlike other facultative anaerobe such as 
E. coli, meningococcal FNR retains substantial DNA binding activity even under aerobic 
condition due to the absence of an anaerobic ribonucleotide reductase (Rock et al, 2007). 
Therefore FNR allows limited transcription of promoters it regulates such as aniA under 
aerobic condition (Heurlier et al, 2008). Paradoxically aniA can be expressed even in the 
presence of 70%-80% oxygen saturation when no NsrR is present. This implies that 
meningococcal FNR is insensitive to oxygen when compared with FNR from E. coli. In 
addition, binding to its cognate DNA also makes the protein less sensitive to oxygen (Edwards 
et al, 2010).  
1.13.5 NarQ/NarP- Nitrite response sensor/regulator 
The first NarQ-NarP regulator was discovered in E.coli (Stewart & Parales, 1988). The two 
component signal transduction pathway is responsible for regulating the expression of aniA in 
Neisseria. NarP is a cytoplasmic protein but NarQ is located at the inner membrane. As a part 
of the two component system, it regulates the expression of target genes when the sensor 
phosphorylates the regulator. In N. gonorrhoeae, NarP increases the expression of aniA 
(Overton et al, 2006). Both oxygen and nitrite availability induces aniA activity in N. 
meningitidis (Rock et al, 2005). Despite the presence of NarQ/NarP, FNR is an absolute 
requirement for the activity of aniA in meningococci (Rock et al, 2005). Therefore, increased 
nitrite reduction activity of N. meningitidis is only commenced after when there is a low 
concentration of oxygen and a high concentration of nitrite. 
1.14 Regulation of transcriptional control of meningococcal partial 
denitrification pathway  
The transition from aerobic to microaerobic growth in N. meningitidis is sophisticated and 
regulated by a variety of genes, stimuli and transcription factors (summarised in Figure 1.8). 
Both aniA and norB are divergently transcribed from promoters sharing a common intergenic 
region which has putative binding sites for NsrR, AsrR, Fur, NarP and FNR.  Amount of 
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available NO in the environment is one of the main determinants of expression of 
denitrification genes. Both constitutive and inducible NO responsive systems are operated by 
meningococci to protect the cells from nitrosative damage and continue denitrification to 
support growth. Cytochrome c’ (CycP) is the part of constitutive NO detoxification system. In 
photosynthetic denitrifying bacterium Rhodobacter capsulatus it provides protection against 
NO in aerobic and microaerobic condition but is not involved in denitrification pathway (Cross 
et al, 2000; Cross et al, 2001). Likewise meningococcal CycP can bind to NO (Huston et al, 
2005) and can presumably offer some protection against NO mediated toxicity prior to a burst 
of NO (Anjum et al, 2002). Similar regulation operates in the closely related organism N. 
gonnorhoeae where CycP protects the organism against NO during transition to denitrification, 
a time before the accumulation of high NO for norB activity (Turner et al, 2005). In low NO 
concentration (< 1µM), limited aniA is expressed by the oxygen tolerant FNR (Section 1.13.4). 
NsrR repressor (Section 1.13.3) is still bound to the operon at this stage. In environment such 
as a lack of oxygen and in the presence of NO2
-, aniA activity is increased to enable the bacteria 
to utilise NO2
- as the respiratory substrate to supplement its growth. Conversion from NO2
- to 
NO results in an accumulation of NO. As NO concentration increases to a high level (~1 µM), 
NsrR is inactivated. Repression of NsrR regulon is relieved as it comes off the DNA.  This 
enables the transcription of genes from norB and dnrN promoters and also increases activity of 
aniA promoter. Meningococcal dnrN is homologous to YftE protein in E. coli where it is 
essential for maintaining and repairing the iron-sulphur cluster upon exposure to NO (Justino 
et al, 2007). Regulation of dnrN by nsrR would indicate that dnrN helps to maintain iron-
sulphur clusters in proteins such as FNR and thereby eliminating the need to synthesise new 
FNR proteins in nitrosative stress conditions. So, in response to high NO, denitrification 
increases to support bacterial growth and NO detoxification helps to protect bacteria from the 
NO mediated toxicity arising from the exposure to high NO concentration (Section 1.11.2). 
This kind of regulation has significant implication for the adaptability of organism to 
nasopharynx as constitutively high levels of NO is detected from human nasopharynx 
(Andersson et al, 2002; Lundberg et al, 1995). NO produced from the immune cells such as 
macrophages can also contribute to the pool of NO present in nasopharynx. Therefore, the NsrR 
regulon could be switched on at all times in nasopharyngeal environment due to high 
physiological concentration of NO.  
When NO concentration increases further (>1 µM), NO binds to [4Fe-4S]2+ cluster of FNR and 
forms dinitrosyl-iron-cysteine complex (DNIC) (Cruz-Ramos et al, 2002). Consequently FNR 
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is inactivated due to its reduced affinity for DNA from aniA promoter region and aniA 
transcription is completely diminished. However, norB and dnrN expression still remain high 
due to the nsrR inactivation. Reduced aniA expression and continued high norB, dnrN prevent 
the NO mediated toxicity by preventing accumulation of intermediate NO and continued NO 
detoxification. In response to varying concentration of NO, sensitivity of FNR and NsrR to NO 
helps to spatiotemporally regulate the optimal expression of denitrification/detoxification 
genes to support bacterial growth as well as to allow NO detoxification.  
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Figure 1.8 Sophisticated environmental and transcriptional regulation of denitrification 
pathway of N. meningitidis. 
Different stimuli, transcription factors, enzymes regulating the truncated denitrification 
pathway of N. meningitidis are shown.  (For further description of the components the reader 
is referred to section 1.13- 1.14) 
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1.15 Importance of meningococcal NO metabolism on host-pathogen 
interactions 
While studying any infectious disease, it is important to consider both host and pathogen 
holistically. Sophisticated interaction between invading microbe and host determine the 
progression and outcome of the disease. This is more applicable in the case of N. meningitidis 
which is normally a harmless commensal in 10% -35 % of the adults. When the interplay 
between host and commensal is disrupted by various factors, commensal can go on to become 
a pathogen. N. meningitidis has developed a set of exquisite mechanisms such as LOS, capsule, 
adhesins, factor H binding protein to evade the immune response and cause systemic infection. 
It still remains a paradox that why such a commensal would develop a range of mechanisms to 
trigger hyperimmune response as it would represent an evolutionary dead end for this 
accidental pathogen. 
By conducting a number of studies our group has shown the importance of NO detoxification 
pathway of N. meningitidis as a virulence factor. NorB and to a lesser extent CycP are essential 
for the survival of N. meningitidis inside human MDM and organ culture of human 
nasopharyngeal mucosa. The effect was diminished when iNOS was inhibited by L-arginine 
analogue, (L-NMMA), N (G)-monomethyl- L-arginine (Stevanin et al, 2005). Therefore, N. 
meningitidis counteracts NO mediated toxicity in phagocytic cells such as MDM by expressing 
norB. Incubation of resting macrophage with an exogenous NO donor, SNAP (S-nitroso-N-
acetylpenicillamine) alters the cytokine and chemokine profile (Stevanin et al, 2007). Same 
work showed that infection of MDM for 20 hours with ∆norB significantly increased the 
production of TNFα, IL-8, IL-10, IL-12 but lowered the production of CCL5 compared to Wt 
infected MDM. This implies bacterial NO detoxification can differentially modulate the 
cytokine profile of immune cells such as MDMs.   
Apoptosis is an important process initiated by the immune cells to kill the invading microbes. 
NO has dichotomous role in the regulation of apoptosis as it has both stimulatory and inhibitory 
effects on cell death. Infection of human MDM with either ∆norB or ∆cycP for 20 hours leads 
to a significant increase in the number of MDM undergoing apoptosis compared to Wt infection 
(Tunbridge et al, 2006). This would help the bacteria to survive longer inside the phagocytic 
cells in an infection situation. 
A study from our group has demonstrated that NO detoxification of N. meningitidis reduces 
the SNO formation in the murine macrophage cell line J774.2 (Laver et al, 2010).  Murine 
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macrophage cell lines were stimulated with LPS and IFNɣ for 18 hours to induce iNOS activity. 
NO detoxification machinery was able to reduce the formation of SNO by metabolising iNOS 
induced NO. Similar SNO depletion mechanism was observed with NO detoxifying 
flavohemoglobin (Hmp) gene mutants of Escherichia coli and Salmonella enterica. This would 
have far reaching consequences in the regulation of cellular processes as SNO is a tightly 
regulated signalling molecule. Therefore, any reduction in local SNO concentration by active 
bacterial NO metabolism as demonstrated by Laver and his colleagues has the potential to 
cause pathology in clinics. This work was particularly important for this thesis as it provided 
the foundation for Chapter 3 which investigated if the similar observation is noticed in vivo in 
a murine model of acute fulminant meningococcal sepsis.  
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1.16 Aims and Objectives 
This thesis set out to establish an animal model of early acute meningococcal sepsis in which 
we can measure NO metabolites in a reproducible manner. Subsequently, it will be exploited 
to examine if SNO depletion by the active NO detoxification of N. meningitidis in the murine 
J774.2 cell line (Laver et al, 2010) can be replicated in vivo (Chapter 3).  
To date we have used isogenic single mutants of meningococcal denitrification genes for 
studying the cellular pathology of sepsis. Since NO is subject to sophisticated redox based 
regulation in biology and meningococcal denitrification is a multifactorial process (Figure 1.8) 
defect in multiple genes could have profound impact on the cellular pathology of 
meningococcal sepsis. Therefore, it was decided to generate and characterise a panel of 
denitrification mutants (∆aniA/∆norB, ∆nsrR/∆norB, ∆aniA/∆norB/∆nsrR) which will serve as 
important tools in studying the contribution of meningococcal denitrification pathway to 
pathogenesis (Chapter 4). 
Differentiated human primary bronchial airway epithelial cell cultured at an air-liquid 
interphase (HPEC-ALI) is a differentiated and polarised epithelial layer forming tight junctions 
sharing similar characteristics with the nasopharyngeal epithelial cells. Meningococci have to 
interact with the nasopharyngeal epithelium during colonisation and pathogenesis. NO is 
present in high concentrations in the airway epithelium where it is an important regulator of 
many important processes such as barrier function and immune response of the airway 
epithelium. Therefore, we decided to investigate if meningococci could use its denitrification 
pathway to modulate barrier function and immune response of the HPEC-ALIs (Chapter 5).  
As nasopharynx is an NO rich habitat, meningococcal denitrification would be essential for the 
survival and successful colonisation of the organism in nasopharynx. Biofilm formation could 
be one of the strategies employed by the meningococci to colonise nasopharynx. In the closely 
related pathogen N. gonorrhoeae, the denitrification pathway plays an important role in biofilm 
formation both in vitro and in vivo. So it was decided to examine the role of meningococcal 
denitrification pathway on biofilm formation in vitro (Chapter 6).   
Details on the experimental rationale and methods are mentioned in each chapter.  
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2 Chapter 2: Materials and Methods  
2.1 Reagents 
2.1.1 Antifoaming agent FG-10 
Antifoaming agent FG-10 30x concentrate was supplied by Dow Corning. This was diluted 
with dH2O to a working concentration prior to usage. 
2.1.2 Complete, Mini EDTA-free protease inhibitor cocktail tablets 
Complete mini EDTA-free protease inhibitor tablets were purchased from Roche. 
2.1.3 Drabkin’s solution 
In 1000 ml of distilled water, 200 mg K3Fe
III (CN)6, 50 mg KCN (FW 65.12, Aldrich 
Chemicals), 140 mg (KH2PO4), 0.5 ml of Sterox SE were added to make Drabkin’s solution. 
2.1.4 Human holo transferrin (hHTF) 
Each bolus of injection into the mice where appropriate contained 8 mg of hHTF purchased 
from Sigma-Aldrich, UK. 
2.1.5 Polymerase chain reaction primers 
PCR primers were purchased from Eurofins and Sigma-Aldrich. After receiving the primers 
from the company they were briefly centrifuged and mixed with the specified amount of 
molecular biology water (as mentioned on the primer label) to give a final concentration of 100 
µM. Then they were diluted by 10 fold to have a final concentration of 10 µM and stored in 
the freezer for future applications.  
2.2 Buffers 
2.2.1 Phosphate buffered saline (PBS) at pH 7.4 
Phosphate buffered saline was produced in-house by the addition of 10 PBS tablets (Thermo 
Fisher Scientific, USA) to 1 L of dH2O.  Sterilisation of PBS in 500 ml aliquots were performed 
by autoclaving at 121°C for 15 minutes. The PBS contains NaCl (140 mM), Na2HPO4 (8.0 
mM), K2H2PO4 (1.5 mM) and KCl (2.7 mM), 50 mM Phosphate buffer + 1 mM 
Diethylenetriaminepentaacetic acid (DTPA) at pH 7.4.  
2.2.2 S-nitrosothiol compatible lysis buffer 
SNO compatible lysis buffer solution was prepared for processing the liver lysates.  Sixty three 
mg of N-ethylmaleimide (NEM) was mixed with 5 ml of 50 mM phosphate buffer + 1 mM 
DTPA, 12.5 µl of 0.5 mM Phenylmethanesulphonyl flouride (PMSF) and ½ tablet of protease 
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inhibitor cocktail tablet.  The solution was prepared by vortexing for 15 minutes in a light 
protected tube.  For ensuring maximum efficacy, the buffer had to be prepared prior to the 
experiment and stored in the dark, on ice along the experimental procedures. 
2.2.3 50 mM Phosphate buffer + 1 mM DTPA, pH 7.4 
For preparing GSNO standards, 50 mM phosphate buffer was prepared. 3.87 ml of 1 M 
Na2HPO4 and 1.13 ml of 1 M NaH2PO4, 39.3 mg of DTPA were topped up with 100 ml of 
dH2O and pH of the solution was adjusted to 7.4. 
2.3 Solutions  
2.3.1 100 mM Sulphanilamide in 2 N HCl 
A total of 1.722 g of sulphanilamide was added to 100 ml of 2 N HCl to produce 100 mM 
sulphanilamide and stored at 4°C for later usage. 
2.3.2 50 mM Mercury (II) chloride (HgCl2) 
Produced by dissolving 1.358 g of Mercury chloride in 100 ml of dH2O. 
2.3.3 Hanks Balanced Salt Solution (HBSS) without Ca2+ or Mg2+  
(Life Technologies Cat No: 14170-138) 
 
2.3.4 Tri-iodide (I3-) reaction mixture  
For each chemiluminescence experiment, fresh tri-iodide mixture was prepared in a light 
protected conical flask.  525 mg Potassium Iodide (KI), 336 mg dry Iodin (I2)  were dissolved 
in 21 ml dH2O and 73.5 ml glacial acetic acid.  The solution was mixed at least for 20 minutes 
by using a magnetic stirrer and stirring plate.  The dark brown coloured final solution can be 
stored for 24 hours at room temperature without the loss of reactivity.  
2.3.5 Preparation of S-nitrosoglutathione (GSNO) 
In a small beaker containing 4 ml of ice-cold H2O, 0.76 g of L-glutathione was added and 
mixed using a magnetic stirrer.  Then 1.25 ml of ice-cold 2 N HCl was added with a 
concentration of NaNO2 between 0.17 g and 0.2 g. The subsequent colour of the mixture was 
pink.  The whole apparatus was stirred for 40 minutes in the cold room at 4°C.  10 ml of ice-
cold acetone was added and the mixture was stirred further for 10 minutes to precipitate S-
nitrosoglutathione (GSNO).  Pink solid GSNO was separated using a vacuum flask and filter 
paper.  The GSNO was washed with 10 ml of ice-cold acetone for the second time to precipitate 
any remaining GSNO.  The freshly prepared GSNO on filter paper was placed in a light 
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shielding vacuum desiccator.  Small quantities of GSNO were stored at -80°C in the light 
shielded microcentrifuge tubes following the overnight desiccation period. 
2.3.6 RF1 solution for competent cell 
For preparing 100 ml of RF1, 100 mM KCl (0.745 g), 50 mM MnCl2.4H2O (0.98g), 30 mM 
K- acetate (0.29g), 10 mM CaCl2.2H2O (0.246g), 15% (m/v) Glycerol were mixed and topped 
up to 100 ml sterile Milli-Q H2O. Final pH of the solution was adjusted to 5.8 with acetic acid. 
Then the solution was used after filter sterilisation. 
2.3.7 RF2 solution for competent cell 
RF2 solution was prepared by adding 10 mM MOPS (50 mg), 10 mM KCl (15 mg), 75 mM 
CaCl2.2H2O (369 mg), 15% (w/v) glycerol (3 g). pH was adjusted to 6.8 with NaOH. The final 
solution was filter sterilised before final use.  
2.3.8 Spermine NONOate 
Spermine NONOate was purchased from AG Scientific Inc., San Diego, CA. Concentration of 
50 mM was prepared by suspending the compound in 0.01 M NaOH. Working concentration 
of 50 µM was used prepared by making 1 in 1000 dilution. The compound has a half-life of 39 
minutes at 37°C at neutral pH.   
 
2.4 Bacterial Culture Techniques 
2.4.1 Columbia Blood Agar 
Columbia blood agar supplemented with horse blood was purchased from Oxoid, UK. 
2.4.2 GC Agar 
GC Agar was produced by autoclaving 10.8 g of GC agar base powder (Oxoid, UK) in 300 ml 
dH2O at 121°C for 15 minutes and was allowed to cool for 10 minutes.  Following this step, 
agar solution was supplemented with 1% (v/v) Vitox supplement (Oxoid).  For preparing 
Spectinomycin containing GC agar plates, the cooled solution was also supplemented with 50 
µg/ml stock of spectinomycin (Sigma-Aldrich). Where appropriate other antibiotics were used 
at a concentration of Kanamycin 50 µg/ml, Chloramphenicol 0.75 µg/ml, Tetracycline 2.5 
µg/ml and Erythromycin 2 µg/ml. 
2.4.3 LB Media 
For preparing 1000 ml of LB media, 10 g tryptone, 5 g yeast extract and 10 g NaCl were 
dissolved in 1000 ml deionised water. The solution was autoclaved for 20 minutes at 121°C. 
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2.4.4 LB Agar 
With LB media (Section 2.4.3), 1% agar was added and the resulting solution was autoclaved 
for 20 minutes at 121°C. After autoclaving, the solution was cooled and poured on agar plates 
with the addition of antibiotics where appropriate. Antibiotic concentrations used were 
Ampicillin 100 µg/ml; Chloramphenicol 25 µg/ml; Kanamycin 50 µg/ml. For long term storage 
plates were stored at 4°C. 
2.4.5 Mueller Hinton Broth 
Mueller Hinton Broth was prepared by mixing 10.5 g of Mueller Hinton Broth powder 
(OXOID, UK) in 500 ml dH2O, then autoclaving for 20 minutes at 121°C. 
2.4.6 Maintenance and growth of bacterial cultures 
For this work, a serogroup B N. meningitidis strain, originally isolated from an English patient 
suffering from meningococcal meningitis (McGuinness et al, 1991) was used (MC58).  Full 
genome of this strain has been sequenced (Tettelin et al, 2000). Mutant derivatives of MC58; 
ΔaniA, ΔnorB and ΔnsrR were generated by the disruption of aniA (NMB 1623), norB (NMB 
1622) and nsrR (NMB0437) genes (Anjum et al, 2002; Rock et al, 2005; Rock et al, 2007).  
Insertion of the omega interposons, conferring resistance to an antibiotic rendered these genes 
inactive which were confirmed later by PCR analysis. ∆nsrR/∆aniA was a kind gift from our 
collaborator (Dr James Moir, University of York). During the course of this project, the strains 
generated by author are mentioned in Table 2.1 and detailed in Chapter 4 and 6. 
Table 2.1 Strains used for this project 
N. meningitidis strain Genotype and antibiotic resistance Reference 
MC 58  Wild type (McGuinness et al, 
1991) 
∆aniA aniA :: SpecR Dr Jay Laver, PhD 
thesis 
 
∆norB norB :: SpecR (Anjum et al, 2002) 
 
∆nsrR nsrR :: SpecR (Rock et al, 2007) 
∆nsrR nsrR :: TetR (Heurlier et al, 2008) 
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∆nsrR/∆aniA nsrR/aniA :: TetR/ SpecR  
 
(Heurlier et al, 2008) 
 
∆aniA/∆norB 
 
aniA/norB :: SpecR/KanR 
 
Created by the 
author 
 
∆nsrR/∆norB 
 
nsrR/norB :: TetR/KanR 
 
Created by the 
author 
 
∆aniA/∆norB/∆nsrR 
 
aniA/norB/nsrR :: SpecR/KanR/TetR 
 
Created by the 
author 
 
∆aniA/aniA+ 
 
aniA/aniA+ :: SpecR/CmR Created by the 
author 
 
∆aniA/aniAIPTG+ 
 
aniA/aniAIPTG+ :: SpecR/EryR Created by the 
author 
 
 
Table 2.2 List of plasmids from the project 
Plasmid name Antibiotic resistance  Description Source 
pGEM-3zf AmpR Plasmid with multiple 
cloning sites widely 
used for cloning  
Commercially 
purchased 
pJMK30 KanR Plasmid containing 
1.452 Kbp Kanamycin 
cassette 
Kindly provided 
by Dr Jon Shaw, 
University of 
Sheffield 
 
pGCC4 KanR Plasmid permits ectopic 
complementation of a 
Neisseria spp. gene at an 
unlinked locus between 
Kindly provided 
by Professor 
Christoph Tang, 
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aspC and lctP region 
under the control of 
IPTG promoter with lac 
regulatory elements. 
University of 
Oxford 
pGCC5 KanR Plasmid allows ectopic 
complementation of a 
Neisseria spp. gene 
along with its 
endogenous promoter 
between aspC and lctP 
region of Neisseria 
Commercially 
purchased from 
Addgene 
pGEM-3zf:: ΔnorB KanR 2.5 Kbp norB F1-Kan- 
norB F2 cloned into the 
pGEM-3zf 
Created by the 
author 
pGCC5 :: aniA2+ KanR/CmR Approximately 1.6 Kb 
aniA along with its 
endogenous promoter 
containing 300 bp 
upstream sequence was 
cloned into pGCC5 
plasmid 
Created by the 
author 
pGCC4 ::  
aniAIPTG3+ 
KanR/ EryR 1.173 Kb aniA gene 
coding sequence was 
cloned into pGCC4 
plasmid under the 
control of an IPTG 
inducible promoter 
Created by the 
author 
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2.4.7 Propagation of viable N. meningitidis 
Frozen aliquots of viable bacteria were maintained in cryopreservation fluid (ProtectTM, TSC) 
at -80°C.  Sterile loops were used to streak aliquots of frozen bacteria onto solid GC agar plates 
(Section 2.4.2) supplemented where applicable with appropriate antibiotic. Plates were 
incubated overnight in a CO2 incubator at 37°C for at least 12 hours to produce colonies.  Single 
colonies were chosen and propagated onto fresh plates with no less than three colonies being 
pooled to avoid the issues associated with phase variability of N. meningitidis surface 
structures.  
2.4.8 Broth Culture of N. meningitidis 
At least three single colonies were cultured in 10 ml Muller-Hinton broth (MHB) (Section 
2.4.5) in 25 ml universal tubes.  These cultures were agitated at 37°C, 5 % CO2 by a plate mixer 
until an optical density of 0.25 at 600 nm (OD600nm), representing log-phase bacterial growth, 
was reached.  
2.4.9 Counting and manipulation of bacterial numbers for experiments 
Tenfold serial dilution of culture, supernatants and liver lysates was performed to estimate the 
number of used bacteria according to the method established by Miles and Misra (Miles et al, 
1938).  Triplicate aliquots (10 µl) of each dilution were separately spotted on Columbia blood 
agar plates and left in a microbiological safety cabinet for 10 minutes to allow them to dry.  
Following overnight incubation at 37°C, 5 % CO2, the mean number of colonies for each 
dilution were counted and corrected for the dilution factor and volume. Thus the mean of 
countable dilutions were averaged to estimate the number of bacteria present in the original 
suspension. This process was performed before and after the experiment to get an estimation 
of the input and output viable count. Using the viable counts of triplicate cultures at OD600nm, 
the average number of viable bacteria per ml of culture was calculated as: wild type = 2.04 x 
108 cfu/ml, ΔaniA = 1.15 x 108 cfu/ml, ΔnsrR = 2.74 x 108 cfu/ml and ΔnorB = 3.33 x 108 
cfu/ml.  These values were used to determine the volume of log phase culture (absorbance = 
0.25 at OD600nm) needed for an experiment requiring a defined number of bacteria.  Viable 
counts using the Miles and Misra method were always performed on bacteria containing media 
or lysates. In order to provide a heat-killed control for metabolic activity, an aliquot of wild 
type bacteria, containing the same number of cells as the wild type inoculum, were incubated 
at 80oC in a dry heat block for 20 minutes. 
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2.5 Infection of mice and preparation of liver lysates and whole blood 
samples from the murine model of fulminant meningococcal sepsis 
2.5.1 Infection of mice 
Female C57BI/6 mice aged between 7-10 weeks were ordered from HARLAN, UK and 
maintained at the Field Laboratories, University of Sheffield.  All the mice were acclimatised 
at least for a week before experiment and had access to the recommended laboratory rodent 
food and water. Health conditions of mice were monitored by the Field Laboratories staff, as 
per the guidelines of ASPA (Animal Scientific Procedures Act 1986).  Prior to each 
experiment, mice were weighed to determine the maximum volume that could be injected 
(100 μl per g).  The appropriate volume of bacterial culture (OD600nm = 0.25) was isolated, 
washed twice in sterile PBS (Section 2.2.1) then resuspended into the relevant diluents: either 
LPS-free PBS, or LPS-free PBS supplemented with 8 mg human holo transferrin (hHTF) 
(Section 2.1.4).  In experiments involving the administration of lipopolysaccharide (LPS), the 
LPS-free PBS was supplemented with E. coli LPS (Serogroup 026:B6, Sigma-Aldrich) such 
that 10 μl (1 unit) contained 25,000 endotoxin units (EU).  
2.5.2 Severity score for meningococcal sepsis 
Mice were intraperitoneally injected with the bacteria and were monitored for any departure 
from the normal well-being.  In accordance with our infection protocol under the auspices of 
our Project Licence, the severity of sepsis was scored for each mouse at hourly intervals.  Any 
mouse judged to score a cumulative score of 25 or a 5 in any one particular category was 
euthanized (see Score assessment, below).  As severity of the disease progressed (cumulatively 
scoring 21 or more), the frequency of observation was increased.  All mice were terminally 
anaesthetised with a 5 unit injection of 200 mM sodium pentobarbital.  The exsanguination by 
cardiac puncture was performed following the confirmation of deep anaesthesia by the 
withdrawal of pedal reflex.  A heparinised syringe containing 5 units of heparin per syringe 
was used for exsanguination. Throughout the entire procedure every effort was made to 
minimise the suffering of the mice. 
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Table 2.3 Severity score assessment 
Score Appearance Activity 
(without 
stimulation) 
Response 
to 
stimulation 
Respiration Response 
to 
handling 
Behaviour 
in new 
setting 
1 Normal Normal Normal Normal Normal Normal 
2 Partial 
piloerection 
Slightly 
Subdued 
    
3 Partial 
piloerection, 
slightly 
hunched 
Subdued Slightly 
subdued 
Slightly 
altered 
Slightly 
docile 
Curious 
but 
subdued 
4 Marked 
piloerection, 
Hunched 
Markedly 
subdued 
Markedly 
subdued 
Markedly 
altered 
Docile Lack of 
curiosity 
 
5 Marked 
piloerection, 
Markedly 
Hunched 
Immobile No 
response 
Labored Impaired 
righting 
response 
Immobile 
 
Guidelines for overall severity assessment: 
Cumulative score 6 = Normal 
Cumulative score 7-8 = Mild 
Cumulative score 9-18 = Moderate 
Cumulative score 19-24 = Substantial (Observation frequency increased) 
Cumulative Score 25-30 = Substantial (Mice should be culled) 
As the severity scores increased, the frequency of observations also had to be increased. Mice 
had to be immediately culled when severity score of 5 was reached in any single category. 
Severity score adapted from (Khan et al, 2002).  
 Bacterial nitric oxide metabolism in the pathogenesis of meningococcal sepsis 
64 
 
2.5.3  Preparation of liver lysates  
Mice liver were extracted from cadavers into light protected, 1.5 ml microcentrifuge tubes and 
weighed.  In case of mouse with bacterial inoculation, the whole liver was washed in 20 ml of 
0.25 % bile salts (Sodium taurocholate) for 30 seconds.  This was done to kill any bacteria on 
the surface of the liver tissue. Following this step, mice livers were washed twice in 20 ml of 
sterile PBS in universal tube.  Sterile tweezers were used to transfer the whole liver in different 
solution containing tubes.  Liver was homogenised using a hand held rotor stator homogeniser 
(OMNI International, USA) in 4 ml of lysis buffer (50 mM phosphate buffer plus + 1 mM 
DTPA, 0.5 mM PMSF and ½ protease inhibitor cocktail tablet in each 5 ml) (Section 2.2.2) .  
30 µl aliquot of each infected liver lysate was used for checking viable bacterial counts.  The 
rest of the lysate was centrifuged at 500 g for 5 minutes using a Falcon 6/300 centrifuge and 
approximately 2 ml of supernatant was extracted.  Another centrifugation step was performed 
at 16000 g for 3 minutes to remove any remaining pellet.  Final supernatant was mixed in a 1 
in 2 dilution with NEM containing lysis buffer (100 mM NEM, 50 mM phosphate buffer plus 
+ 1 mM DTPA, 0.5 mM PMSF and ½ protease inhibitor cocktail tablet in each 5 ml), to give 
a final NEM concentration of 50 mM.  The NEM buffer containing liver lysates were left on 
ice at least for 20 minutes to block the thiol residues present in the sample and stored in liquid 
nitrogen for later analysis. 
2.5.4 Preparation of plasma from C57BI/6 mouse blood 
Plasma was extracted after centrifuging the whole blood at 16000 g, 4°C for 5 minutes, the 
supernatant was diluted 2 fold in 50 mM phosphate buffer + 1mM DTPA + 100 mM NEM. 
2.5.5 Preparation of stabilisation solution for SNO haemoglobin 
SNO haemoglobin stabilisation solution was composed of 4 mM ferricyanide (K3Fe
III(CN)6), 
10 mM N-ethylmaleimide (NEM), 100 µM diethylenetriaminepentaacetic acid (DTPA), and 
1% nonidet-P-40 detergent (NP-40) in PBS. 
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2.5.6 Preparation of SNO haemoglobin from mouse blood 
 In the light protected tubes, 900 µl of stabilisation (Section 2.5.5) solution was aliquoted. It 
was important to use a light protected tube as light can break down SNO. Plasma was removed 
after centrifuging the whole blood at 13000 rpm for 5 minutes and 100 µl of red blood cell 
pellet was added into 900 µl stabilising solution. Sample was vortexed and stored in a light 
protected tube. A 9.5 ml bed volume G-25 sephadex column was thoroughly washed with 
degassed PBS (at pH 7-7.4) in a dark room. The column had two caps, one on the top and other 
in the bottom for controlling the entry and exit of the solution through the column. The PBS 
run through the column was collected in a liquid waste reservoir. The bottom cap column was 
put back. After defrosting and a vortexing step, 500 µl of 100 µl red blood cell plus 900 µl of 
stabilisation solution was added onto the G-25 Sephadex column by removing the top cap. 
Then the bottom cap was released and the lysed red blood cell mixture soaked the upper disc 
of the column. The bottom cap was put back and a volume of 3 ml of degassed PBS was added 
to the column. Then the bottom cap was removed and the PBS was allowed to run through the 
column. By the time 3 ml of PBS has soaked into the upper disc, the readily identifiable red 
band containing haemoglobin was at the bottom of the column. The haemoglobin was eluted 
by the addition of 700 µl of PBS and collected in a light protected tube. Immediately, the 
haemoglobin solution was placed on ice. An aliquot of 50 µl of haemoglobin was separated for 
measuring heme concentration with Drabkin’s reagent. The remaining solution was split into 
two 270 µl fractions. One fraction was treated with 30 µl of 50 mM HgCl2 (Section 2.3.2). The 
sample was vortexed and left at room temperature for 2 minutes. Then 30 µl of 5% acidified 
sulphanilamide (Section 2.3.1) was added to both the fractions and mixed thoroughly. In the 
purge vessel of NO analyser, 300 µl of sample was added in the triiodide solution. Injection 
volumes varied depending on the concentration of sample. Percentage of SNO per heme 
molecule was determined using the following equation: 
Percent SNO per heme = (mM NO concentration determined using I3
-/ mM Heme 
concentration from Drabkin’s assay) x 100 
2.5.7 Measurement of heme concentration 
In a cuvette 50 µl haemoglobin solution per sample was placed and mixed with 950 µl 
Drabkin’s solution (Section 2.1.3). In another cuvette 950 µl Drabkin’s solution was pipetted 
as a blank. The solutions were incubated at room temperature after thorough mixing. The 
spectrophotometer was blanked with only Drabkin solution containing cuvette. The absorbance 
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was read at 540 nm wavelength. The haemoglobin concentration was determined using the 
equation below: 
Concentration of heme (at mM) = (measured absorbance at 540 λ/ Extinction coefficient at 
540λ= 11) 
2.6 Chemiluminescence Techniques 
2.6.1 Analysis of S-nitrosothiol, nitrite (NO2-) and nitrate (NO3-) concentrations 
2.6.1.1 Calibration of GSNO solutions of known concentration 
Small concentration of GSNO between 5 -10 mg was weighed in a microcentrifuge tube and 
dissolved in 50 mM phosphate buffer + 1 mM DTPA (Section 2.2.3) (referred as PB-DTPA) 
by vortexing.  This generated a 100 mM solution and was allowed to settle on ice in a light 
protected environment.  Spectrophotometry was used to accurately determine the GSNO 
concentration.  The spectrophotometer was blanked at OD336nm using 1 ml of PB-DTPA 
solution in a quartz cuvette (Shimadzu Europa, UK).  Stock solution of GSNO was diluted 100 
times in PB-DTPA solution without disturbing the settled solid.  GSNO concentration in mM 
was finally determined by dividing this absorbance reading at OD336nm by 0.77, the absorbance 
of 1 mM GSNO solution at OD336nm.  Due to the light-sensitivity of the S-nitrosothiol bond, all 
the solutions were stored on ice in a light protected environment. GSNO solutions and 
calibration curve were prepared fresh before the start of each experiment. 
2.6.1.2 Ozone-based Chemiluminescence 
All the nitric oxide (NO) measurements were performed using a Sievers Nitric Oxide Analyser 
(NOA) 280i (Sievers, Boulder, CA). All the parameters and procedures were identical for all 
NO measurements. NO was removed from the purging vessel by bubbling N2 gas at a pressure 
of 1 bar and O2 was supplied to the NOA at the same pressure. The pressure inside the purging 
vessel was adjusted before the start of each experiment to match that of atmospheric pressure. 
Throughout the measurements, cold water was run through the condenser. Before making any 
injections for NO measurement, the apparatus was run for at least 15 minutes to have a steady 
state low baseline signal. In case of NOx measurement using Vanadium (III) chloride (VCl3) 
solution, the purge vessel containing 4 ml VCl3 in HCl solution was run for at least 30 minutes 
for establishing a low baseline signal.  After injection of any sample, the purge vessel was 
rinsed thoroughly with dH2O. 
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2.6.2 Measurement of samples by triiodide (I3-) dependant, ozone-based 
chemiluminescence 
The tri-iodide solution (Section 2.3.4) was able to generate chemiluminescence signal from all 
reducible NO species apart from the nitrate (NO3
-).  All the samples and standards were pre-
treated with 10% (v/v) sulphanilamide (in 2 N HCl) to remove contaminating NO2
-.  The 
reaction is triggered on ice and in light protected environment to prevent degradation of the S-
nitrosothiol bond.  S-nitrosothiol was measured by using a variety of reducing agents and 
samples were treated in three different ways to achieve this.  Firstly, the untreated plasma and 
liver lysate were injected to measure the combined amount of nitrite (NO2
-), nitrosyls, 
nitrosoamines and S-nitrosothiol (SNO) compounds present in the sample (collectively termed 
tri-iodide reactive NO species (NOI3-)).  Secondly, sample was treated with 10% (v/v) 100 mM 
sulphanalimide in 2N HCl (Section 2.3.1) on ice for 10 minutes to complex free NO2
-.  This 
was achieved by the formation of a diazonium salt following the reaction between nitrite and 
acidified sulphanilamide, which cannot be reduced to NO when introduced to the I3
- reagent.  
Finally, sample was treated first with 10 % (v/v) of a 50 mM HgCl2 solution (Section 2.3.2) 
on ice for 10 minutes which was followed by the treatment with 10% (v/v) acidified 
sulphanilamide.  Subtraction of the values of the concentration of NOI3- measured in the latter 
two samples from the value of the concentration of NOI3- measured in the first allows the 
determination of the concentrations of specific NO species. 
2.6.3 Measurement of samples by Vanadium (III) Chloride (VCl3) dependant ozone-
based chemiluminescence 
Acidified vanadium chloride solution was prepared by adding 0.8 g VCl3 (MW: 157.30) to 100 
ml of 1M HCl.  A deep blue solution resulted.  This reagent was strong enough to produce 
chemiluminescence signal from all reducible NO species including the nitrates (NO3
-).  1M 
NaNO3 solution was made by dissolving 0.43 g of NaNO3 (MW: 83.99) in 5 ml dH2O and 10 
fold serial dilutions were made from 10 mM to 100 nM.  A calibration curve was prepared by 
measuring NO from these solutions which was used to calculate the NOx present in the sample.  
Solutions were always prepared fresh and stored in a light-protected environment when not in 
use.  For NOx measurement, the purging vessel had to be connected to a water bath set at 90
°C.  
Four ml of acidified VCl3 was added to the purge vessel and the apparatus had to be run for at 
least 30 minutes to establish a low stable baseline reading.  Typically, 3-5 µl injections without 
any treatment were made for NOx measurement. 
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2.6.4 Injection of samples into the purging vessel 
Gas-tight microsyringes (Analytix, UK) were used to inject specific amounts of samples into 
the purging vessel.  For measuring NO in liver lysates, typically 10-150 µl of liver lysates were 
injected.  For each injection, a 10 µl headspace of air was taken for ensuring the maximum 
efficacy of injection. With complete depression of plunger, samples were injected as a bolus 
into the purging vessel. Duplicate injections were made depending on the availability of the 
sample.  Microsyringes were washed three times with dH2O between injections.  To avoid 
contamination, the needle of the syringe was thoroughly dried before each injection was made. 
2.6.5 Analysing chemiluminescence data using the Origin 8.1 program 
The release of NO from its oxidised forms is stoichiometric in the purging vessel, meaning one 
molecule of NO is generated for every nitrogen atom in a sample (dependent upon the strength 
of the reducing agent employed).  In the chemiluminometer, NO reacts with ozone in a high 
energy collision which releases a photon.  These photons are detected by a photomultiplier 
tube, which produces an electric current.  The voltage of the current is directly proportional to 
the number of photons detected, which in turn is directly proportional to the amount of NO 
released from the sample.  Thus using the LIQUID program we generate a graph of mV against 
time, the Area Under Curve (AUC) which we can integrate and relate to a curve of areas 
generated from standards of known concentrations, in order to determine the concentration of 
NO produced in our purging vessel. The mean of AUC from duplicate injections of known 
concentration of NaNO2 is used for measuring NO2
-, NOx and GSNO (Section 2.6.1.1) is used 
for measuring SNO. LIQUID program used to capture the data is reportedly less effective at 
integrating the area under smaller peaks than is Origin 8.1 (Laver et al, 2008), so it is the latter 
software we employ to smooth and subsequently integrate our data.  We used a Savitzky-Golay 
filter with a gate size of 21 to smooth out the traces generated in our experiments.  Post-
integration, the concentration of NO measured in Hg-treated samples was multiplied by a factor 
of 1.1 to account for the addition 10 % (v/v) dilution. 
2.7 Statistics 
All the statistics were performed by using the GraphPad Prism 5 software. The statistical test 
used depended and varied on nature of experimental design and result. Chosen statistical tests 
are highlighted in the figure legends. If the skewness was double or equal to the standard error 
of skewness, non parametric test was used but if the skewness was less than double the standard 
error of skewness, parametric test was used. 
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2.8 Immunological Techniques 
2.8.1 IL-8 and TNFα cytokine measurement by ELISA 
For IL-8 and TNFα measurement human DuoSet ELISA development kit from R & D was 
used. Capture antibody (720 µg/ml) was reconstituted with 1ml PBS. For longer term storage 
antibody was kept in aliquots at -20°C freezer for up to 6 months. Before the assay, the antibody 
was diluted at the working concentration of 4 µg/ml in PBS. 3.6 µg/ml (63 µg/ml for TNFα) 
biotinylated goat anti-human IL-8 detection antibody was reconstituted in 1 ml of reagent 
diluent. Before assay, a working concentration of antibody was made at 20 ng/ml (350 ng/ml 
for TNFα) in reagent diluent. 100 ng/ml human IL-8 was reconstituted with 0.5 ml of water. 
TNFα (at 320 ng/ml) was reconstituted in 0.5 ml reagent diluent. The standard was let to set at 
room temperature for 15 minutes before storing it at -20°C freezer for long term storage. A 
standard solution of high concentration (2000 pg/ml) was prepared prior to the assay and a 
seven point standard curve was made using 2 fold dilution. Streptavidin- HRP, PBS, block 
buffer, substrate and stop solution were prepared according to manufacturer’s instruction. 
Firstly, the ELISA plate had to be prepared. The required number of wells of 96 well ELISA 
plate were coated with 100 µl of capture antibody in each well. Plate was sealed and incubated 
overnight at room temperature. Following day, contents of the plate were discarded and washed 
with the wash buffer for three times. Each wash step was done by adding 400 µl of wash buffer. 
Plate was aspirated or inverted to remove any residual wash buffer left in the well before 
starting next was step. Then 300 µl of block buffer was added to each well and incubated at 
room temperature for 2 hours. 100 µl sample diluted in reagent diluent was added to the wells 
and the plate was incubated at 4°C overnight after sealing with an adhesive strip. Following 
day, the plate was washed three times with 400 µl of wash buffer. Any residual wash buffer 
had to be removed before proceeding to the next step. 100 µl of detection antibody at working 
concentration was added and the plate was incubated at room temperature for 2 hours. The 
plate was washed with wash buffer as before and aspirated thoroughly. Subsequently, 100 µl 
working concentration of Streptavidin-HRP was added and plate was incubated at room 
temperature for 30 minutes. Wash step was performed again for three times to remove any 
Streptavidin-HRP. After washing 100 µl of substrate solution was added to each well and 
incubated at room temperature for 30 minutes protecting from light. Then 50 µl of stop solution 
was added to each well and plate was gently tapped to ensure thorough mixing. The plate was 
read using a microplate reader set to 450 nm. Final analysis was performed after correcting for 
the background reading using the built in software.  
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2.9 Cell Culture Techniques 
Culture and maintenance of human primary bronchial epithelial cells at air-
liquid interphase (HPEC-ALI) 
2.9.1 Consumables 
 20 ml polystyrene Universals (Greiner, Cat No: 201172) 
 5 ml stripettes (Fisher, Cat No: FB55483) 
 10 ml stripettes (Fisher, Cat No: FB55484) 
 25 ml stripettes (Fisher, Cat No: FB55485) 
 Extended Fine Tip Pastette: alpha Laboratories, Cat No: LW4232 
 Syringe driven sterile filter unit (Millex-GP, 0.22 µm, polyethersulfone, 33 mm, radio-
sterilized): Millipore, Cat No: SLGP033RS 
 6.5 mm Transwell® with 0.4 µm Pore Polyester Membrane Insert, Sterile: Corning, Cat 
No 3470 
 
2.9.2  Reagents 
 Trypsin, 0.5% (10 x) with EDTA 4Na (Life Technologies, Cat No: 15400) diluted 1:10 
with HBSS, aliquoted in 10 ml and stored at -20°C 
 Fetal Bovine Serum (heat inactivated) (Life Technologies ,Cat No: 10108-165) 
 RPMI 1640 medium without L-Glutamine (Life Technologies, Cat No:31870-025) 
 Dulbecco's Modified Eagle Medium (DMEM) high glucose (Life Technologies, Cat No: 
11960-085) 
 Penicillin-Streptomycin (5000 IU/ml Penicillin, 5000 µg/ml Streptomycin) (Life 
Technologies, Cat No: 15070-063) 
 Non Essential Amino Acids (x 100) w/o L-Glut: Life Technologies (Cat No: 11140-035) 
 Sodium Pyruvate MEM 100 mM (Life Technologies, Cat No: 11360-039) 
 L-Glutamine 200 mM (x 100) (Life Technologies, Cat No: 25030-024) 
 BEGM BulletKit (contains BEBM and SingleQuots) (Lonza, Cat No: CC3170) 
 Retinoic acid (RA) (Sigma, Cat No R2625) and BEGM SingleQuot Kit Suppl. & Growth 
Factors (Lonza, Cat No: CC-4175)  
 
2.9.3 Preparation of reagents for ALI medium 
2.9.3.1 Collagen I solution (1:100) 
A volume of 30 µg/ml collagen I solution (PureCol, Advanced Biomatrix) was prepared by 
adding 0.5 ml of 3 mg/ml collagen I stock to 49.5 ml of sterile ddH2O in a 50 ml conical tube. 
2.9.3.2 BSA stock (1.5mg/ml) for 2x ALI medium 
An amount of 100 mg/ml BSA (Bovine serum albumin, Sigma, Cat No: A3059-100G) stock 
was prepared by dissolving 1g BSA in 10 ml ddH2O. The stock was filter sterilised using a low 
protein binding filter and 100 µl aliquots (0.5 ml microtubes) were prepared and stored at -
20°C in TC3 freezer. Another 1.5 mg/ml BSA stock was prepared by adding 90 µl (100 mg/ml) 
to 5910 µl of BEBM (1/66.7 dilution). 600 µl aliquots were made and stored at -20°C in freezer. 
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2.9.3.3 Preparation of 2x BEGM medium  
The singlequot vials should not be freeze/thawed. Making up 2x BEGM enables the singlequots 
to be used for both monolayer and ALI cultures. The following steps were followed: 
In 250 ml sterile bottle, 244.5 ml of BEBM medium and the following reagents from BEGM 
singlequots were added (Table 2.4). After defrosting the singlequots were briefly centrifuged 
(12000 rpm, 1 min) to ensure all the contents are in the bottom of the vial and transferred to 
the 250 ml bottle. The contents in the 250 ml bottle were thoroughly mixed by pipetting up and 
down using a 25 ml pipette. 
Table 2.4 Recipe for preparation of BEGM for ALI media 
Reagent Vol/250ml 
2x BEGM 
(ml) 
BEBM 244.5 
Bovine Pituitary extract      (BEGM singlequot) 2 
hEGF                                  (BEGM sinlgequot) 0.5 
Insulin                                 (BEGM sinlgequot) 0.5 
Hydrocortisone                   (BEGM sinlgequot) 0.5 
Transferrin                          (BEGM sinlgequot) 0.5 
Triiodothyronine                 (BEGM sinlgequot) 0.5 
Epinephrine                        (BEGM sinlgequot) 0.5 
BSA (1.5 mg/ml) 0.5 
 
2.9.3.4 Recipe for preparation of DMEM for 1x ALI medium 
Table 2.5 Recipe for preparation of DMEM for ALI medium 
Reagent Vol/50 ml 
(ml) 
Vol/250 ml 
(ml) 
Vol/500 ml 
(ml) 
DMEM 48 240 480 
Non-essential amino acids 0.5 2.5 5.0 
Sodium pyruvate 0.5 2.5 5.0 
Penicillin/streptomycin (100X) 0.5 2.5 5.0 
L-glutamine (100X) 0.5 2.5 5.0 
 
A minimum of 50 ml of DMEM was prepared and stored in 50ml conicals 
2.9.3.5  Preparation of Retinoic acid (all-trans RA) 5x10-5 M (50 µM) 
The primary stock solution was made by dissolving 50 mg retinoic acid (MW 300) in 16.67 ml 
DMSO in a darkened room to exclude UV light to give a final concentration of 3 mg/ml (10 
mM). 25 µl of aliquots were made and stored in a bag wrapped in tin foil at -80°C freezer. To 
make a working stock solution 20 µl of the primary stock was diluted in 4 ml DMSO to have 
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a final concentration of 50 µM (5 x 10-5 M) and stored in 60 µl aliquots at -20°C in a light tight 
container. Care was taken not to thaw and freeze the aliquots. 
2.9.3.6 Preparation of 1x ALI media 
BEGM is an expensive media which cannot be used further after addition of the retinoic acid. 
So only the amount required was made up. The amount of media required was worked out (300 
µl/transwell + a couple of mls for pipetting losses). Into a 25/50 ml universal tube half the total 
volume of ALI DMEM (Section 2.9.3.4) and half the total volume of 2 x ALI BEGM (Section 
2.9.3.3) was added. Just before usage, a vial of retinoic acid (50 µM was thawed) (Section 
2.9.3.5) was added in 1 µl per ml of 1 x ALI media. It is to be noted that retinoic acid is unstable 
and light sensitive. While using it was protected from light under all circumstances and 
repeated thaw/freeze cycles had to be avoided. 
2.9.4 Methods for the establishment and maintenance of ALI cultures 
2.9.4.1 Collection of HPEC after bronchoscopy 
Human primary bronchial epithelial cells (HPEC) were obtained from the healthy volunteers 
by epithelial brushing. All the procedures were approved by the Southampton and South West 
Hampshire Research Ethics Committee. Passage 12 of HPEC was used for generating air-
liquid interphase cultures. 
2.9.4.2 Preparation of a cell suspension 
The cells were trypsinised and resuspended in 10% FBS/RPMI. They were pelleted after 
centrifugation and the supernatant was discarded. Pellet was resuspended in 1-2 ml of BEGM. 
After cell counting with haemocytometer (Section 2.9.4.8), the suspension was diluted at 0.35 
x 106 cells/ml in BEGM. 
2.9.4.3  Preparation of the transwell trays (Day 0) 
Collagen I solution (1:100) from stock of 3 mg/ml = 30 µg/ml in sterile double distilled water 
was prepared. 100 µl/well was added into apical compartment of required transwell of 24-well 
plates. The collagen was let to polymerise in 37°C incubator for 30 minutes. Collagen was 
removed with fine-tip sterile pastette. In transwell 200 µl of the 0.35 x 106 cells/ml was pipetted 
(0.7 x 105 cells/well). 0.5 ml of BEGM was added to the basal compartment of each transwell. 
1 ml HBSS was added to empty wells to minimise evaporation. Each plate was thoroughly 
labelled with the date, donor code and phenotype and incubated overnight (at 37°C, 5% CO2) 
to form a confluent monolayer. 
 Bacterial nitric oxide metabolism in the pathogenesis of meningococcal sepsis 
73 
 
2.9.4.4 Taking transwells to air-liquid interphase day 1 
 
A minimum of 50 ml of 2 x ALI and DMEM was prepared. If there were lots of cells in culture 
then 250 ml of media each was prepared as per recipe at the end of protocol. Tubes were 
labelled with name and date. The amount of ALI medium needed was calculated (4 ml /each 
12-well transwell plate; (12 x 0.3 ml = 3.6 ml) in 50 ml conicals. Just before use an aliquot of 
RA (5 x 10-5 M) (Section 2.9.3.5) was defrosted by placing in hand or wrapped in foil. With 
special care 1:1 (v/v) DMEM : 2 x ALI medium to required volume was prepared. Then 1µl of 
50 µM RA stock for each ml of ALI medium (Section 2.9.3.6) was added immediately prior 
to the use. The conical was wrapped with aluminium foil. This was done to protect the ALI 
media from light as RA is UV sensitive. Using a fine-tip sterile pastette first basal then apical 
media was removed from the transwell by not disturbing the cell layer. In the basal 
compartment 300 µl of 1 x ALI media underneath the transwell was added. No media was 
added to the apical compartment. The plate was incubated at 37°C. 
2.9.4.5 Points to consider for growing and maintaining ALI culture 
On day 1 the cultures should be 95%-100% confluent.  If they are subconfluent the cells are 
fed as described above and they may become confluent over the following few days.  Persistent 
subconfluent cultures indicate that the cells are becoming quiescent and are less likely to 
differentiate. After the first few days a confluent cell layer may appears to form ‘holes’ that 
give a lace curtain appearance. This will not inhibit differentiation and these areas will regress 
over time. The cells start to visibly produce mucus at around 7 days. Ciliated cells should start 
to appear from day 14-19 but may not be visible under an inverted microscope if there is mucus 
impeding their beat. Cells are generally used for assays from day 19-21. However, leaving the 
cultures left for longer (e.g. another week) generally increases the percentage of ciliated cells. 
Transepithelial resistance can be determined using chop-stick electrodes of voltohmmeter 
EVOM. Basal resistance = approx. 150 , resistance of differentiated cultures = approx. 400 
Ω – 2500 Ω. 
2.9.4.6 Continuous feeding of ALI cultures DAY 2-21 onwards 
 
From freezer 2 x ALI culture media and DMEM media was taken out and required volumes of 
1 x ALI medium without RA into 50 ml conicals were made. The media was warmed by leaving 
at 37°C for at least 20 minutes. Just before feeding the cells, the required amount of RA 
(1µl/ml) was added into 1 x ALI media immediately before replacing media. The RA was 
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protected from UV light by wrapping it with aluminium foil. Using a fine-tip sterile pastette, 
the basal media was removed from the transwell. Any excess mucus accumulating on the 
surface of apical layer along with any additional media was removed from approximately day 
7 onwards. Care was taken not to dislodge the cell layer. 300 µl of 1 x ALI media underneath 
the transwell in the basal compartment was added. 
2.9.4.7 Transepithelial resistance (TER) measurement (day 7, 14, 21) 
TER was measured on day 7, 14 and 21 to check the epithelial barrier integrity (Section 2.10.3). 
In 5 ml bijoux tube 5 ml of HBSS was aliquoted and warmed at 37°C incubator for 30 minutes. 
Chopsticks from the TER machine was sterilised by placing in a 25 ml conical with IMS. Any 
excess mucus from the apical compartment of the transwells was removed. Pre-warmed 100 µl 
of HBSS was added to the apical compartment and incubated at 37°C for 15 minutes. Chopstick 
of TER machine was removed from IMS and let to evaporate. The electrodes were dipped into 
HBSS. After drying, the electrodes were positioned at a 90° angel to the base of the plate, with 
the longest electrode on the outside (basal) and shortest electrode on the inside (apical) side of 
the transwell insert. After recording TER, basal medium was removed along with HBSS from 
the apical compartment with fine-tipped pastette. Freshly prepared 1x ALI was added into the 
basal compartment. TER reading was taken again. 
 
Figure 2.1 Progression of HPEC-ALI culture over a period of 21 days. 
After bronchoscopy HPEC were seeded for generating ALI culture. As can be seen with the 
progression to day 14 and day 21 density of the cell population increased which was depicted 
by high TER reading. (Image kindly provided by Dr Emily Swindle, University of 
Southampton). Image taken by Light microscopy. 
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2.9.4.8 Counting the cells prior to the experiment 
A well containing ALI culture was used for counting the cells using haemocytometer. 1 ml of 
prewarmed HBSS was applied on top of the transwell and was let to overflow. On the apical 
side of the well 200 µl trypsin and in the basal compartment 300 µl trypsin was added. The 
plate was left in the incubator for 5-10 minutes. The detachment of the cells was monitored by 
microscope by pipetting up and down. After trypsinisation, all cells/trypsin were added to 100 
µl FBS in the Eppendorf. The trypsinised well was rinsed to dissolve the total cells in 1 ml 
volume. The cells were repeatedly pipetted up and down and vortexed to break down any clump 
to interfere with cell counting. Since the cells have tendency to settle to the bottom, pipetting 
and vortexing had to be performed just before counting the cells. This step was pivotal as 
clumped cells in solution would provide an inaccurate cell count. A total 50 µl of cell 
suspension was mixed with 10 µl of (0.4 %) trypan blue solution and 40 µl of HBSS. These 
mixtures were mixed thoroughly. An aliquot of 10 µl was used to perform cell count using 
haemocytometer. A small volume of trypan blue containing sample was added to the space 
between the surface of the counting chamber and the underside of the glass coverslip. Average 
of total number of cells in specified four grids of haemocytometer was multiplied by 104 to get 
the number of cells ml-1 in the suspension. Approximately 0.2-0.7 x 106 cells were found from 
one transwell and this count was used to determine the required MOI for infection. 
2.10 Biochemical Techniques 
2.10.1 Measurement of NO2- by Griess Assay 
Measurement of NO2
- in batch culture was performed by Griess Assay Kit (Promega). The 
assay relies on the Griess reaction which was first described by Peter Griess (Griess, 1879). Kit 
came with Sulfanilamide (1% sulphanilamide in 5% phosphoric acid), NED solution (0.1% N-
1-napthylethylenediamine) and nitrite standard.  
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Figure 2.2 Chemical interactions involved in the measurement of NO2- using the Griess 
Reagent System.  
Sulfanilamide reacts with NO2
- present in the sample and forms a diazonium salt. The reaction 
of this salt with Azo dye (NED) leads to the development of pink colour which is detected by 
a spectrophotometer at an absorbance between 520-550 nm. 
(http://www.promega.co.uk/~/media/Files/Resources/Protocols/Technical%20Bulletins/0/Gri
ess%20Reagent%20System%20Protocol.pdf) 
The media from 5 mM NaNO2 containing growth curve was diluted 1 in 200/300 growth media 
prior to the assay. Media from 50 µM SperNO growth curve was measured after making 1 in 
2 dilution. Supplied 0.1 M NaNO2 standard was diluted 1000 fold in MHB to prepare 100 µM 
nitrite standard. 100 µl of 100 µM nitrite was plated in triplicates in a 96 well flat bottom plate. 
This solution was serially diluted (1 in 2) 6 times by transferring 50 µl of sample to prepare 50, 
25, 12.5, 6.25, 3.13, 1.56 µM solution. 50 µl of sample was discarded from the 1.56 µM 
standard. In separate 3 wells, 50 µl MHB were added and this was counted 0 as standard. Half 
an hour before the assay Sulfanilamide and NED were equilibriated at the room temperature 
protected from light. 50 µl of each sample was added to the well in triplicates. Using a 
multichannel pipettor, 50 µl of acidified sulphanilamide was added to each experimental well 
and the plate was incubated at room temperature for 5-10 minutes protected from light. After 
that 50 µl of NED was added to each well and incubated at room temperature for 5-10 minutes. 
Purple colour will start to form immediately. Within 30 minutes absorbance was read at 
OD540nm. Reading from standard 0 well was considered as background and was subtracted from 
each output. Average absorbance reading from nitrite standards was plotted against 
concentration to draw the standard curve. Absorbance readings of the samples were determined 
from the standard curve. 
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2.10.2 Glutathione peroxidase assay 
The Glutathione peroxidase (Gpx) is an enzyme that plays a pivotal role in counteracting 
oxidative damage. In this project Gpx activity was determined using a commercial kit 
according to the manufacturer’s instruction (Abcam ab 102530). This kit measured Gpx 
indirectly through enzymatic consumption of NADPH. Reduced glutathione (GSH) is 
converted to oxidized glutathione (GSSG) by Gpx. Supplied glutathione reductase reduces 
GSSG back to GSH by utilising NADPH which can be easily detected at 340nm. The decrease 
in NADPH consumption is directly proportional to Gpx activity. Meningococcal overnight 
cultures were lysed by sonication. The supernatant was collected by centrifuging the cells at 
10000 g for 15 minutes at 4°C. 50 µl samples were used for the assay in a 96 well plate. NADPH 
was used as a standard for Gpx activity detection. NADPH were prepared in concentrations (0, 
20, 40, 60, 80, 100 nmol/well) and added to the 96 well plates. A volume of 5 µl Gpx was 
topped up to 50 µl with assay buffer and used as a positive control. A volume of 40 µl reaction 
mix was prepared by adding 33 µl assay buffer, 3 µl 40 mM NADPH, 2 µl GR, 2 µl GSH. To 
each test sample 40 µl reaction mix was added and incubated for 15 minutes to allow GSSG 
depletion. Then OD340nm reading was taken by a 96 well plate reader. After that 10 µl of cumene 
hydroperoxide was added and the plate was incubated for 40 minutes protected from light. 
Absorbance reading was taken again at OD340nm. For calculating the final Gpx activity in 
mU/ml, NADPH reduction between t =0 and t = 40 minutes were determined by subtraction 
and adjusted with sample volume and timepoint (40 minute). Initial experiments showed that 
beyond 40 minutes timepoint, the Gpx signal is significantly diminished and therefore 40 
minutes timepoint was used for the Gpx measurement. 
2.10.3  Measurement of Transepithelial cell resistance (TER) 
During the maintenance of HPEC-ALI cultures, the differentiation state of the cells is 
confirmed by TER readings. Before and after infection TER of HPEC-ALI was measured. TER 
measurement was performed by an EVOM Voltohmmeter (World precision instruments) with 
chopstick electrodes. Chopsticks from the TER machine was sterilised by placing in a 25 ml 
conical with IMS. Pre-warmed 100 µl of HBSS was added to the apical compartment and 
incubated at 37°C for 15 minutes. Chopstick of TER machine was removed from IMS and let 
to evaporate. The electrodes were dipped into 25 ml HBSS containing conical. After drying, 
the electrodes were positioned at a 90° angel to the base of the plate, with the longest electrode 
on the outside (basal) and shortest electrode on the inside (apical) side of the transwell insert. 
TER reading on display was recorded. The electrodes had to be kept steady while taking the 
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measurement to get results devoid of noise. Readings before and after the experiments are used 
to measure TER (Ω). TER reading after experiment was divided by TER reading before the 
experiment to get a ratio. Then the ratio found was normalised to the TER ratio of the control 
well (No bacteria) to get the final TER reading. 
2.10.4 Determination of Protein Concentration 
Protein concentration of plasma, bacterial cell lysates and liver lysates were calculated using 
the RC DC protein Assay kit (Bio Rad, USA), according to the manufacturer’s instruction.  In 
this colorimetric assay, protein concentrations were calculated in reference to a bovine serum 
albumin (BSA) standard curve.  BSA standard curve was prepared fresh by making dilutions 
from 1.5 mg/ml to 0 mg/ml and colour change was quantified at OD750nm using a 
spectrophotometer. 
2.11 Molecular Biology Techniques 
2.11.1 Preparation of DH5α Cells 
One distinct colony from freshly grown DH5α cells (NEB C2987) was inoculated in sterile 25 
ml LB media (Section 2.4.3) overnight at 37°C.  In the following morning 500 µl of overnight 
culture was mixed with 100 ml of LB media in a 500 ml flask and incubated in a shaker 
incubator at 37°C.  The culture was grown exactly up to the mid log phase (OD600nm = 0.5) and 
transferred to two 50 ml centrifuge tubes. The mid log phase (OD600nm = 0.5) was critical for 
the efficacy of the competent cells. Therefore, the OD600nm was more frequently observed after 
the culture reached at OD600nm 0.2-0.3. After incubation on ice for 15 minutes, the cells were 
centrifuged at 15 Kg at 4°C for 15 minutes. The supernatant was carefully poured off and 
resuspended in 50 ml RF1 (Section 2.3.6) per tube. Following 15 minute incubation on ice, the 
cells were centrifuged as before. Pellets from two tubes were combined in 8 ml RF2 (Section 
2.3.7) and incubated on ice for 20 minutes. The cells were aliquoted in eppendorf tubes and 
stored at -80°C. It was pivotal to maintain aseptic environment throughout the whole process. 
2.11.2 Transformation of E. coli DH5α competent cells with DNA 
Competent cells (Section 2.11.1) were thawed on ice just prior to the use. Approximately 1-5 
µl of DNA from ligation reaction (Section 2.11.10) was chilled in a clean 1.5 ml 
microcentrifuge tube. Around 150-200 µl of competent cells were added to DNA. The tube 
was flicked 4-5 times to mix the cells and DNA. Vortexing was avoided as a way of mixing as 
it could damage the competent cells. The mixture was incubated on ice for 30 minutes. The 
tube was heat shocked at 42°C for 30 seconds without mixing. Prewarmed and sterile 800 µl 
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of LB media was added to the tube and was incubated at 37°C for 60 minutes at 250 rpm. After 
1 hour, 100 µl of this mixture was spread plated on prewarmed LB agar plates containing 
appropriate antibiotics (Section 2.4.4). The remainder of the mixture from tube was centrifuged 
and resuspended in 100 µl LB media and spread plated on a separate LB agar plate. All the 
plates were incubated 37°C overnight and screened for positive colonies the following day. 
2.11.3 Primers 
Table 2.6 Primers used for this project 
Primers Sequence Description 
norB F1-FWD GAGCTCGGTACCCGGGGATCCTCTAGAGTC
ACGGCAGCGTCGTCATCAGC 
 
This primer contained 30 
bp sequence homologous 
to the pGEM-3zf before 
the HincII restriction site 
plus 20 bp from the 
beginning of the part 
(underlined) of chosen 
524 bp norB sequence 
norB F1-REV AAGCTGTCAAACATGAGAACCAAGGAGAAT
ACCCTGGCCTTCGACGGTGT 
The reverse primer 
contained 30 bp adapter 
sequence which was 
homologous to the 
reverse complement of 
the start of the Kan 
cassette from pJMK30 
plus 20 bp of the reverse 
complement of the last 
part (underlined) of the 
chosen 524 bp norB 
sequence 
norB F2-FWD GAATTGTTTTAGTACCTAGCCAAGGTGTGC
ACTGCCTCCACTTTGGCCGC 
 
The forward primer 
contained a 30 bp 
sequence  homologous to 
the last 30 bp of pJMK30 
plus 20 bp from the start 
(underlined) of the  
chosen 522 bp of norB 
sequence 
norB F2-REV AGAATACTCAAGCTTGCATGCCTGCAGGTC
CTGAATCGCGCCGACAGGCA 
The reverse primer 
contained sequence 
homologous to the last 30 
bp of pGEM-3zf after the 
HincII restriction site plus 
20 bp from the reverse 
complement (underlined)  
of last part of chosen 522 
bp norB sequence 
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Kan- FWD ATTCTCCTTGGTTCTCATGTTTGACAGCTTA
T 
Forward primer for 
amplifying the Kan 
cassette from pJMK30 
Kan-REV GCACACCTTGGCTAGGTACTAAAACAATTC
AT 
Reverse primer for 
amplifying the Kan 
cassette from pJMK30 
aniA_RUH1_FWD 
 
TGCCTGATTTGCCGAAGCCCT Forward primer for 
amplifying the 1.3 Kb of 
aniA region 
aniA_RUH1_REV AAGCAGCAGGAGCTGCACCG Reverse primer for 
amplifying the 1.3 Kb of 
aniA region 
norB_RUH2_FWD TACTTGCTGTTTGCCGTTCT Forward primer for 
amplifying the 2.0 Kb of 
norB coding region 
norB_RUH2_REV GCAGCCAGAAGCCCCAAGTC Reverse primer for 
amplifying the 2.0 Kb of 
norB coding region 
nsrR_RUH3_FWD CGATGCCTTTCTTCCGGCGT 
 
Forward primer for 
amplifying the 1.4 Kb of 
nsrR region 
nsrR_RUH3_REV CCTCATCAAGCAGGCGGTTG Reverse primer for 
amplifying the 1.4 Kb of 
nsrR region 
AniA_compl_RUH8
_FWD 
ACGATACAGACGTCTACCGCGCAAATAAAC Forward primer for PCR 
amplifying the aniA 
coding sequence along 
with its 300 bp upstream 
regulatory region and 100 
bp downstream of the 
coding stop codon with 
AatII restriction site 
underlined 
AniA_compl_RUH8
_REV 
GGACTGCGATGCATATCAATCTTCCGAAAG 
 
Reverse primer for PCR 
amplifying the aniA 
coding sequence along 
with its 300 bp upstream 
regulatory region and 100 
bp downstream of the 
coding stop codon with 
NsiI restriction site 
underlined 
Comp1_check_RUH
14_lctP/aspC_FWD 
 
ATGGCACTTTTCCTCAGCATATTCC 
 
Forward primer for PCR 
amplifying the region 
from aspC to lctP of 
pGCC5 plasmid 
Comp1_check_RUH
14_lctP/aspC_REV 
 
CTATACTTTCACGATGCTTTCACAC 
 
Reverse primer for PCR 
amplifying the region 
from aspC to lctP of 
pGCC5 plasmid 
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Comp_check_RUH1
9_aniA1 
 
TACCGCGCAAATAAACATTTGTTC 
 
Sequencing primer for 
checking the first 800 bp 
of reverse complemented 
aniA sequence along with 
its 300 bp upstream 
endogenous promoter 
region 
Comp_check_RUH2
0_aniA2 
 
ACAACGTCGACTTCCACGCGGCTA 
 
Sequencing primer for 
checking the last 800 bp 
of reverse complemented 
aniA sequence along with 
its endogenous promoter 
region 
Ampli_aniA_Comp_
Forward 
CGTTGTACTTAATTAAATGAAACGCCAAGC
CTTAGC 
Forward primer for PCR 
amplifying the aniA 
coding region with PacI 
restriction site 
(Underlined) 
Ampli_aniA_Comp_
Reverse 
CGTTGTACGGCCGGCCTTAATAAACGCTTT
TTTCGGATGCAGAGG 
 
Reverse primer for PCR 
amplifying the aniA 
coding region with FseI 
restriction site 
(Underlined) 
Ampli-
pGCC4Forward 
 
CTATGAAAGGTTGGGCTTCGGAATC Forward primer for PCR 
amplifying the aspC to 
lctP region of pGCC4 
plasmid 
Ampli-
pGCC4Reverse 
GTCATCCGCAAATGGCTGGC Reverse primer for PCR 
amplifying the aspC to 
lctP region of pGCC4 
plasmid 
pGCC4_diagnostic_
Fwd 
GCATTCAGGCGTAGTAATGATGCG Forward primer for PCR 
amplifying the 1.224 Kb 
region of pGCC4 
containing lac promoter 
regulatory elements 
pGCC4_diagnostic_
Rev 
CAGTTGATCGGCGCGAGATTTAATC Reverse  primer for PCR 
amplifying the 1.224 Kb 
region of pGCC4 
containing lac promoter 
regulatory elements 
Sequencing Primer 
aniA 1 
GCCGACATCATAACGGTTCTGGCAAA 
 
Primer for sequencing the 
integrated aniA sequence 
along with the upstream 
lacI promoter region of 
pGCC4 
Sequencing Primer 
aniA 2 
GCCAACAAGAACCATCCGTTCTG Primer for sequencing the 
integrated aniA sequence 
along with the upstream 
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lacI promoter region of 
pGCC4 
aniA_Fwd_start ATGAAACGCCAAGCCTTAGC Forward primer for PCR 
amplifying the aniA 
coding region 
aniA_Rev_end TTAATAAACGCTTTTTTCGGATGCAGAGG Reverse primer for PCR 
amplifying the aniA 
coding region 
 
2.11.4 Preparation of Isocloning buffer 
Table 2.7 Preparation of Isothermal Buffer 
1 ml 
(µl) 
3 ml 
(µl) 
6 ml 
(µl) 
Components Mw  g µg 
500 1500 3000 1M Tris-HCl 
pH 7.5 
121.14 50 ml 6.06  
25 75 150 2M 
MgCl2.6H20 
203.30 2 ml 0.81  
10 30 60 100 mM dGTP N/A N/A N/A N/A 
10 30 60 100 mM dCTP N/A N/A N/A N/A 
10 30 60 100 mM dTTP N/A N/A N/A N/A 
10 30 60 100 mM dATP N/A N/A N/A N/A 
50 150 300 1M DTT 154.25 1 ml 0.15 154.3 
0.25 g 0.75 g 1.5 g PEG-8000 N/A N/A   
50 150 300 100 mM NAD 663.45 250 µl 0.02 16.6 
335 1005 2010 dH2O      
 
Table 2.8 Preparation of Isothermal assembly buffer for final Isocloning reaction 
Components 5 tubes (µl) 10 tubes 
(µl) 
5X isothermal assembly 
buffer 
20 40 
Dilute T5 Exonuclease 
(Dilute 8x – 1 µl to 7 µl 1x 
ISA buffer) 
0.5 1 
Phusion polymerase 1.25 2.5 
Taq ligase 10 20 
H2O 43.3 86.5 
 
The resulting final buffer was aliquoted into 15 µl volumes and stored in -20°C. 
2.11.5 DNA quantification by NanoDrop 
DNA was quantified by NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, 
Inc). The sample retention system in NanoDrop contains two surfaces, the upper and lower 
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optical surface. 2 µl of deionized water was added to the lower optical surface. The lever arm 
was closed to bath the upper optical surface several times. Both the optical surfaces were 
cleaned with Kimwipe. From the dropdown menu of NanoDrop software, nucleic acid module 
was selected. On the lower optical surface carefully 2 µl clean water was pipetted. Care had to 
be taken to avoid touching the optical surface with pipette tip. The level arm was brought down 
gently to touch the water and lower optical surface. The button ‘initialize’ from NanoDrop 
software was pressed. This step approximately lasted for 10 seconds. Both the surfaces were 
wiped with clean Kimwipe. A volume of 2 µl of DNA sample to be measured was pipetted 
carefully on the lower optical surface and liver arm was lowered gently to touch the sample. 
Reading was taken after pressing ‘measure’ button from the software. Alongside the DNA 
concentration reading, the 260/280 ratio reading was noted. A ratio between 1.8 and 2.0 was 
normally considered as an acceptable measure for DNA purity.    
2.11.6 Bacterial genomic DNA extraction 
A commercial bacterial genomic DNA extraction kit was used (Omega bio-tek, USA). Three 
single colonies of bacteria were incubated in the Mueller hinton broth overnight at 37°C, 5% 
CO2. No more than 3 ml culture or 1x10
9 cells were centrifuged at 4000 x g for 10 minutes at 
room temperature. The media was discarded and 100 µl TE buffer was added to the pellet. The 
pellet was resuspended completely by vortexing. After addition of 10 µl lysozyme, the bacteria 
were incubated at 37°C for 10 minutes. 100 µl BTL buffer and 20 µl proteinase K solution 
were mixed with the sample and vortexed thoroughly. The sample was incubated at 55° C water 
bath shaking every 20 minutes for 1 hour. Then 5 µl RNase A was added and the tube was 
inverted several times to mix. After incubating at room temperature for 5 minutes, the sample 
was centrifuged at 10000 x g for 2 minutes to pellet any undigested component. The supernatant 
was transferred to a fresh 1.5 mL microcentrifuge tube. Special care was taken not to dislodging 
the pellet. To the supernatant 220 µl BDL buffer was added and incubated at 65°C for 10 
minutes. 220 µl of 100% ethanol was added and vortexed for minimum 20 seconds at maximum 
speed. A HiBind DNA mini column (Omega Bio-Tek) was inserted into a 2 mL collection tube. 
The entire sample was transferred to the mini column along with any formed precipitate. After 
centrifugation at 10000 g for 1 minute the filtrate and collection tube were discarded. 500 µl 
HBC buffer was added after transferring the column to a new collection tube. After centrifuging 
at 10000 g for 1 minute the filtrate was discarded and the collection tube was reused for two 
700 µl DNA buffer wash. After the second DNA buffer wash, the empty column was 
centrifuged for 2 minutes at 10000 x g to get rid of any unwanted content on the column. The 
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column was inserted into a new 1.5 ml microcentrifuge tube. Preheated (at 65°C) elution buffer 
was added to the middle of the column and let to sit for 5 minutes at room temperature. DNA 
was eluted in the microcentrifuge tube after centrifuging at 10000 x g for a minute. After 
quantification with a NanoDrop spectrophotometer (Section 2.11.5), the DNA was stored at -
20°C with appropriate labelling. 
2.11.7  PCR Purification 
The PCR products were purified with Qiagen PCR purification kit before any cloning step to 
remove any carry over products from PCR reaction and restriction digest. Total 5 volume of 
Buffer PB was added to 1 volume of PCR sample and mixed thoroughly. A QIAquick spin 
column was placed in a 2 ml collection tube in the kit. The whole sample was applied to the 
column and centrifuged at 17900 x g (13000 rpm) for 30 to 60 seconds. The flow through was 
discarded and the column was placed back in the collection tube. For washing, the column was 
centrifuged after adding 750 µl of Buffer PE. For getting rid of any unwanted residue of PCR 
purification, the column was centrifuged for another minute. Then the column was placed in a 
clean 1.5 ml microcentrifuge tube. 50µl elution buffer was added to the centre of column and 
left at room temperature for 5 minutes. After centrifugation, the sample was collected and 
preserved in -20°C. 
2.11.8 Plasmid DNA extraction 
Plasmid DNA extraction kit from Qiagen was used. To extract plasmid from bacterial cultures 
one colony of plasmid from respective LB plate was inoculated in 5 ml of LB media. 
Antibiotics were added where appropriate: Ampicillin 100 µg/ml, Kanamycin 50 µg/ml, 
Erythromycin 300 µg/ml. The overnight culture was pelleted by centrifugation at 8000 rpm for 
3 minutes at room temperature. Bacterial pellet was transferred to a microcentrifuge tube after 
resuspending in 250 µl Buffer P1. The sample was mixed with 250 µl Buffer P2 and vortexed. 
After adding 350 µl Buffer N3 sample was centrifuged at 13000 rpm for 10 minutes. The 
supernatant was applied on to a QIAprep spin column and centrifuged for a minute and the 
flow through was discarded. The column was discarded again after adding 750 µl Buffer PE. 
The column was centrifuged twice to wash all the residual buffer and was let to stand for 5 
minutes at room temperature. Lastly, the plasmid was eluted by adding preheated 50 µl elution 
buffer to the centre of the column. After measuring the quality and quantity by using the 
NanoDrop spectrophotometer (Section 2.11.5), the plasmid was stored in the -20°C. 
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2.11.9 Restriction digest 
The restriction enzymes for cloning were carefully selected by avoiding the ones with star 
activity. Then the following recipe was used for setting up the restriction digest. Enzymes were 
purchased from Promega or NEB. Digests were set up according to the manufacturer’s 
instruction using the following protocol as standard: 
Table 2.9 Recipe for Restriction digest 
Components 20 µl reaction (For 
Promega enzymes) 
50 µl reaction (For 
NEB enzymes) 
DNA 1 µg 1 µg 
Restriction enzyme 1 µl (For double digest 2 µl, 
1µl for each enzyme) 
1 µl (For double digest 2 
µl, 1µl for each enzyme) 
Restriction digest buffer 2 µl 10X buffer 5 µl of 10X buffer 
BSA (if recommended) Up to 3 µl 10x buffer  
Nuclease free water Up to 20 µl Up to 50 µl 
 
The enzyme was the last item added to the mixture and taken out of the freezer just immediately 
before addition. Incubation time of digestion time depended on manufacturer’s instructions. 
For sequential double digest, product was digested with enzyme requiring low salt buffer first 
using the above recipe. Then product was digested with 2nd restriction enzyme with addition of 
1 µl of restriction enzyme, 5 µl buffer and 32 µl nuclease free water. After digestion enzymes 
were heat inactivated according to manufacturer’s instruction for each enzyme. Restriction 
digested product was run by 1% Agarose gel (Section 2.11.14) for digestion confirmation. 
2.11.10 DNA Ligation 
All the ligations were carried out by NEB’s T4 DNA ligase (M0202). The reaction was set up 
as follow: 
Table 2.10 Recipe for DNA ligation 
Components 20 µl Reaction 
10X DNA Ligase Buffer 2 µl 
Vector DNA : Insert 1:1, 1:3, 1:5 and 1:10 ratio 
Nuclease free water Up to 20 µl 
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T4 DNA Ligase 1 µl 
 
The mixture was pipetted gently and incubated at 16°C overnight in a thermocycler.  
Table 2.11 Control for ligation reactions 
Control Ligase Interpretation 
Uncut vector - Checks for the viability of the competent cells 
and efficacy of the antibiotic resistance of the 
agar plates. 
Cut vector - Background colonies due to undigested vector. 
Cut vector + Background colonies due to recircularisation 
of vector in particular useful for verifying 
phosphatase treated vector. 
Water or insert + Presence of any colony indicates the 
contamination of intact plasmid in ligation or 
transformation agents. 
Cut vector + insert + Grown colonies likely to contain the desired 
cloned sequence and have to be screened for 
the presence of right sequence by diagnostic 
PCR, restriction digest and sequencing. 
 
2.11.11 Phosphatase treatment 
Where appropriate the plasmid vector had to be treated with phosphatase to remove 5' 
phosphate group. Therefore, the chance of vector re-circularisation following ligation step was 
minimised. During this project, Antarctic Phosphatase (NEB, M0289S) was used. Following 
double digestion, 5 µl of Antarctic phosphatase reaction buffer (x10) and 1 µl Antarctic 
phosphatase enzyme were added. The reaction mix was incubated at 37°C for 1 hour. 
2.11.12 Broth culture transformation of N. meningitidis 
Cells from frozen stocks of N. meningitidis were plated on GC Agar plate (with 2% Vitox 
supplement) containing appropriate antibiotic in the CO2 incubator at 37
°C. Colonies from 
overnight plate were inoculated in 2 ml of liquid MHB containing 10 mM MgCl2 at OD550nm ~ 
0.1. Two micrograms of DNA was added to the culture followed by a 6 hour incubation period 
at 37°C with shaking. After this incubation period, 100 µl of pure culture, undiluted or diluted 
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1/10, 1/100 and 1/1000 were spread on GC Agar plates containing appropriate antibiotic 
(Section 2.4.2). Recombinant colonies normally appeared after 48 hour period of incubation at 
37°C in the presence of 5% CO2. 
2.11.13 Spot transformation of N. meningitidis 
An overnight (around 16 hour) growth culture of N. meningitidis was grown on a GC agar plate 
(Section 2.4.2). A square of 1x1 cm was drawn on the back of GC Agar plate using a marker 
pen and a small amount (barely visible) of the overnight culture was streaked onto this square. 
The DNA to be transformed was spotted onto the bacteria on the square and the plates were 
incubated at 37°C with 5% CO2 for 8 hours. Following incubation period, the whole bacterial 
population within the square was plated on a fresh GC agar plate containing appropriate 
antibiotics. Single colonies from the plates were picked after 48 hours and were restreaked onto 
fresh antibiotic containing plates. Prior to testing by colony PCR (Section 2.11.15.1) this 
process was repeated again to prevent selecting false positives from non incorporated DNA 
used for the transformation. This also ensured the stability of antibiotic resistance over longer 
period of time before screening. 
2.11.14 Agarose gel electrophoresis 
Genetically manipulated DNA was checked by separating them on agarose gel. For visualising 
normal bands 1% gel was run. The larger bands (5.0 -10.0 Kb) were checked on a lower 
percentage (0.6%) gel. 0.5 g of agarose was melted in 50 ml of 1 x TAE buffer to produce 1% 
agarose gel. For visualising DNA bands, 0.1 µg ml-1 ethidium bromide was added to the 
agarose gel solution before pouring. The gel was set in an appropriate gel tank which was 
carefully sealed around by tapes to prevent any possible leakage. The gel tank was transferred 
to a horizontal tank and submerged in 1 x TAE buffer. All the PCR product to be run were 
mixed with 5 X DNA loading buffer (Qiagen) to a final solution of 1 X 5 ul of PCR product 
which was loaded on the gel along with 1 Kb DNA Hyperladder I (Bioline). The gel was run 
at 90 V for an hour using a Bio Rad powerpack. A dual intensity transilluminator (UVP) was 
used for the ultraviolet visualisation of the DNA bands. 
2.11.15 PCR reactions 
2.11.15.1 Colony PCR  
For performing confirmatory PCR, colonies from appropriate antibiotic containing plates were 
picked by pipette tip and dissolved in 20 µl RNase free water (Qiagen). 5 µl of this mix was 
plated on appropriate antibiotic containing plate and the rest was denatured by a PCR machine 
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at 95°C for 5 minutes. This solution was used as a template for subsequent PCR. My TaqTMRed 
mix (Bioline) (Section 2.11.15.2) was used to screen for positive colonies. 
2.11.15.2 My Taq Red Mix 
My Taq Red Mix (MyTaqTM, BIO-25043, Bioline) contains a very efficient and rapid Taq 
polymerase. The mix contains all the essential components for optimum PCR such as Taq 
buffer, dNTPs, MgCl2, enhancers and stabilizers. Therefore, the mix was added with the 
template and primers directly. After PCR, samples can be directly loaded on to the Agarose gel 
as the My Taq mixture contains red loading dye which does not interfere with the PCR process. 
Table 2.12 PCR mix for My Taq Mix 
Components Amount 
Template 100 ng 
Primers (10 µM) each 1 µl 
My Taq Mix, 2x 12.5 µl 
Water Up to 25 µl 
Total 25 µl 
 
Table 2.13 PCR cycling conditions for My Taq PCR 
Step Temperature Time Cycles 
Initial denaturation 95°C 1 minute 1 
Denaturation 95°C 15 second  
 
25-35 
Annealing Variable 
 (Depended on the 
primers used, normally 
calculated from primer 
Tm calculators from 
website) 
 
15 second 
Extension 72°C 30 second per 
Kb 
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2.11.15.3 ACCUZYME DNA polymerase 
ACCUZYME™ is a very high yield DNA polymerase (BIO-21051, Bioline). It’s a 
thermostable and high-fidelity enzyme producing blunt end amplicons of up to 5 Kb in length. 
It possesses 5'→ 3' polymerase and 3' → 5' exonuclease activity. Mg2+ containing 10X reaction 
buffer helps to optimise a range of PCR conditions.  
Table 2.14 PCR mix for Accuzyme polymerase 
Components Amount 
10 X AccuBuffer 5 µl 
50 mM MgCl2 Optional 
100 mM dNTP 0.5 – 1 µl 
Template As required 
Primers 20 mM each 1 µl 
ACCUZYME DNA polymerase 2.5 U/µl 1 – 3 µl 
Water (ddH2O) Up to  50 µl 
Total 50 µl 
 
Table 2.15 PCR cycling conditions for Accuzyme DNA polymerase 
Step Temperature Time Cycles 
Initial denaturation 95°C – 98°C 3 minute 1 
Denaturation 95°C – 98°C 15 second  
25-30 cycle Annealing 55°C – 60°C 
(Variable, depended 
on the primers of the 
reaction) 
15 second 
Extension 72°C 1.5-2 minute/Kb 
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2.11.15.4 NEB PhusionR high-fidelity Master Mix with HF buffer 
NEB high-fidelity phusion polymerase (NEB, M0531S) is important for applications in which 
the target DNA sequence has to be correctly amplified. It’s a thermostable polymerase that has 
an error rate of 50% lower than that of Taq polymerase. It possesses 5'→ 3' polymerase and 3' 
→ 5' exonuclease activity. The following reaction mix and cycling conditions were used: 
Table 2.16 PCR mix for NEB Phusion polymerase 
Component Concentration 
5 X Phusion HF or GC buffer 10 µl 
10 mM dNTPs 1 µl 
10 µM forward primer 2.5 µl 
10 µM reverse primer 2.5 µl 
Template DNA Variable 
DMSO (1.5 µl) 
Phusion DNA polymerase 0.5 µl 
Nuclease free-water Up to 50 µl  
Total  50 µl 
Table 2.17 PCR cycling condition for NEB Phusion polymerase 
Step Temperature Time 
Initial denaturation 98°C 30 second 
25-35 cycles 98°C 
45°-72°C (Was calculated 
using the Tm calculator 
available in the NEB 
website) 
72°C 
5-10 second 
10-30 second 
15-30 second per Kb 
Final extension 72°C 5-10 minute 
Hold 4°-10°C 10 minute 
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2.11.15.5 Q5 High Fidelity DNA Polymerase 
Q5 High-Fidelity DNA polymerase (M0491S, NEB) is a high fidelity polymerase from NEB 
which has 12 times lower error rate compared to the Pfu (Pyrococcus furiosus) and 100 fold 
lower than the Taq DNA polymerase.  It is a thermostable DNA polymerase with 3' – 5' 
exonuclease activity. The following reaction conditions were used: 
Table 2.18 PCR recipe for Q5 DNA polymerase 
Components 50 µl reaction Final Concentration 
5 x Q5 reaction buffer 5 µl 1 x 
10 mM dNTPs 1 µl 200 µM 
10 µM Forward Primer 1.25 µl 500 nM 
10 µM Reverse Primer 1.25 µl 500 nM 
Template DNA Variable 
(Genomic DNA 1 ng – 1 µg, 
Plasmid DNA 1 pg – 1 ng) 
<1000 ng 
Q5 High Fidelity DNA 
Polymerase 
0.25 µl 0.02 U/µl 
Nuclease free water Up to 50 µl  
 
Table 2.19 PCR cycling condition for Q5 DNA Polymerase 
Step Temp Time 
Initial Denaturation 98°C 30 second 
18-20 cycles 98°C 5-10 second 
 50°C - 72°C (Was calculated 
using the Tm calculator from 
the NEB website) 
10-30 second 
 72°C 20-30 second/Kb 
Final Extension 72°C 2 minute 
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3 Chapter 3: Role of denitrification of N. meningitidis in 
the homeostasis of NO metabolites in a murine model of 
early fulminant meningococcal sepsis  
3.1 Introduction 
Meningococcal sepsis is a complex systemic inflammatory condition which causes significant 
morbidity and mortality around the world. The mortality rate for those diagnosed with 
fulminant meningococcal sepsis (FMS) is up to 50% although recent advancements in medicine 
have helped to lower the death rates (Booy et al, 2001). Pathophysiology in sepsis is 
characterized by a rapid burst of pro-inflammatory immune response. Subsequently, increased 
vascular permeability, intravascular thrombosis and both abnormal vasodilation and 
vasoconstriction can result in the failure of circulatory system, leading to multiple organ failure 
and death (Klein et al, 1992; Oragui et al, 2000) (for details see Section 1.6). Unlike other 
forms of sepsis caused by gram negative bacteria, FMS causes severe pathology within few 
hours which can lead to death.  Despite aggressive resuscitation and treatment with drugs and 
fluid, the mortality rate from meningococcal sepsis remains high.  
One of the main features of sepsis is failure of the tightly regulated microvasculature. NO is a 
pivotal signalling molecule for maintaining vascular homeostasis and hemodynamics (Section 
1.11.1). Therefore, NO could be a key molecule whose disruption might affect the 
pathophysiological course of meningococcal sepsis. In septic patients there is a high correlation 
between sepsis severity and detectable levels of lipooligosaccharides (LOS), endotoxin present 
in the cell wall of N. meningitidis (Brandtzaeg et al, 1992). Likewise there is a strong 
association between bacterial genomic load and severity of meningococcal disease (Darton et 
al, 2009). Bacterial LOS induces iNOS production at a very high rate. During sepsis high levels 
of NO from iNOS may contribute to hypotension and inflammatory tissue damage (Kilbourn 
et al, 1997; Thiemermann, 1997).  
There have been a number of studies that reported a positive correlation between infection and 
amounts of circulating nitrogen oxides such as NO2
-
 and NO3
- in sepsis. Children with septic 
syndrome such as hypotension have high levels of NO2
- and NO3
- in serum (Wong et al, 1995). 
Similar analysis in the CSF of meningitis patients reported a 3 fold increase in NO3
- and almost 
50 fold increase in NO2
- (Visser et al, 1994). In children, meningococcal sepsis is characterised 
by high bacterial titres in blood and sepsis severity correlates with an increased production of 
circulating nitric oxides, including NO2
- and NO3
- (Baines et al, 1999). High plasma levels of 
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NO2
-/NO3
- is found in new born infants with sepsis (Shi et al, 1993) and adult patients in 
intensive care unit (Gomez-Jimenez et al, 1995; Ochoa et al, 1991). Formation of SNO, termed 
S-nitrosylation, is an important form of post-translational protein modification akin to 
phosphorylation and is important for regulating myriad cellular processes such as vasodilation, 
apoptosis, neurotransmission, cell signalling and gene expression (Allen & Piantadosi, 2006; 
Seth & Stamler, 2010; Stamler et al, 2001). Previous studies from our group have shown 
that NorB-mediated NO detoxification by N. meningitidis reduces the concentration of 
host-cell SNO (Laver et al, 2010). This could have far reaching consequences for 
homeostasis of the pathways regulated by SNO such as SNO-Hb mediated vascular 
regulation. Following deoxygenation of blood, NO bound to conserved cysteine of SNO-
Hb is dispensed at microvascular sites leading to vasodilation (Section 1.10). This process 
couples deoxygenation of haemoglobin to vasodilation. If a similar SNO depletion effect 
can be observed in vivo following meningococcal infection, then it is plausible that SNO 
repletion may be a viable therapy for treatment of meningococcal sepsis. 
Supplementation with S-nitrosoglutathione (GSNO) has been shown to be effective in 
repairing cerebrovascular damage in an animal model of haemorrhage (Sehba et al, 
2007). We hypothesise that bacterial NO denitrification during sepsis interferes with the 
amount of NO metabolites, including SNO, within the organs of the host in vivo and 
contributes toward pathogenesis. To test this we decided to establish a murine model of 
early acute meningococcal sepsis and to do a comparative analysis of NO metabolites 
produced in response to bacterial infection by N. meningitidis. By using both a wild type 
strain (MC58) and mutants with different insertionally-inactivated NO denitrification 
genes, we intend to investigate whether bacterial mechanisms of NO detoxification are 
able to impact on systemic levels of NO metabolites. 
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3.2 Ozone based chemiluminescence and NO analyser 
One of the most enduring and sensitive techniques for measuring NO is the ozone based 
chemiluminescence. Quantification of NO is performed by gas-phase chemiluminescence 
detection using ozone (O3). Singlet oxygen molecules react readily with a variety of gases such 
as NO, NO2, SO2 and CO. In contrast, ozone reacts more rapidly with NO due to lower 
activation energy of the reaction. In the gas phase, O3 reacts with NO and generates NO2 in an 
excited state (NO2*) (Reaction 1). The excited NO2* returns to the ground state either by 
colliding with another molecule, or by the release of a photon. Photon release is detected in the 
red and near infrared region of the spectrum (Gorimar, 1985). The amount of NO present in 
the sample is directly proportional to the emission of light. The whole reaction is pressure and 
temperature sensitive. 
NO + O3 NO2* + O2 NO2 + O2 + hv…………………….(1) 
Although the first chemiluminescence based NO analyser was developed in 1970 (Fontijn et 
al, 1970), the basic design of the apparatus has remained unaltered. The Sievers 280i Nitric 
Oxide Analyser used for this study consists of a reaction cell, an ozone generating pump and a 
cooled photomultiplier tube (Figure 3.1). Ozone is supplied to the machine in excess, ensuring 
that O3 does not become a limiting factor in the generation of NO2*.  The samples are drawn 
to the reaction cell through a vacuum of gas-impermeable reaction tube. Reaction with O3 takes 
place inside the vacuum, ensuring minimal mechanical quenching of excited NO2*. The 
vacuum also acts to stabilise NO by removing O2, which could react with NO to form NO2. 
Since NO2 does not emit light following interaction with O3, the presence of the vacuum 
therefore prevents loss of signal strength. The NO analyser is built in with a specific and very 
sensitive photomultiplier tube capable of detecting light in the near-infrared range. This is 
pivotal to the accurate detection of signal from reaction vessel as red and infrared light 
generated from the relaxation of NO2* is of very low intensity. It enables individual photons 
from the light to be detected on a photosensitive surface and causes the release of electrons 
which are accelerated in an electron multiplier field comprising of several dynodes. The 
cumulative action of multiple dynodes leads to the generation of several million electrons from 
a single photon. These electrons are drawn to the anode resulting in the production of a current 
pulse by the accumulation of charges. The current is used by NO analyser to detect amount of 
NO present in the sample. The signal by current pulse is digitalised and relayed to a computer 
attached to the machine. It is plotted as the intensity of signal (mV) against time using the user 
friendly LIQUID software. As the reaction of NO with O3 takes place in the gas phase, NO
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 present in the liquid samples have to be stripped into gas phase. High partition coefficient of 
NO helps the voluntary diffusion of NO from liquid to gas phase. To aid this process an inert 
gas, nitrogen (N2) is passed through the liquid sample in the purge vessel. In addition, this helps 
to maintain an oxygen depleted environment inside the purge vessel and thereby preventing 
the formation of NO2 from NO. 
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Figure 3.1 A cartoon summarising the apparatus set up for NO measurement by ozone 
based chemiluminescence. 
Sample is added on to the reactant (reducing agent) inside the purge vessel. Generated NO 
diffuses into the headspace above the reactant through NaOH trap and pulled into the NO 
analysed by an external vacuum. NO reacts with the O3 from ozone generator and light emitted 
in the reaction is detected, amplified and converted into electrical signal by photomultiplier 
tube (PMT). The final output displayed on the monitor of attached computer. The data is 
analysed by specialised LIQUID software. Figure reproduced from (Samouilov & Zweier, 
1998) 
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3.3 Measurement of NO metabolites by chemiluminescence 
For measuring NO metabolites such as NO2
-, NOx and SNO, samples were reduced using a 
variety of reducing agents. The most commonly used method for measuring SNO is triiodide 
(I3
-) based chemiluminescence. The method was first used for measuring low molecular weight 
SNO (Samouilov & Zweier, 1998). Later adaption of the method enabled the measurement of 
larger molecular weight SNO such as SNO-albumin (Marley et al, 2000). In a series of 
reactions (Reactions 2-6), the NO moiety from SNO is released by reduction at a stoichiometry 
of 1:1. During the process, the reaction chamber is maintained at 30°C by connection to a 
circulating water bath, and acidic vapours are neutralised in an acid-vapour trap. The I3
- 
solution (Section 2.3.4) can yield a chemiluminescence signal from all NO species except 
nitrate (NO3
-). Therefore, signal coming from the reduction of each NO species has to be 
separated for determining the concentration of any particular NO moiety. This is achieved by 
splitting the samples into aliquots and treating them with different reagents, in order to remove 
or otherwise render the moiety/moieties inert that would otherwise contribute to the 
chemiluminescence signal (Figure 3.2). Treatment of sample with acidified sulphanilamide 
complexes the NO2
- present in the sample, incorporating it into a stable diazonium compound 
that can no longer be reduced into NO by I3
- solution. Treatment of samples with HgCl2 releases 
a nitrosonium ion (NO+) from SNO, which replaces NO group present in SNO with Hg+ ion. 
After measuring the output from differentially treated samples, it is possible to subtract the 
signals derived from each measurement from the overall (untreated) signal, enabling the 
operator to calculate the concentration of a given NO compound. A detail overview of the 
process in presented in Figure 3.2. 
I2 + I
- → I3-.............................................(2) 
I3
- + 2RSNO → 3I- + 2RS + 2NO+…....(3) 
2NO+ + 2I- → 2NO + I2……………….(4) 
RSNO → RS● + NO………………….(5) 
2RS● → RSSR………………………..(6) 
To measure higher NO oxides such as NO3
- by ozone-based chemiluminescence, a stronger 
reducing agent is required. An acidified, saturated VCl3 solution is used to liberate NO from 
NO3
- (Reaction 7). The solution reduces all oxidised NO metabolites (NOx) such as NO2
-, S-
nitrosocompounds, N-nitrosamines and Fe-nitrosyls, producing NO. The reaction takes place 
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at 95°C in the purge vessel. The acid vapour trap is particularly important when making these 
measurements, and contains 1 M NaOH to neutralise the hot acidic vapour from the acidified 
VCl3 solution (Section 2.6.3).  
2NO3
- + 3V3+ + 2H2O → 2NO + 3VO2+ + 4H+………………(7) 
An anti-foaming agent (Section 2.1.1) is used to prevent excessive foam formation, which is 
often encountered while measuring NOx with acidified VCl3. Excess foam can interfere with 
the chemiluminescence signal. 
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Figure 3.2 Schematic summarising the processes involved in the measurement of NO 
metabolites by I3- based chemiluminescence. 
Samples were split into different parts and treated with different compounds prior to I3
- based 
chemiluminescence. Measurement of each compound achieved different objectives: HgCl2 
released NO from SNO present in the sample. Acidified sulfanilamide converted NO2
- present 
in the samples into a non I3
- reactive diazonium salt. Concentrations calculated for treated 
samples (adjusted for extra dilution) were deducted from the concentration calculated for 
untreated samples, allowing the concentration of SNO and NO2
- to be elucidated. Adapted from 
(Yang et al, 2003 ) 
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3.4 Considerations for preparation of biological samples for 
chemiluminescence 
Careful preparation of biological samples is pivotal for accurate measurement of NO 
metabolites by chemiluminescence. Sonication is a widely used method for cell lysis. However, 
exposure of low molecular weight thiols to ultrasonication in presence of air leads to the 
production of S-nitrosocompounds (Stepuro et al, 2000). This property eliminates 
ultrasonication as a choice of method for cell lysis. Detergents are normally avoided to lyse 
cells for NO measurement by chemiluminescence due to their propensity to form excessive 
foams in the purge vessel. However, no such problem was encountered with NP-40, the 
detergent used for cell lysis during this study. 
N-ethylmaleimide (NEM), an alkylating agent; is used in the lysis buffer to block any free thiol 
residue in the samples. NEM is a thiol-reactive substance, and prevents artefactual SNO 
formation in the lysates. Samples were incubated on ice for 10 minutes for this reaction to 
happen. In addition, the lysis solution contained protease inhibitor cocktail and 
phenylmethanesulfonate (PMSF), a serine-protease inhibitor, to prevent protein degradation. 
This step was crucial as all the SNO readings were normalised to protein concentration in those 
samples.  
The NO-heme adduct iron-nitrosyl-hemoglobin (HbFeIINO) is formed through the reversible 
reaction between NO and haemoglobin. The resulting HbFeIINO can bind to thiol on cysteine-
93 of the β-globin chain to form S-nitrosohaemoglobin (SNO-Hb). After collecting whole 
blood it was centrifuged and plasma from the upper layer was stored in a separate tube. From 
the bottom of the pellet red blood cells were moved and rapidly collected in a stabilisation 
solution (Section 2.5.5). SNO-Hb had to be stabilised as it degrades rapidly in red blood cell 
environment in a temperature and redox dependant manner (Gladwin et al, 2002). SNO-Hb 
stabilising solution consisted of potassium ferricyanide (K3Fe
III(CN)6), N-ethylmaleimide 
(NEM), diethylenetriaminepentaacetic acid (DTPA) and 1% NP-40 detergent in PBS. The 
potassium ferricyanide component redox inactivated the heme group by forming 
cyanomethemoglobin. Red blood cell membranes were rapidly solubilised and lysed by NP-40 
detergent which released any membrane bound S-nitrososthiol.  NEM blocked the free thiol 
groups on the lysates and contaminating copper and trace metals were chelated with DTPA.  
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In addition, all the samples were preserved in light protected tubes and stored in liquid nitrogen 
to keep degradation of NO metabolites such as SNO to a minimal level.  Repeated freeze-
thawing also was avoided.  
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3.5 Results 
3.5.1 Establishing a murine model of early fulminant meningococcal sepsis 
Section Summary: 
 A high bacterial inocula (109) causes severe bacteraemia in a murine 
model of meningococcal septicaemia within 6 hour 
 NO metabolite concentrations in liver homogenate and whole blood are 
not differentially affected by meningococcal NO detoxification 
 
3.5.1.1 Rationale and methods 
 
It was necessary to establish a murine model capable of producing fulminant meningococcal 
sepsis in a reproducible manner. This model was to be used to measure NO metabolites such 
as SNO, NO2
- and NOx. Previous studies from our lab have shown that NO detoxification of 
N. meningitidis prevents the formation of S-nitrosothiol in a murine macrophage cell line 
J774.2 (Laver et al, 2010). The initial aim of this study was to establish a model to investigate 
if the observation can be replicated in vivo.  
Preliminary experiments revealed that a dosage of 1010 bacteria per mouse elicited highly 
severe sepsis from the mice. Dosages from 106-108 bacteria per mouse were too low to establish 
bacteraemia (data not shown). Inocula of 109 bacteria per mouse, however was able to 
reproducibly induce sepsis, which was confirmed by the recovery of viable meningococci from 
murine blood and liver lysates. Preliminary experiments also showed that detectable levels of 
SNO are found in murine blood and liver but not from kidney and spleen (data not shown). 
High levels of iNOS mRNA have been detected from septic rat (Hom et al, 1995). NO 
signalling is critically important in the regulation of SNO proteins in blood such as SNO-
albumin and SNO-Hb (Stamler, 2004). Substantial iNOS activity (Knowles et al, 1990) and 
presence of an extensive S-nitrosoproteome (Lopez-Sanchez et al, 2008) have been reported in 
the murine liver. As such, the decision was made to measure NO metabolites exclusively in 
blood and from liver.   
To investigate whether the activity of the nitric oxide reductase (NorB) of the meningococcus 
had any effect on circulating and/or hepatic concentrations of NO metabolites in the acute cases 
of murine meningococcal sepsis, C57Bl/6 mice (Harlan, UK) were inoculated intraperitoneally 
(i/p) with a bolus of 109 wild type or ΔnorB mid-log phase bacteria suspended in 10 units (100 
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μl) of sterile PBS (Section 2.5.1). Mice were monitored continually and were scored hourly on 
the severity of infection (Section 2.5.2).  The frequency of scoring was increased from hourly 
to half-hourly upon individual mice reaching a cumulative severity score of 19 or more. Upon 
reaching the end point of the experiment, mice were terminally anaesthetised using an i/p 
injection of sodium pentobarbitone (5 units/mouse). Mid-place anaesthesia was confirmed by 
the loss of pedal withdrawal-reflex. Blood was collected by exsanguination through cardiac 
puncture and whole liver was excised. After collecting the whole blood it was centrifuged and 
plasma from the upper layer was stored in a separate tube. From the bottom of the pellet red 
blood cells were moved and rapidly collected in a stabilisation solution (Section 2.5.5). After 
stabilisation, the mix was filtered through a Sephadex G25 sizing column to remove low 
molecular weight SNO and elute the SNO-Hb. The SNO-Hb solution was split into two 
fractions. The first fraction was treated with HgCl2 to liberate nitrosonium ion (NO
+) from 
SNO. Subsequently it was treated with acidified sulphanilamide to eliminate any contaminating 
NO2
- through the formation of diazonium salt. Second fraction was treated with acidified 
sulphanilamide to remove NO2
-. Difference in readings between two fractions corresponded to 
the amount of SNO-Hb in the sample (Figure 3.2). The reading was normalised to percentage 
of SNO per heme molecule determined using Drabkin’s solution (Section 2.5.7). Whole liver 
was treated with 0.25% bile salt to remove external bacteria and homogenised using a hand 
held rotor-stator homogeniser in SNO compatible lysis buffer (Section 2.5.3 and Figure 3.3).  
After appropriate preparation of plasma (Section 2.5.4), SNO-Hb (Section 2.5.6) and liver 
lysates (Section 2.5.3) samples, they were measured by I3
- based chemiluminescence (Section 
2.6.2). For SNO measurement samples were normalised to the protein concentration of the 
lysate (Section 2.10.4). Plasma NOx was measured by acidified VCl3 (Section 2.6.3). All the 
measurements were subsequently analysed by using the Origin software (Section 2.6.5).  A 
summarised schematic for the experimental procedure is presented in Figure 3.3. 
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3.5.1.2 Results 
 
Each infected mouse demonstrated an increasing severity of infection over time, with the 
severity limit being equalled or exceeded in each infected mouse at 6 hour (Figure 3.4 B and 
C).  Injection with a bolus of PBS alone did not result in the generation of sepsis symptoms, 
and the mice were phenotypically unaffected (Figure 3.4 A).  There was no significant 
difference in the severity of sepsis between mice infected with wild type bacteria and mice 
infected with ∆norB bacteria (Area under curve analysis, p = 0.58). 
Sepsis was confirmed by serial tenfold dilution of either blood or liver homogenate in PBS, 
followed by viable count (Figure 3.5). There was no statistically significant difference between 
the viable counts of the inocula between Wt = 5.9 x 108 cfu/ml (IQR = 5.1 x 108 – 8.3 x 108) 
and ∆norB = 5.89 x 108 cfu/ml (IQR = 4.58 x 108 – 8.22 x 108) infected mice. Recovery of 
viable bacteria from blood and liver homogenates was possible for both wt and ∆norB-infected 
mice, however there was no statistically significant difference in the viable count recovered 
from whole blood and liver lysates between Wt and ∆norB infected mice. 
Mice infected with ∆norB showed significantly higher plasma NOx concentrations (160.9 µM 
(IQR = 112.8 - 237.3)) compared to the PBS control group (18.74 µM (IQR = 5.69 – 63.39)) 
(Figure 3.6 A). This was not seen in case of the NO2
- output (Figure 3.6 B). Infection with 
either wild type or ∆norB strain led to a significant increase in the concentration of plasma 
SNO (Wt = 58.49 nM (IQR = 33.92 – 73.17); ∆norB = 59.32 nM (IQR = 51.33 – 73.60)), as 
compared to PBS-injected mice (19.79 nM (IQR= 14.18 – 38.61) (*p <0.05). There was no 
statistically significant difference between Wt and ∆norB infected mice (Figure 3.6 C). A 
similar observation was made for SNO-Hb measurements, which were significantly elevated 
in the RBC of infected mice as compared to those injected with PBS alone. Mice infected with 
wt strain contained 3.2 x 10-3 % SNO per heme (IQR =1.96 x 10-3 % - 4.52 x 10-3 % SNO per 
heme) and mice infected with ∆norB bacteria produced 3.38 x 10-3 % SNO per heme (IQR= 
2.22 x 10-3 % - 6.84 x 10-3 % SNO per heme).  The concentration of SNO-Hb in PBS-injected 
mice was 6.3 x 10-4 % SNO per heme (IQR= 4.13 x 10-4 % - 1.19 x 10-3 % SNO per heme) 
(*p<0.01) (Figure 3.6 D). 
The concentration of SNO measured in liver homogenates, produced from the liver of wt-
infected mice was 3.006 pmol/mg (IQR= 2.40 - 4.78) and in liver homogenates produced from 
the liver of ∆norB-infected mice was 3.32 pmol/mg (IQR = 2.36 - 4.49) (Figure 3.7).  While 
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these concentrations are not significantly different from one another, infected mice exhibited a 
significantly higher concentration of liver homogenate SNO than did PBS-injected controls, 
(0.63 pmol/mg (IQR= 0.06 – 1.09)) (*p<0.01). A similar pattern was observed in the 
concentrations of liver homogenate NO2
-, insofar as there was a general increase in the 
concentration of this metabolite in the livers of infected mice as compared to PBS-injected 
controls, but in this instance the increase was not statistically significant. 
Table 3.1 details the breakdown of the concentrations of various NO metabolites measured in 
both murine blood and liver homogenates. 
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Table 3.1 Summary of NO metabolites output from mice infected with 109 bacteria/mouse 
suspended in PBS for 6 hours. Values are given as median, with interquartile range (IQR) 
in parentheses 
NO metabolites PBS Wt ∆norB 
Plasma NOx 18.74 µM 
(5.69 - 63.87) 
153.5 µM 
(131.4 – 176.7) 
160.9 µM 
(112.8 – 237.3) 
Plasma NO2- 1.12 x 103 nM ( 5.74 
x 102 – 3.71 x 103) 
1.6 x 103 nM ( 1.1 x 
103 – 1.84 x 103) 
1.46 x 103 nM (1.14 x 
103 – 1.68 x 103) 
Plasma SNO 19.79 nM (14.18 – 
38.61) 
58.49 nM (33.92 – 
73.17) 
59.32 nM (51.33 – 
73.60) 
SNO-Hb 6.3 x 10-4 % SNO 
per heme (4.13x10-4 
% – 1.19 x 10-3 %) 
3.2 x 10-3 % SNO 
per heme (1.96 x 10-
3 % – 4.52 x 10-3 %) 
3.37 x 10-3 % SNO per 
heme (2.22 x 10-3 % – 
6.84 x 10-3%) 
Liver SNO 0.63 pmol/mg (0.06 
– 1.089) 
3.006 pmol/mg (2.41 
– 4.78) 
3.32 pmol/mg (2.36 – 
4.49) 
Liver NO2- 18.27 pmol/mg 
(12.79 – 29.64) 
63.17 pmol/mg 
(18.63 – 85.00) 
69.26 pmol/mg (31.72 
– 103.7) 
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Figure 3.3 Workflow of experimental procedures for the measurement of NO metabolites 
in a murine model of early fulminant meningococcal sepsis. 
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Figure 3.4 Severity scoring data in 7-10 week old female C57BI6 mice infected with 109 
bacteria/mouse suspended in PBS over the course of 6 hours A) PBS B) Wt and C) ∆norB. 
Following intraperitoneal injection mice were monitored for severity every hour according to 
the sepsis severity scoring guideline (Section 2.5.2). Total score 9-18 = moderate, 19- 24 = 
substantial (monitored every 30 minutes), 25-30= substantial (mice had to be culled). Bars 
denote median. One way ANOVA with Dunn’s post test.  
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Figure 3.5 Viable bacteria recovered from inocula (A), whole blood output (B), and liver 
lysates (C) after experiment in murine model infected with 109 bacteria/mouse in PBS for 
6 hours. 
Samples were serially diluted and triplicate of 10 µl aliquots of each dilution were separately 
spotted on CBA plates, left in a microbiological safety cabinet for 10 minutes to allow them to 
air-dry.  Following overnight incubation at 37°C, 5% CO2, the mean number of colonies for 
each dilution were counted and corrected for the dilution factor and volume. Thus the mean of 
countable dilutions were averaged to estimate the number of bacteria present in the original 
suspension. Viable counts of bacteria recovered from mice liver lysates infected with Neisseria.  
Liver lysate viable counts were normalised to CFU/g of excised liver (wet weight). Bars denote 
median. For statistical analysis, Unpaired t-test was used.  
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Figure 3.6 Measurement of plasma NOx (A), NO2- (B), SNO (C) and SNO-Hb (D) in mice 
infected with 109 bacteria + PBS for 6 hours. 
NO metabolites were measured in red blood cell after bolus injection of endotoxin free PBS + 
Wild type/ΔnorB N. meningitidis (109 bacteria/mouse) into 7-10 weeks old female C57BI6 
mice. NOx (A) was measured by acidified VCl3 at 90
°C (Section 2.6.3). NO2
- (B) and SNO (C) 
were measured by I3
- dependent, Ozone-based chemiluminescence with reference to a GSNO 
standard curve (Section 2.6.2).  SNO-Hb (D) was normalised to heme % (Section 2.5.6- 2.5.7). 
Bars denote median. For statistical analysis, One way ANOVA with Dunns test was performed 
using Graphpad Prism (v5). *p<0.05, **p<0.01.  
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Figure 3.7 Measurement of Liver NO2- (A), SNO (B) in mice infected with 109 bacteria 
suspended in PBS for 6 hours. 
Liver lysates were processed by a hand held rotor stator homogeniser (Section 2.5.3). NO 
metabolites (A and B) were measured by I3
- dependent, Ozone-based chemiluminescence with 
reference to a GSNO standard curve (Section 2.6.2). Bars denote median. For statistical 
analysis One way ANOVA with Dunns post test was performed. *p<0.05 
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3.5.2 Refining the murine model of acute meningococcal sepsis 
Section Summary: 
 Inclusion of human holo transferrin induces prolonged sepsis with a 
lower dosage of bacterial inocula (107) 
 Bacterial NO denitrification pathway does not affect the production of 
NO metabolites in liver and whole blood 
 Bacterial burden correlates with increased Plasma SNO, increased 
hepatic NO2- and decreased hepatic NOx 
 
3.5.2.1 Rationale and methods 
 
Despite successfully establishing a model of reproducible meningococcal sepsis, the bacterial 
inoculum was relatively high (109 bacteria/mouse) (Section 3.5.1.1). One consequence of a 
large inoculum was the rapid increase in severity score, such that the severity became 
substantial within 5 hour and equalled or exceeded our severity limits within 6 hour (Figure 
3.4). A previous in vitro study in J774 murine macrophages showed that iNOS expression is 
mandatory for norB mediated SNO depletion (Laver et al, 2010). Given that synthesis of iNOS 
and the accumulation of iNOS-derived NO take time, it would be preferable for the model to 
be run over a longer time period.  
A large bacterial inoculum was necessary to induce sepsis in our original model, most likely 
due to the inaccessibility of iron in the murine system (Figure 3.4 - 3.7). N. meningitidis 
accesses iron by binding to the human transferrin, achieved through the expression of outer 
membrane receptor proteins termed as transferrin binding proteins (TbpA and TbpB) (Renauld-
Mongenie et al, 2004). However, these proteins are highly specific for human transferrin, and 
N. meningitidis is unable to bind to and liberate free iron from murine transferrin (Gorringe et 
al, 2005). Importantly, it has been shown that the iron responsive Fur protein binds to the 
intergenic promoter region between aniA and norB (Delany et al, 2004) and acts as an activator 
of the denitrification regulon (Figure 1.8). In addition, another study reported that Fur is 
responsible for aniA activation in N. meningitidis (Edwards et al, 2012).  It might therefore be 
crucial for efficient expression of the denitrification genes in our model.  
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Previous studies have shown that injection of 8 mg of human holo transferrin (human holoTf) 
into mice results in the physiological levels of circulating human holoTf for up to 24 hour (Yi 
et al, 2003). Therefore, mice supplemented with human holoTf could mimic a human model 
of sepsis more closely and enable bacteria to thrive for longer by utilising transferrin. As the 
aim of the investigation was to examine bacterial metabolism-mediated alterations in the 
concentration of NO-related species, a longer sepsis protocol was favourable to allow sufficient 
time for NOS activity. As such, it was decided that the bacterial inocula should be 
supplemented with 8 mg human holoTf.    
Initial range finding experiments for determining appropriate bacterial inocula in presence of 
holoTf were carried out using 106-109 bacteria/mouse. Severity score showed that a dose of 107 
bacteria/mouse can cause bacteraemia in the presence of human holoTf. Therefore, the 
bacterial dose used for i/p injection was lowered to 107 bacteria/mouse from previously used 
109 bacteria/mouse for these set of experiments. Along with Wt and ∆norB, another isogenic 
mutant, ∆nsrR, which negatively regulates the denitrification genes such as aniA and norB 
(Heurlier et al, 2008) was used. Strain ∆nsrR would serve as condition where denitrification 
genes could be upregulated in absence of nsrR mediated repression as evidenced by previous 
studies (Rock et al, 2007). Sepsis progression was monitored by severity scoring as described 
before (Section 3.5.1.1). Mice were exsanguinated after the cumulative severity score was 
equalled or exceeded. After processing the plasma (Section 2.5.4), SNO-Hb (Section 2.5.6) 
and liver lysates samples (Section 2.5.3) were measured by I3
- dependent chemiluminescence 
(Section 2.6.2). NOx was measured by acidified VCl3 (Section 2.6.3).  
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3.5.2.2 Results 
 
As can be seen from Figure 3.8, sepsis was prolonged to 8 hour, an increase of 33% on the 
previous length of 6 hour (Figure 3.4). Infection with different strains did not make any 
difference to either progression or severity of sepsis. Importantly, there was no significant 
difference in the inocula from the strains used for this study (Figure 3.9). Relatively high 
number of bacteria was recovered from whole blood and liver lysate despite using a lower dose 
inocula, 107 bacteria/mouse (Figure 3.9 B and 3.9 C).  
Regardless of the NO metabolites (SNO, NOx, NO2
-, SNO-Hb) quantified no significant 
difference was found in relation to the presence of bacterial NO denitrification machinery 
(Figure 3.10 and Figure 3.11 and Table 3.2) 
Non parametric Spearman correlation test was performed to investigate the correlation between 
bacterial burden and NO metabolites. In response to bacterial infection, there was a positive 
correlation between whole blood output viable count and plasma SNO (p = 0.03), a positive 
correlation between liver lysate output viable count and liver NO2
- (p = 0.002) and a negative 
correlation between liver lysate output viable count and liver NOx (p = 0.022) (Figure 3.12)  
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Table 3.2 Summary of NO metabolites output from mice infected with 107 bacteria/mouse 
in presence of 8 mg hTf for 8 hours. Values are given as median, with interquartile range 
(IQR) in parentheses. 
NO metabolites Wt ∆norB ∆nsrR 
Plasma NOx 129.9 µM 
(92.67 – 154.4) 
105.6 µM 
(77.20 – 142.7) 
106.1 µM 
(90.39 – 162.7) 
Plasma NO2- 1.15 x 103 nM 
(9.94 x 102 –1.61 x 
103) 
1.31 x 103 nM 
(1.14 x 103 – 2.35 
x 103) 
2.32 x 103 nM 
(1.10 x 103 – 3.61 x 103) 
Plasma SNO 38.59 nM (21.33 – 
54.40) 
38.68 nM (32.31 – 
58.04) 
50.44 nM ( 34.86 – 120.1) 
SNO-Hb 1.49 x 10-3 % SNO 
per heme (1.20 x 
10-3 % –2.72 x 10-3 
%) 
2.09 x 10-3 % SNO 
per heme (1.46 x 
10-3 % – 3.32 x10-3 
%) 
2.04 x 10-4 % SNO per 
heme (1.46 x 10-3 % – 3.17 
x 10-3 %) 
Liver NOx 3.29 x 103 
pmol/mg (1.58 x 
103 – 4.62 x 103) 
2.87 x 103 
pmol/mg (1.32 x 
103 – 3.91 x 103) 
2.17 x 103 pmol/mg (1.37 
x 103 – 3.09 x 103) 
Liver NO2- 172 pmol/mg 
(48.40 – 270) 
169 pmol/mg 
(62.35 – 344.0) 
200 pmol/mg (58.05 – 
327.5) 
Liver SNO 3.78 pmol/mg 
(1.74 – 5.59) 
1.2 pmol/mg  (0.94 
- 4.44) 
2.97 pmol/mg (0.91 – 
7.60) 
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Figure 3.8 Confirmation of meningococcal sepsis by severity scoring in 7-10 weeks old 
female C57BI6 mice infected with 107 bacteria/mouse suspended in PBS + 8 mg hTf for 8 
hours A) Wt, B) ∆norB and C) ∆nsrR. 
Following intraperitoneal injection mice were monitored for severity every hour according to 
the sepsis severity scoring guideline (Section 2.5.2). Total score 9-18 = moderate, 19- 24 = 
substantial (monitored every 30 minutes), 25-30= substantial (mice had to be culled). Bars 
denote median. 
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Figure 3.9 Viable bacteria recovered from inocula (A), whole blood output (B) and liver 
lysates output (C) in the murine model infected with PBS + 8 mg hTf + 107 bacteria/mouse 
for 8 hours. 
Samples were serially diluted and triplicate of 10 µl aliquots of each dilution were separately 
spotted on CBA plates, left in a microbiological safety cabinet for 10 minutes to allow them to 
air-dry.  Following overnight incubation at 37°C, 5% CO2, the mean number of colonies for 
each dilution were counted and corrected for the dilution factor and volume. Thus the mean of 
countable dilutions were averaged to estimate the number of bacteria present in the original 
suspension. Viable counts of bacteria recovered from mice liver lysates infected with Neisseria.  
Liver lysate viable counts were normalised to CFU/g of excised liver (wet weight). Bars denote 
median. For statistical analysis, One way ANOVA with Dunn’s post test. 
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Figure 3.10 Measurement of plasma NOx (A), NO2- (B), SNO (C) and SNO-Hb (D) in mice 
infected with PBS + 8 mg hTf + 107 bacteria for 8 hours. 
NO metabolites were measured after bolus injection of PBS + Wild type/ΔnorB/∆nsrR N. 
meningitidis (107 bacteria/mouse) into 7-10 weeks old female C57BI6 mice. NOx (A) was 
measured by acidified VCl3 at 90
°C (Section 2.6.3). NO2
- (B), SNO (C) were measured by I3
- 
dependent, ozone-based chemiluminescence with reference to a GSNO standard curve 
(Section 2.6.2).  SNO-Hb (D) was normalised to heme % (Section 2.5.6- 2.5.7). Bars denote 
median. For statistical analysis, One way ANOVA with Dunn’s post test was performed. 
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Figure 3.11 Measurement of Liver NOx (A), NO2- (B), SNO (C) in mice infected with 107 
bacteria suspended in PBS + 8 mg hTf for 8 hours. 
Liver lysates were processed by a hand held rotor stator homogeniser (Section 2.5.3). NOx (A) 
was measured by acidified VCl3 at 90
°C (Section 2.6.3). NO metabolites (B and C) were 
measured by I3
- dependent, Ozone-based chemiluminescence with reference to a GSNO 
standard curve (Section 2.6.2). Bars denote median. For statistical analysis One way ANOVA 
with Dunns post test was performed.  
  
W t  n o rB  n s rR
0
2 0 0 0
4 0 0 0
6 0 0 0
L iv e r  [N O x ]
[N
O
x
] 
p
m
o
l/
m
g
W t  n o rB  n s rR
0
2 0 0
4 0 0
6 0 0
8 0 0
1 0 0 0
L iv e r  [N O 2
-
]
[N
O
2
- ]
p
m
o
l/
m
g
W t  n o rB  n s rR
0
5
1 0
1 5
L iv e r  [S N O ]
[S
-n
it
ro
s
o
th
io
l]
 p
m
o
l/
m
g
A .
B .
C .
 Bacterial nitric oxide metabolism in the pathogenesis of meningococcal sepsis 
120 
 
P la s m a  [S N O ]
1 0 6 1 0 7 1 0 8
0
5 0
1 0 0
1 5 0
2 0 0
B a c te r ia l b u rd e n  C F U  m l
-1
(S p e a r m a n 's  r a n k  c o r r e la t io n ,  r  =  0 .4 2 1 3 , p  =  0 .0 3 2 1 , n  =  9 )
[S
-n
it
ro
s
o
th
io
l]
 (
n
M
)
1 0 6 1 0 7 1 0 8 1 0 9
0
2 0 0
4 0 0
6 0 0
8 0 0
1 0 0 0
L iv e r  ly s a te  [N O 2
-
]
B a c te r ia l b u rd e n  C F U  m l
-1
(S p e a r m a n 's  r a n k  c o r r e la t io n ,  r  =  0 .5 6 8 2 , p  =  0 .0 0 2 0 , n  =  9 )
 [
N
O
2
- ]
 p
m
o
l/
m
g
1 0 6 1 0 7 1 0 8 1 0 9
0
2 0 0 0
4 0 0 0
6 0 0 0
L iv e r  ly s a te  [N O x ]
B a c te r ia l b u rd e n  C F U  m l
-1
(S p e a r m a n 's  r a n k  c o r r e la t io n ,  r  = -  0 .4 3 9 0 , p  =  0 .0 2 2 0 , n  =  9 )
[N
O
x
] 
p
m
o
l/
m
g
A .
B .
C .
 
Figure 3.12 Statistically significant correlation between recovered bacterial burden and 
Plasma SNO A), Liver lysate NO2- B) and Liver lysate NOx C) in the PBS + hTf + 107 
bacteria/mouse supplemented sepsis model. 
Spearman’s rank correlation test, Graphpad prism.   
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3.5.3 Attempting to bolster the SNO signal from the murine model of 
meningococcal sepsis with LPS 
Section Summary: 
 Inclusion of LPS along with human holo transferrin increases the sepsis 
severity 
 In the presence of LPS and human holo transferrin, bacterial infection 
still does not result in a differential profile of NO metabolites with 
regards to NO denitrification machinery in whole blood and liver 
 
3.5.3.1 Rationale and methods 
LPS treatment induces the production of SNO-albumin and SNO-Hb in rat model of sepsis 
within 5 hour of stimulation (Jourd'heuil et al, 2000). It was found to be essential for the 
increase in endogenously produced SNO from murine J774.2 cell lines by the activation of 
iNOS (Laver et al, 2010). In an LPS induced septic model of rat high levels of  SNO from 
RBCs is generated in an iNOS dependent manner (Crawford et al, 2004). These observations 
indicate the role of LPS as an inducer for NO generation by iNOS activity. High iNOS is also 
necessary to relieve nsrR mediated repression of norB. In the presence of high concentrations 
of NO (> 1 µM) nsrR repressor comes off the NO denitrification operon to increase NO 
detoxification by norB (Section 1.12- 1.14) (Rock et al, 2007). At 8 hour time point the amount 
of iNOS in our model could have been insufficient to relieve nsrR mediated repression of norB 
(Section 3.5.2). Therefore, it was decided to infect the mouse with bacterial bolus containing 
both LPS and hTf to induce NO mediated processes.  
Initial observation from our group has shown that infection of mice with LPS at concentration 
of 2.5 x 104 EU/g increases the detectable levels of SNO, which was also confirmed by biotin 
switch technique (Harrison, L., PhD thesis). So mice were infected intraperitoneally with bolus 
containing 25000 EU/g LPS, 8 mg hTf and 106 bacteria/mouse suspended in PBS. To keep the 
suffering of the animal to minimal level, a 10 fold lower bacterial dosage was used as LPS 
itself triggers bacteraemia. Alongside the Wt strain, two isogenic mutant strains for 
meningococcal denitrification pathway, ∆aniA and ∆norB were included to investigate the role 
of these two denitrification genes in the regulation of NO adduct production. Another condition 
heat killed wild type (HkWt) bacteria was also included to act as a metabolically inert strain 
incapable of involving aniA and norB in NO denitrification. Progression of infection was 
followed according to the severity scoring for sepsis (Section 2.5.2). Mice were terminally 
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anaesthetised using an intraperitoneal injection of sodium pentobarbitone (5 units/mouse). 
Mid-place anaesthesia was confirmed by loss of the pedal withdrawal reflex. Blood was 
collected by exsanguination and whole liver was excised. Plasma and haemoglobin were 
separated for analysis from whole blood using SNO compatible lysis buffer and stabilising 
solution. Whole liver was treated with 0.25% bile salt to remove external bacteria and 
homogenised using a hand held rotor-stator homogeniser in SNO compatible lysis buffer 
(Section 2.2.2 and Figure 3.3). After appropriate preparation, NO metabolites in samples were 
measured by I3
- dependent chemiluminescence (Section 2.6.2). Plasma NOx was measured by 
acidified VCl3 (Section 2.6.3).  
3.5.3.2 Results 
As can be seen from Figure 3.13, the infection could be prolonged up to 6 hour time point 
according to the severity scoring. Interestingly infection with LPS + HolohTf and Hk Wt 
registered the same substantial severity as other conditions.  
There was no statistically significant difference in input viable count of the conditions; Wt 3.47 
x 108 cfu/ml (IQR= 2.83 x 108 – 4.87 x 108), ∆norB, 4.43 x 108 cfu/ml (IQR= 2.27 x 108 – 7.57 
x 108) and ∆aniA, 5.33 x 108 cfu/ml (IQR = 4.23 x 108 – 5.67 x 108) (Figure 3.14 A). Despite 
using a lower bacterial inocula, relatively high number of bacteria was recovered from whole 
blood; Wt, 4.43 x 108 cfu/ml (IQR= 7.87 x 106 – 6.9 x 108), ∆norB, 3.28 x 108 cfu/ml (IQR= 
1.41 x 108 – 5.74 x 108) and ∆aniA, 4.63 x 108cfu/ml (IQR= 3.97 x 108 – 5.2 x 108) (Figure 
3.14 B). Although lower than the number of bacterial output from whole blood, recovery of 
bacterial load from liver lysates were also substantial; Wt, 1.38 x 107 cfu/ml (IQR =  9.80 x 106 
– 2.11 x 107), ∆norB, 1.54 x 107 (IQR= 1.32 x 107 – 2.0 x 107) and ∆aniA, 1.08 x 107 cfu/ml 
(IQR = 8.26 x 106 – 1.33 x 107) (Figure 3.14 C) . 
There was no significant difference in the amount of plasma NOx, NO2
-, SNO, SNO-Hb and 
liver SNO and NO2
- measured across the different strains studied (Table 3.3, Figure 3.15 and 
Figure 3.16).  
  
 Bacterial nitric oxide metabolism in the pathogenesis of meningococcal sepsis 
123 
 
Table 3.3 Summary of NO metabolites measured from mice infected with 106 
bacteria/mouse in presence of LPS + 8 mg hTf for 6 hours. (Values are given as median, 
with interquartile range (IQR) in parentheses) 
NO 
metabolites 
LPS 
+ HolohTf 
Wt ∆norB ∆aniA HkWt (Heat 
killed Wt) 
Plasma 
NOx 
318.4 µM (122.5 
- 754.5) 
163.7 µM 
(137.1 – 
284.3) 
280.5 µM 
(162.3 – 
402.2) 
166.2 µM 
(117.9 – 
568.5) 
156.7 µM 
(89.30 – 510.3) 
Plasma 
NO2- 
3.77 x 103 nM  
(2.18 x103 – 
5.70 x 103) 
2.95 x 103 
nM  
(2.05 x 103 – 
5.22 x 103) 
3.33 x 103 
nM  
(2.62 x 103 
– 5.02 x 
103) 
2.86 x 103 
nM  
(1.87 x 103 – 
4.80 x 103) 
3.05 x 103 nM  
(2.22 x 103 – 
5.54 x 103) 
Plasma 
SNO 
87.65 nM  
(80.05 – 138.2) 
120.9 nM 
(99.38 – 
153.0) 
73.55 nM 
(49.34 – 
144.3) 
85.85 nM 
(52.59 – 
212.4) 
83.15 nM 
(74.43 – 125.4) 
SNO-Hb 3.12 x 10-3 % 
SNO per heme 
(1.91 x 10-3 % – 
5.73 x 10-3 %) 
3.419 x 10-3 
% SNO per 
heme (1.61 x 
10-3 % – 4.49 
x 10-3 %) 
3.66 x 10-3 
% SNO 
per heme 
(2.42 x 10-
3 % – 5.82 
x 10-3 %) 
3.14 x 10-3 % 
SNO per 
heme (1.34 x 
10-3 % – 7.14 
x 10-3 %) 
2.67 x 10-3 % 
SNO per heme  
(1.97 x 10-3 % – 
4.19 x 10-3 %) 
Liver SNO 2.36 pmol/mg  
(1.65 – 3.21) 
2.17 
pmol/mg    
(1.78 – 4.00) 
3.69 
pmol/mg 
(1.5- 3.75) 
2.92 pmol/mg      
( 1.71 – 4.14) 
2.11 pmol/mg 
(1.26 – 2.95) 
Liver NO2- 25.90 pmol/mg        
( 22.50 – 32.00) 
32.00 
pmol/mg     
( 31.70 – 
34.50) 
38.10 
pmol/mg     
(20.00 – 
49.80) 
27.00 
pmol/mg     
(22.50 – 
49.60) 
25.20 pmol/mg 
(15.60 – 26.90) 
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Figure 3.13 Confirmation of meningococcal sepsis by severity scoring in 7-10 weeks old 
female C57BI6 mice infected with 106 bacteria/mouse suspended in PBS + 25000 EU/g 
LPS + 8 mg hTf for 6 hours A) LPS + Htf, B) Wt, C) ∆norB, D) ∆aniA and E) HkWt (Heat 
killed Wt) 
Following intraperitoneal injection mice were monitored for severity every hour according to 
the sepsis severity scoring guideline (Section 2.5.2). Total score 9-18 = moderate, 19- 24 = 
substantial (monitored every 30 minutes), 25-30= substantial (mice had to be culled). Bars 
denote median. 
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Figure 3.14 Viable bacteria recovered from inocula (A), whole blood output (B), and  liver 
lysates output (C) in murine model infected with bolus injection of  PBS + 25000 EU/g 
LPS + 8 mg human holo transferrin + 106 bacteria/mouse for 6 hours. 
Samples were serially diluted and triplicate of 10 µl aliquots of each dilution were separately 
spotted CBA plates, left in a microbiological safety cabinet for 10 minutes to allow them to 
air-dry.  Following overnight incubation at 37°C, 5% CO2, the mean number of colonies for 
each dilution were counted and corrected for the dilution factor and volume. Thus the mean of 
countable dilutions were averaged to estimate the number of bacteria present in the original 
suspension. Viable counts of bacteria recovered from mice liver lysates infected with Neisseria.  
Liver lysate viable counts were normalised to CFU/g of excised liver (wet weight). Bars denote 
median. For statistical analysis, one way ANOVA with Dunn’s post test was used.  
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Figure 3.15 Measurement of plasma NOx (A), NO2- (B), SNO (C) and SNO-Hb (D) in mice 
infected with PBS + 25000 EU/g LPS + 8 mg hTf + 106 bacteria for 6 hours. 
NO metabolites were measured after bolus injection of PBS + 25000 EU/g LPS+ wild 
type/ΔnorB/∆aniA/HkWt (Heat killed Wt) N. meningitidis (107 bacteria/mouse) into 7-10 weeks 
old female C57BI6 mice. NOx (A) was measured by acidified VCl3 at 90
°C (Section 2.6.3). 
NO2
- (B), SNO (C) were measured by I3
- dependent, Ozone-based chemiluminescence with 
reference to a GSNO standard curve (Section 2.6.2). SNO-Hb (D) was normalised to heme% 
(Section 2.5.6- 2.5.7). HkWt refers to heat inactivated bolus of Wt MC58. Bars denote median. 
For statistical analysis, one way ANOVA with Dunns test was performed. 
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Figure 3.16 Measurement of Liver SNO (A) and NO2- (B) in mice infected with 106 
bacteria suspended in PBS + 8 mg hTf + 25000 EU/g LPS for 6 hours. 
Liver lysates were processed by a hand held rotor stator homogeniser (Section 2.5.3). NO 
metabolites (A and B) were measured by I3
- dependent, Ozone-based chemiluminescence with 
reference to a GSNO standard curve (Section 2.6.2). Bars denote median. For statistical 
analysis one way ANOVA with Dunns post test was performed. HkWt – Heat killed wild type.  
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3.6 Discussion 
This chapter reports the establishment of a murine model of early fulminant meningococcal 
sepsis, in which we were able to reproducibly detect increased levels of NO metabolites such 
as SNO, NO2
- and NOx. Although N. meningitidis is an exclusively human pathogen, the 
ubiquity of S-nitrosylation in biology, and the higher overall NO output from murine cells in 
response to immunological agonists made development of a murine model of meningococcal 
sepsis worthwhile. We intended to use the model to test whether meningococcal NO 
detoxification impacts upon the concentration of NO metabolites at a systemic level during 
acute, fulminant infection, as we had previously demonstrated in vitro on the J774.2 murine 
macrophage cell line (Laver et al, 2010). This investigation was essential as it is only the animal 
models that provide the opportunity to investigate the regulation of a certain phenotype at the 
whole organism level by combining factors such as the innate, humoral and cellular immune 
defence machinery etc.  
The role of bacterial denitrification in the regulation of NO metabolites was investigated in 
three variations of our murine model of meningococcal sepsis. In the initial model (Figure 3.4-
3.7), a high bacterial inoculum (109 bacteria/mouse) in PBS was used to induce sepsis. Severe 
septicaemia was apparent at the 6 hour time point (Figure 3.4), at which point our severity 
limits for the experiment were equalled or exceeded and the mice were euthanized. In the 
second model, mice were infected intraperitoneally (i/p) with 107 bacteria/mouse in PBS, 
supplemented with 8 mg human holoTf for 8 hours (Figure 3.8 -3.12). Inclusion of human 
holo transferrin was found to be optimal for inducing sepsis with a lower dosage of bacteria 
(107 bacteria/mouse) which was not capable of inducing sepsis in absence of human holoTf 
(data not shown). This supports the previous observation that the rapid clearance of N. 
meningitidis is prevented in transgenic mice expressing human transferrin (Zarantonelli et al, 
2007). Inability of meningococcal transferrin to bind to murine transferrin is circumvented by 
the presence of human holoTf, thus providing the bacteria with access to the iron required for 
normal growth and metabolism. In the final model, LPS was used along with human holoTf to 
infect mice (Figure 3.13 – 3.16) with the aim of rapidly inducing iNOS expression and 
increasing the production of NO within the infection time frame. However, as LPS 
administration induces strong proinflammatory immune responses (Michie et al, 1988; Remick 
et al, 1990) and causes sepsis syndrome (Waage et al, 1987); the infection could only be 
continued for 6 hour before equalling or exceeding the severity limits of the study, despite 
using a lower bacterial dose (106 bacteria/mouse). In fact, the progression of sepsis severity 
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was the same for mice injected with only LPS and human holoTf as it was for similarly treated 
but simultaneously-infected mice (Figure 3.13).  
It is noteworthy that none of the denitrification gene mutant-infected mice showed any 
difference in sepsis severity when compared with Wt-infected mice (Figure 3.4, 3.8 and 3.13). 
This demonstrates that lack of NO denitrification had no qualitative impact on the severity of 
the disease. However, the severity of infection in all three models confirmed the features of 
overwhelming sepsis which is one of the common aspects of invasive meningococcal disease 
(Pace & Pollard, 2012).  
Statistically significant increases in plasma SNO, SNO-Hb (Figure 3.6 C and D) and liver 
SNO (Figure 3.7 B) were observed in response to bacterial infection compared to PBS control. 
Statistically non significant similar increase in plasma NO2
-, NOx and liver NO2
- was noticed 
(Table 3.1). This is the first study to report an abundance of SNOs in the plasma and liver of 
early acutely septic mice infected with N. meningitidis. This could be due to an increase in 
iNOS activity and increased exposure to meningococcal LOS (Titheradge, 1999) following 
infection with high bacterial load (109 bacteria/mouse). However, there was not any statistically 
significant difference among the measured SNO, NO2
- and NOx with regards to the bacterial 
NO metabolism in any of our experimental models (Figure 3.4-3.7, Figure 3.8 – 3.12 and 
Figure 3.13 – 3.16).  
A number of reasons could account for not seeing a difference in the production of NO 
metabolites by bacterial denitrification in vivo. Firstly, it could be due to the insufficient 
expression of iNOS at a given time point in vivo. An in vitro study from our group showed that 
iNOS expression is induced after 18 hours following the stimulation of J774.2 macrophages 
with LPS/IFNɣ (Laver et al, 2010). Similar maximal iNOS induction time was reported with 
RAW macrophages (Chiou et al, 2000). However, we could not prolong the sepsis beyond the 
6 hour (Figure 3.13) and 8 hour (Figure 3.8) time points given the severity of the disease. 
Spatiotemporal activation of iNOS has also important ramification for norB activity which is 
switched off by the nsrR repressor at low NO concentration (< 1µM) (Rock et al, 2007).  It is 
not clear whether and when iNOS was expressed to a level high enough for NO to trigger NorB 
production in an in vivo murine model. The similar numbers of bacteria found from the whole 
blood and liver lysates of wt and ∆norB infected mice (Figure 3.5, 3.9 and 3.14) further 
intensifies this suspicion given that the lack of norB results in decreased survival of the 
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organism in the presence of NO in human macrophages and nasopharyngeal mucosa (Stevanin 
et al, 2005). 
Secondly, as meningococcal sepsis is a severe condition, we could perform certain protocols 
and use limited number of mice for this study. While studying sepsis in an animal model, it is 
essential to strike a balance between experimental objective and animal suffering. Thirdly, 
SNO degrading enzymes from host could be more potent in regulating the concentration of 
SNOs in vivo compared to the bacterial NO detoxification. Enzyme such as GSNO reductase 
(GSNOR) is conserved across species (Liu et al, 2001) and important for SNO homeostasis 
due to their capability to degrade SNO enzymatically. GSNOR has maximal activity in murine 
liver and is directly involved in protection of tissue during endotoxemia (Liu et al, 2004).  
Finally, SNO depletion by bacteria does not take place or could naturally be a localised cell 
specific phenomenon in vivo. Hepatic SNO is pivotal for regeneration of damaged part of liver 
during endotoxin induced injury (Cox et al, 2014). Previously, we have shown that NO 
detoxification mechanism of N. meningitidis depletes the formation of SNO at cellular level in 
J774.2 cell line (Laver et al, 2010). In a recent work, total SNO protein from J774.2 cells 
infected with N. meningitidis were extracted using SNO-RAC technique. Proteomic analysis 
revealed the differential regulation of a number of SNO proteins in relation to the bacterial NO 
detoxification machinery (Dr Jay Laver, personal communication). In an animal model, liver 
could have been perfused with blood containing bacteria. Then transient NO detoxification by 
bacteria could possibly damage parts of liver by depleting localised SNO, which perhaps was 
undetectable at the tissue/whole animal level.  Taken together the observation from this study 
it is plausible that SNO depletion by NO detoxification of N. meningitidis could perhaps be 
happening at the cellular level but not at the tissue or whole animal level.  
As the only natural habitat for N. meningitidis is human nasopharynx, it is impossible to 
establish an ideal murine model for studying meningococcal sepsis. Infection with live and 
multiplying bacteria in tissue and blood mimics the model of human sepsis more closely than 
the model which involves the administration of endotoxin such as LPS. Of the three models 
studied here, infection of mice with 107 bacteria/mouse represents the most physiologically 
relevant model of early fulminant meningococcal sepsis (Figure 3.8 -3.12) due to inclusion of 
hTf. Although septic model with 106 bacteria/mouse contained hTf (Figure 3.13- 3.16), 
inclusion of LPS could mask or interfere with the effect generated in response to bacterial 
infection since LPS can trigger high and rapid proinflammatory cytokine response which is 
 Bacterial nitric oxide metabolism in the pathogenesis of meningococcal sepsis 
131 
 
several orders of magnitude higher than what is found in human septic condition (Buras et al, 
2005). 
A number of interesting and novel correlations were found between bacterial burden and NO 
metabolites in the murine model supplemented with hTf along with 107 bacteria/mouse for 8 
hours (Figure 3.8 - 3.12). We observed significant, positive correlations between the number 
of bacteria cultured from plasma (in CFU/ml) and the concentration of circulating SNO, and 
between the number of bacteria cultured from liver lysates and the concentration of NO2
- in 
these lysates (Figure 3.12).  We also observed a significant, negative correlation between the 
bacterial burden of liver lysates and the total concentration of NO derivatives (NOx) in these 
samples (Figure 3.12). These data indicate a dose-dependent systemic increase in nitric oxide 
synthase activity in response to meningococcal infection, which makes good biological sense: 
insofar as a larger stimulation leads to a larger response. In liver, where meningococci 
circulating in the bloodstream could conceivably aggregate in the microvasculature, the 
increased bacterial burden result in an overall decrease in the total amount of NO-derived 
species in hepatocytes, but is not associated with expression of the nitric oxide reductase.  One 
possible explanation of these relationships is that inflammation in response to infecting 
meningococci resulted in hepatic ischaemia, consistent with observations of endotoxin-induced 
acute liver injury (Matuschak et al, 2001).  In such a low-oxygen environment, the oxidation 
of NO would be precluded. This would locally increase the half-life of NO and allow diversion 
of NO per se along other metabolic routes.  Most likely, NO would first come into contact with 
the bloodstream, with rapid formation of Hb-Fe(II)-NO and transport of hepatically-
synthesised NO away from the tissue. In addition, the low oxygen tension would activate the 
SNO synthase function of a subset of haemoglobin molecules, which produce S-nitrosylated 
haemoglobin (SNO-Hb) at Cys93 of the haemoglobin beta chain as they undergo allosteric 
conversion from the ‘T’ to the ‘R’ state (Allen & Piantadosi, 2006; Stamler et al, 1997a).  As 
red blood cells harbouring SNO-Hb migrate into areas of increased oxygenation, there may be 
transfer of SNO groups to serum proteins by transnitrosylation; enriching the circulating pool 
of SNO-proteins in plasma. This could be clinically important as SNOs can play cytoprotective 
role in myocardial ischemic injury after endotoxemia (Lima et al, 2009).   
In summary, N. meningitidis reproducibly produces severe sepsis in mice following intra-
peritoneal injection and supplementation with human holo-transferrin. Meningococcal 
infection results in the increased abundance of NO metabolites in plasma and liver which is a 
novel finding. However, no differences were found in NO adducts within blood and liver in 
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relation to the bacterial NO detoxification machinery.  There is a possibility that SNO 
depletion, if it occurs, is happening exclusively at a cellular level as we have shown previously 
(Laver et al, 2010) and is inapparent at the tissue/whole animal level, or that the experimental 
methodology utilised is unable to detect the effect.   
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4 Chapter 4: Creation and characterisation of a set of 
denitrification gene mutants (∆aniA/∆norB, 
∆nsrR/∆norB, ∆aniA/∆norB/∆nsrR) 
4.1 Introduction 
Regulation of aniA and norB is complex and involves multiple factors such as the oxygen-
sensing transcription factor FNR, the transcriptional repressor AsrR, the ferric uptake regulator 
Fur, the two-component signalling system NarQ/NarP and the NO-sensitive repressor protein, 
NsrR (Figure 1.8). 
In response to varying concentrations of NO, NsrR tightly regulates the operon containing the 
aniA and norB genes, which act to supplement meningococcal respiration under microaerobic 
conditions. Although the meningococcal nsrR regulon has been characterised (Heurlier et al, 
2008; Rock et al, 2007), there is little known about its impact on the cellular pathology of 
meningococcal sepsis. To date, our group has used isogenic single mutants of aniA, norB and 
nsrR to investigate the different aspects of meningococcal pathogenesis both in vitro (Laver et 
al, 2010; Stevanin et al, 2007; Stevanin et al, 2005; Tunbridge et al, 2006) and in vivo 
(Harrison, L., PhD thesis, Chapter 6 and current thesis, Chapter 3). As the half life of NO in 
biological systems is very short, the major resevoir of nitrogen oxides in cell or tissue at any 
given time is NO2
- or NO3
-. In human tisssue, oxygenation of NO leads to production of NO2
-. 
Facultative denitrifiers in the mouth and pharynx can also convert NO3
- into NO2
- (Lundberg 
et al, 2004). Creation of a mutant unable to metabolise both NO2
- and NO could be an  important  
experimental tool to study physiological conditions such as meningococcal sepsis, which is 
often characterised by high concentrations of circulating NO metabolites (Baines et al, 1999). 
Therefore, it was decided to create mutants where multiple genes of denitrification pathway 
were inactivated. 
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4.2 Results 
4.2.1 Creation of ∆aniA/∆norB/∆nsrR (∆Triple) mutant 
4.2.1.1 Rationale and methods 
Firstly, a triple mutant (∆aniA/∆norB/∆nsrR) was created to investigate the role of bacterial 
denitrification genes in the absence of nsrR, the negative regulator of the genes involved in 
meningococcal partial denitrification. The triple mutant was generated through insertional 
inactivation of each of the three genes with three different antibiotic resistance cassettes. A 
kanamycin-resistance cassette in the middle of the norB gene was cloned into plasmid pGEM-
3zf. The Kanamycin-disrupted norB cassette was then PCR-amplified and transformed into the 
existing strain ∆nsrR/∆aniA (a kind gift from the Moir group, University of York), in which  
the nsrR gene was inactivated by an omega insertion cassette conferring resistance to 
tetracycline, and the aniA gene was inactivated by the omega cassette, conferring resistance to 
spectinomycin (Heurlier et al, 2008). The resulting strain (∆aniA/∆norB/∆nsrR) was selected 
on spectinomycin/kanamycin/tetracycline (SKT)-containing plates.  
Assembly of a construct suitable for the insertional inactivation of the norB gene with a 
kanamycin resistance-conferring cassette was to be achieved using Isothermal Assembly 
(ISA).  The method is also known as ‘Gibson Assembly’ and requires all the participating 
components to have overlapping DNA sequences (Figure 4.1). All four fragments in this 
reaction had overlapping adaptor sequences (see below). ISA mastermix contains a 5' 
exonuclease, a thermostable DNA polymerase and a thermostable DNA ligase (Section 
2.11.4). The 5' exonuclease in the ISA mix ‘chews up’ the fragments in the reaction from the 
5' end and generates single stranded 3' complementary overhangs (Figure 4.1 C). The key to 
the success of ISA is the fact that the exonuclease is thermo-labile and degrades after only 15 
minutes when incubated at 50°C. Thermo-lability of the exonuclease ensures only a small 
portion of the DNA is degraded, and the molecule remains ostensibly double-stranded DNA. 
Following 5' exonuclease activity, the paired ends of each of the DNA molecules to be ligated 
anneal to one another through complementary base-pairing, hence the requirement for identical 
overlapping sequences between fragments. A high fidelity DNA polymerase from the ISA mix 
then fills in gaps within each annealed fragment. Finally, a DNA ligase present in ISA mix 
covalently joins seals the nicks in assembled DNA. For a schematic overview of the isothermal 
assembly process, see Figure 4.1.  
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To generate a kanamycin-disrupted norB cassette in plasmid pGEM-3Zf, two parts of the norB 
gene sequence were chosen (Figure 4.1 A). The norB gene (NMB1622) is 2.256 Kbp in length. 
The first part (524 bp) was chosen by avoiding the first 406 bp of the norB coding sequence. 
The forward primer (termed as norB F1-FWD) contained 30 bp sequence homologous to the 
pGEM-3zf before the HincII restriction site plus 20 bp from the beginning of first part of the 
chosen norB sequence. The reverse primer (norB F1-REV) contained 30 bp adapter sequence 
which was homologous to the reverse complement of the start of the Kanamycin resistance 
cassette from pJMK30 plus 20 bp of the reverse complement of the first part of the norB gene. 
The second part was selected by choosing the last 522 bp of norB. The forward primer (norB 
F2-FWD) contained a 30 bp sequence  homologous to the last 30 bp of pJMK30 plus 20 bp 
from the start of the  chosen 522 bp norB sequence. The reverse primer (norB F2-REV) 
contained sequence homologous to the last 30 bp of pGEM-3zf after the HincII restriction site 
plus 20 bp from the reverse complement of last part of norB.  The middle section of the norB 
coding sequence was not considered for primer design, ensuring that mutants generated using 
the final construct could not revert to wild type expression of norB through excision of the 
kanamycin-resistance cassette. Fragments norB F1 and norB F2 were extended using the 
primer pair norB F1-FWD/norB F1-REV  and the primer pair norB F2-FWD/norB F2-REV.  
The products were PCR amplified using My Taq Polymerase protocol (Figure 4.2) (Section 
2.11.15.2). The products of these separate PCR reactions were ISA compatible. 
The kanamycin resistance cassette (hereafter, KAN) was PCR amplified using the primer pair: 
Kan-FWD/Kan-REV using pJMK30 as template (Figure 4.2).  PCR utilised the high fidelity 
Accuzyme DNA Polymerase (Bioline, UK) (Section 2.11.15.3) 
pGEM-3zf plasmid was restriction digested with HincII restriction enzyme (Section 2.11.9) 
(Figure 4.3). All the generated PCR and restriction digest products were PCR purified using 
commercially available PCR Purification kit (Section 2.11.7) and DNA was quantified by 
spectrophotometry using a NanoDrop instrument (Section 2.11.5). The 260/280 ratio reading 
was recorded. A ratio between 1.8 and 2.0 was normally considered to be acceptable for DNA 
purity. 
Each PCR fragment (F1’, F2’and KAN) was added along with HincII digested plasmid 
(VECTOR) at equimolar concentrations between 10-100 ng within the reaction. The total 
volume of the VECTOR plus PCR fragments did not exceed 5 µl or 0.5 pmol DNA.  The 
volume of the mixture was then made up to 10 µl with dH2O, and this was further mixed with 
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10 µl of 2 x ISA mastermix (Section 2.11.4). The mixture was incubated overnight at 50°C in 
a thermocycler, and 1/10th volume of the ISA mixture was transformed into highly competent 
DH5α E. coli (Section 2.11.2). The resulting transformants, putatively containing the desired 
plasmid: pGEM-3zf :: ΔnorB: KanR, were screened on kanamycin-containing LB Agar plates 
(Section 2.4.4). Plasmid DNA was extracted from positive colonies using commercial plasmid 
extraction kit (Section 2.11.8). Identification of positive clones (i.e. those colonies carrying the 
desired plasmid), was confirmed by diagnostic PCR with a combination of different primers 
for the integration of the right fragment (Figure 4.4). The resulting plasmid was named: 
pGEM-3zf NK (Colony 2, Figure 4.4). This plasmid was used as a template to amplify the 
ΔnorB: KanR cassette (approximately 2.558 kbp) with norB F1-FWD/norB F2-REV primers 
(Section 2.11.3) using Accuzyme DNA polymerase (Figure 4.5) (Section 2.11.15.3). Multiple 
PCR reactions were combined and purified (Section 2.11.7). 2 µg of this purified product was 
transformed into ∆nsrR/∆aniA, using the broth culture transformation protocol (Section 
2.11.12).  After transformation, the colonies were screened on SKT-containing GC Agar plates 
(Section 2.4.2). Positive colonies were screened by colony PCR (Section 2.11.15.1). At least 
6 positive colonies from two independent transformation events were combined to account for 
potential phase and antigenic variation of individual colonies.  These were plated on new 
antibiotic containing GC agar plates. The resulting strain was termed as ∆Triple 
(∆aniA/∆norB/∆nsrR) and stored at -80oC in glycerol solution for future usage. 
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4.2.1.2 Results 
 For confirming the inactivation of aniA, norB and nsrR in the newly created 
∆aniA/∆norB/∆nsrR (∆Triple), the three gene containing regions were PCR amplified. Primers 
were designed as such that they were capable of amplifying the whole gene or the gene 
containing region (Section 2.11.3). Genomic DNA (GD) was extracted from the relevant 
strains for PCR confirmation (Section 2.11.6). PCR products were separated on 1% agarose 
gel (Figure 4.6). 
For confirmation of aniA inactivation, GD from Wt, ∆aniA and ∆Triple were PCR amplified 
by aniA_RUH1_FWD and aniA_RUH1_REV primers (amplifies 1.3 Kb of the aniA region) 
(Section 2.11.3). In Lane 1, an intense band of approximately 1.3 Kb was evident from Wt GD 
PCR amplification. Similar band was not seen in Lanes 2-3 with ∆aniA and ∆Triple GD 
templates. Instead, a band of approximately 3.2 Kb length was apparent.  
Products from Lanes 4-6 were PCR amplified by norB_RUH2_FWD and norB_RUH2_REV 
primers (amplifies 2.0 Kb of the norB gene) (Section 2.11.3). As can be seen from Figure 4.6, 
an obvious band of 2.0 Kb was present in Lane 4 with Wt PCR amplification. In Lanes 5-6, a 
band of approximately 2.6 Kb in size was present with ∆norB and ∆Triple GD PCR products. 
For confirming nsrR inactivation, GD from Wt, ∆nsrR and ∆Triple were PCR amplified by 
nsrR_RUH3_FWD and nsrR_RUH3_REV primers (amplifies 1.4 Kb region of the nsrR) 
(Section 2.11.3). In Lane 7, an intense band of 1.4 Kb was present with Wt PCR amplification. 
Similar band was not seen with ∆nsrR and ∆Triple amplification products in Lanes 8-9. Instead 
a band of approximately 4.0 Kb length was apparent. 
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Figure 4.1 Overview of Isothermal Assembly Cloning (ISA) method for generating 
Kanamycin resistant norB cassette in pGEM-3zf plasmid. 
A) Two ends of the norB gene (avoiding the middle part) were chosen to design primers with 
homologous overlapping sequence of plasmid vector, pGEM-3zf and kanamycin cassette. B) 
The products were generated by PCR amplification (norB F1, norB F2, Kan) and vector was 
restriction digested with HincII. C) All components were mixed with a cocktail containing 5' 
exonuclease, DNA polymerase and Taq ligase at 50°C (Section 2.11.4). 5' exonuclease chews 
the 5' end of the overlapping fragments and is only stable for 15 minutes. After that DNA 
polymerase and Taq ligase act to anneal the fragments and seal the nicks. Therefore, norB F1- 
Kan- norB F2 cassette containing plasmid (pGEM-3zf NK) was generated from one step 
isothermal reaction at 50ºC. The resulting plasmid was selected on kanamycin containing plates 
(Figure C adapted from Gibson assembly commercial manual). 
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Figure 4.2 PCR amplification of norBF1, norBF2 fragments and Kanamycin cassette. 
The products were PCR amplified by My Taq Polymerase (Section 2.11.15.2) and were 
separated by running on 1% Agarose gel (Section 2.11.14). Product from Lane 1 was amplified 
using norBF1 Fwd/norBF1 Rev primers and from Lane 2 by norBF2 Fwd/norBF2 Rev primers 
respectively (Section 2.11.3). Lane 1 represents the expected 0.584 Kbp norBF1 and Lane 2 
represents the expexted 0.582 Kbp norBF2. Lanes 3-5 represents the expected approximately 
1.392 Kb long Kanamycin cassettes which were PCR amplified by Kan Fwd/Kan Rev primers 
using Acuzyme polymerase (Section 2.11.15.3) on pJMK30 template (Table 2.2). Promega 
100 bp DNA ladder was used. Image was taken by BioRad Gel Imager.  
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Figure 4.3 Confirmation of HincII Digestion of pGEM-3zf plasmid. 
Lane 1 from the 1% agarose gel (Section 2.11.14) represents the HincII digested (Section 
2.11.9) pGEM-3zf plasmid with the expected 3.2 Kb band. Lane 2 and 3 represent pGEM-3Zf 
uncut plasmid with the expected multiple bands. 1 Kb hyperladder from Bioline, UK was used. 
Image taken by BioRad gel imager.  
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Figure 4.4 Diagnostic PCR screening for selecting positive clones of the pGEM–3zf NK 
plasmid after transformation of isocloning ligation mix into the DH5α competent cells. 
After isocloning, the ligation mix was transformed (Section 2.11.2) and selected on Kanamycin 
containing LB Agar plates (Section 2.4.4). Following plasmid extraction by Qiagen kit 
(Section 2.11.8), the three positive clones (Colony 1, Colony 2 and Colony 3) were screened 
for the presence of right fragment insertion using a combination of primers mentioned in the 
cartoon above the image of the 1% agarose gel (Section 2.11.14). The panel at the bottom of 
the agarose gel (numbers in black) represents the primer combinations. All the colonies 
produced expected PCR products. Colony 2 was chosen for subsequent cloning application. 
Image taken by BioRad gel imager.  
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Figure 4.5 PCR amplification of norBF1-Kan-norBF2 cassette from pGEM–3zf NK 
plasmid. 
The 1% agarose gel (Section 2.11.14) represents the approximately 2.558 Kb long norBF1-
Kan-norBF2 cassette (see the cartoon above) amplified using the newly cloned pGEM-3zf NK 
plasmid as template (Figure 4.4).  The primer pair used is mentioned in the cartoon above the 
gel. Accuzyme polymerase (Section 2.11.15.3) was used for PCR amplification. Image taken 
by BioRad gel imager 
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Figure 4.6 PCR confirmation of ∆aniA/∆norB/∆nsrR (∆Triple) mutant creation. 
Genomic DNA (GD) were extracted from the overnight grown cultures of Wt MC58, ∆aniA, 
∆norB, ∆nsrR and ∆aniA/∆norB/∆nsrR (∆Triple) (Section 2.11.6). Primers for aniA 
(aniA_RUH1_FWD and aniA_RUH1_REV) and norB (norB_RUH2_FWD and 
norB_RUH2_REV) were designed covering the whole gene. nsrR amplification primers 
(nsrR_RUH3_FWD and nsrR_RUH3_REV) were chosen carefully for amplifying extended 
sequences around the gene. PCR was run using My TaqTM Red Mix  polymerase (Section 
2.11.15.2). PCR products were separated on 1% agarose gel containing ethidium bromide with 
reference to a DNA hyperladder I (1 Kb ladder, bioline). Products from Lane 1-3, Lane 4-6, 
Lane 7-9 were PCR amplified by aniA, norB and nsrR primers respectively. The lane 
annotation panel below the gel represents the templates used for respective PCR amplification. 
Lane 1 showed the expected (1.3 Kb) aniA PCR product from Wt MC58. The same primer pair 
could not produce similar size product from ∆aniA and  ∆aniA/∆norB/∆nsrR GD. Similarly 
norB and nsrR primer pairs were able to amplify (2.0 Kb) norB and (1.4 Kb) nsrR from Wt 
GD. Same primers did not produce similar size bands when PCR reaction were run with the 
GD from other mutants.In lanes 2-3, the approximate 3.3 Kb band represented the 2.0 Kb 
spectinomycin cassette flanked by disrupted aniA sequence ; in lanes 5-6, the approximate 2.6 
Kb band represents the 1.4 Kb kanamycin cassette flanked by disrupted norB sequence; in lanes 
8-9, the approximate 4.0 Kb band represents the 2.5 Kb tetracycline cassette flanked by 
disrupted nsrR region. Image taken by Biorad gel imager.  
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4.2.2 Creation of ∆aniA/∆norB and ∆nsrR/∆norB double mutants 
 
4.2.2.1 Rationale and methods 
It was decided to exploit the newly generated pGEM-3zf NK plasmid (Figure 4.4) to generate 
two double mutants, ∆aniA/∆norB and ∆nsrR/∆norB. This was to enable us to have a 
comprehensive set of NO denitrification gene mutants, which could be used to answer 
important research questions in the pathogenesis of meningococcal sepsis. The 2.5 Kb long 
norB F1- Kan- norB F2 cassette (Figure 4.5) was PCR amplified using the Acuzyme 
polymerase (Section 2.11.15.3). PCR product was purified (Section 2.11.7) and bulked up to 
have at least 2 µg of product. Subsequently the cassette was transformed into ∆aniA 
(Spectinomycin) in the presence of MgCl2 (Section 2.11.12) and the positive colonies were 
selected on Spectinomycin/Kanamycin contaning plates to have the resulting ∆aniA/∆norB 
colonies. At least six positive colonies from two independent transformation events were 
combined and streaked on a fresh antibiotic containing plate to counteract phase and antigentic 
variation. A similar method was used to generate ∆nsrR/∆norB strain except the norB F1- Kan- 
norB F2 cassette was transformed into ∆nsrR (Tetracycline) strain and subsequent colonies 
were screened on Tetracycline/Kanamycin containing plates.   
4.2.2.2 Results 
For confirming gene inacitvation of ∆aniA/∆norB, GD (Section 2.11.6) from Wt, ∆aniA, 
∆norB, ∆aniA/∆norB and colony PCR templates from colonies of freshly grown ∆aniA/∆norB 
plate were PCR amplified by aniA primers (aniA_RUH1_FWD, aniA_RUH1_REV) (amplifies 
1.3 Kb of the aniA region) and norB primers (norB_RUH2_FWD and norB_RUH2_REV)  
(amplifies 2.0 Kb of the norB gene) (Section 2.11.3).  All PCR reactions were carried out by 
My TaqTM Red Mix  polymerase (Section 2.11.15.2).  
As can be seen from Figure 4.7, a band of 1.3 Kb length was present in Lane 1 where Wt GD 
was used as a template for PCR amplification with aniA primers. Similar size band was not 
seen in Lanes 2-5. With norB primers, a 2.0 Kb product was evident with Wt GD amplification 
in Lane 6. Approximately 2.6 Kb bands were observed with ∆aniA and ∆aniA/∆norB genomic 
DNA extracted  PCR products in Lanes 7-8. However, similar size band was not seen in Lanes 
9-10 with PCR amplification from colony PCR templates of ∆aniA/∆norB. 
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To verify inactivation of norB and nsrR in ∆nsrR/∆norB, PCR amplification was carried out 
on GD extracted from Wt, ∆norB, ∆nsrR, ∆nsrR/∆norB. For norB amplification 
(norB_RUH2_FWD and norB_RUH2_REV) primers (amplifies 2.0 Kb of the norB gene) and 
nsrR amplification (nsrR_RUH3_FWD and nsrR_RUH3_REV) primers (amplifies 1.4 Kb of 
the nsrR gene) were used (Section 2.11.3).  
Figure 4.8 shows that a 1.4 Kb band was amplified with nsrR primers from the Wt GD 
template. In Lanes 2-3, this band was not seen with the PCR products from ∆nsrR and 
∆nsrR/∆norB GD templates. A band of approximately 4.0 Kb length was apparent from Lanes 
2-3. 
With norB primers, a 2.0 Kb band was seen with Wt GD amplification. A band of 
approximately 2.6 Kb was apparent with ∆norB and ∆nsrR/∆norB GD PCR products (Lanes 
5-6).  
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Figure 4.7 PCR confirmation of ∆aniA/∆norB mutant creation. 
The norB F1- Kan- norB F2 cassette (2.5Kb) (Figure 4.5) generated from isocloning method 
was transformed into ∆aniA (Spectinomycin) and selected on Spectinomycin/Kanamycin 
containing plates (Section 2.4.2). Then the overnight grown positive colonies were used to 
extract genomic DNA (GD) (Section 2.11.6). GD from ∆aniA, ∆norB and ∆aniA/∆norB were 
used for confirmation of mutation by PCR. Alongside the GDs, positive colonies from putative 
strains were processed by colony PCR (Section 2.11.15.1). The lane annotation panel below 
the gel represents the templates used for respective PCR amplification. Primer pairs specific 
for aniA and norB were used to amplify these genes from Wt and mutant strains using My 
TaqTM red mix polymerase (Section 2.11.15.2). Primers for aniA (aniA_RUH1_FWD and 
aniA_RUH1_REV) and norB (norB_RUH2_FWD and norB_RUH2_REV) were designed 
covering the whole gene. PCR products were separated on gel depending on their size. Lanes 
1-5 were amplified by aniA primers and Lane 6-10 were amplified by norB primers. In both 
the conditions only Wt GD template produced the desired sized product (1.3 Kb aniA and 2.0 
Kb norB) following PCR. In lanes 7-8, the approximate 2.6 Kb band represents the 1.4 Kb 
kanamycin cassette flanked by disrupted norB sequence; Gel was imaged by BioRad gel 
imager. 
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Figure 4.8 PCR confirmation of ∆nsrR/∆norB mutant creation. 
The norB F1- Kan- norB F2 cassette (2.5Kb) (Figure 4.5) was transformed into ∆nsrR 
(Tetracycline) and selected on Tetracycline/Kanamycin containing plates to generate 
∆nsrR/∆norB mutant. Then the overnight grown positive colonies were used to extract genomic 
DNA (GD) (Section 2.11.6). GD extracted from ∆nsrR, ∆norB and ∆nsrR/∆norB were used 
for confirmation of mutation by PCR. The lane annotation panel below the gel represents the 
templates used for respective PCR amplification. Primer pairs specific for nsrR  and norB were 
used to amplify these genes from Wt and mutants using My TaqTM red mix (Section 2.11.15.2). 
PCR products were separated on 1% agarose gel (Section 2.11.14) depending on their size. 
Lane 1-3 were amplified by nsrR primers (nsrR_RUH3_FWD and nsrR_RUH3_REV) and Lane 
4 – 6 were amplified by norB primers (norB_RUH2_FWD and norB_RUH2_REV). In both the 
conditions only Wt GD produced the desired sized products (1.4 Kb nsrR region and 2.0 Kb 
norB) following PCR. In lanes 2-3, the approximate 4.0 Kb band represents the 2.5 Kb 
tetracycline cassette flanked by disrupted nsrR region; In lanes 5-6, the approximate 2.6 Kb 
band represents the 1.4 Kb kanamycin cassette flanked by disrupted norB sequence. Gel was 
imaged by BioRad gel imager. 
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4.2.3 Investigation of polar effect of gene deletion of norB in the newly 
created ∆aniA/∆norB/∆nsrR 
 
4.2.3.1 Rationale and methods 
Gene inactivation often creates a conundrum in assigning an observed phenotype to the 
inactivated gene. This could be often to the fact that the observed phenotype could be an 
outcome of cumulative effect of the primary gene inactivation and polar effect of alteration in 
expression of the downstream gene brought about by primary upstream gene inactivation (Link 
et al, 1997). NorB is encoded by NMB1622. In the same direction as NMB1622, NMB1621 
which codes for a glutathione peroxidase (GpxA) is expressed (Figure 4.9 A). GpxA is 
important for protecting the organism from oxidative stress. It detoxifies peroxidases such as 
H2O2 and converts it to stable alcohol using cellular glutathione as reducing agent. N. 
meningitidis lacking GpxA is more sensitive to oxidative damage caused by H2O2 (Moore & 
Sparling, 1996). Therefore, it was essential to establish that the newly created 
∆aniA/∆norB/∆nsrR strain did not have any an altered activity of downstream GpxA due to 
inactivation of the norB.  
Wt, ∆norB and ∆aniA/∆norB/∆nsrR strains were grown overnight on GC agar plates containing 
appropriate antibiotics (Section 2.4.2). Three single colonies from each condition were 
inoculated into 5 ml MHB media and grown overnight with shaking. Cells from all the cultures 
were lysed using a sonicator. Supernatant was collected by centrifuging the cells at 10000 g for 
15 minutes at 4°C and processed for the GpxA determination assay. GpxA activity was 
determined using a commercially available glutathione peroxidase assay kit (Section 2.10.2 ). 
The kit comes with cumene hydroperoxide, glutathione (GSH), NADPH and glutathione 
reductase (GR). Gpx reduces cumene hydroperoxide and oxidises GSH to GSSG (Reaction 1). 
Supplied glutathione reductase (GR) from the kit reduces GSSG back to GSH by consuming 
NADPH (Reaction 2). The decrease in NADPH is detected at 340 nm and  is directly 
proportional to Gpx activity. Therefore, the kit measures glutathione peroxidase activity 
indirectly.  
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4.2.3.2 Results 
As evident from Figure 4.9 B, from the overnight growth culture of Wt, high amounts of Gpx 
activity was detected (319 ± 51.65 mg/ml of protein). The amount of Gpx activity detected 
from ∆aniA/∆norB/∆nsrR was 391.6 ± 77.39 mg/ml of protein. Low Gpx activity was detected 
from ∆norB (160 ± 52.10 mg/ml of protein). However this was not statistically significant from 
the other conditions where Gpx activity was quantified from the overnight grown cultures of 
∆norB and ∆aniA/∆norB/∆nsrR (p = 0.06). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 Bacterial nitric oxide metabolism in the pathogenesis of meningococcal sepsis 
150 
 
 
G
p
x 
m
U
/m
g
 o
f 
p
ro
te
in
W
t

n o
rB
 

a n
iA
/ 
n o
rB
/ 
n s
rR
0
5 0 0
1 0 0 0
1 5 0 0
2 0 0 0
2 5 0 0
B .
  
Figure 4.9 Investigation of polar effect of norB inactivation in ∆aniA/∆norB/∆nsrR on 
downstream GpxA activity. 
A) gpxA and norB are coded by NMB1621 and NMB1622 respectively. Expression of both 
genes is unidirectional. So, effect of norB inactivation on GpxA activity had to be examined. 
B) Comparative GpxA activity measurement of norB deleted strains ∆norB and 
∆aniA/∆norB/∆nsrR. All the selected strains were streaked onto GC agar plate containing vitox 
supplement overnight. Three single colonies were used to inoculate 5 ml MHB.  Bacterial cells 
grown overnight were lysed by sonication and supernatant was collected after centrifugation. 
Supernatant was used to measure glutathione peroxidase (GpxA) activity using a commercial 
kit (Abcam) (Section 2.10.2). NAPDH consumption during enzymatic reaction was a direct 
indicator of GpxA activity. n = 3, Bars denote mean ± SEM, One way ANOVA with Tukey’s 
multiple comparison test.  
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4.2.4 Growth characteristics of strains in aerobic condition 
 
4.2.4.1 Rationale and methods 
To examine the growth characteristics of the newly generated mutants in aerobic conditions, a 
comparative batch culture growth curve was performed with all the available strains (Wt, 
∆aniA, ∆norB, ∆nsrR, ∆aniA/∆norB, ∆nsrR/∆norB, ∆nsrR/∆aniA, ∆aniA/∆norB/∆nsrR) for 24 
hours. Five colonies from each condition was inoculated in 25 ml Mueller Hinton Broth in 50 
ml tubes and cultures were grown aerobically. At t = 0 timepoint, 1 ml of culture was removed  
from each tube for absorbance reading and 30 µl of each sample was used for viable count. The 
same procedure was repeated at 2, 4, 8, 12 and 24 hour time point. Samples were serially diluted 
and triplicate of 10 µl aliquots of each dilution were separately spotted on CBA plates, left in 
a microbiological safety cabinet for 10 minutes to allow them to air-dry.  Following overnight 
incubation at 37°C, 5% CO2, the mean number of colonies for each dilution were counted and 
corrected for the dilution factor and volume. 
4.2.4.2 Results 
As can be seen from Figure 4.10 A, the absorbance at OD600nm was not statistically significant 
from one another at any of the time points investigated (p = 0.8543). The growth of all the 
strain increased with progression of time. Rapid increase in absorbance was noticed after 2 
hour. 
Figure 4.10 B shows the viable counts from all the strains at different timepoints. At any given 
timepoint there was no significant difference in viable bacteria recovered from the strains 
present (p = 0.2991). Comparative area under curve analysis of all the strains also did not reveal 
any difference over time in viable bacterial growth (p = 0.3025, One way ANOVA with 
Tukey’s multiple comparison test). 
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Figure 4.10 Growth curve of the newly constructed mutant strains under normal aerobic 
condition. 
Five single colonies from each strain were incoculated in 50 ml tube containing MHB and 
grown with shaking at 37°C, 5% CO2. The sample was collected every hour for A) Absorbance 
and B) Viable Counts (expressed in cfu/ml) readings. n = 3, Bars denote mean ± SEM. Two 
way ANOVA with Tukey’s multiple comparison test.  
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4.2.5 Characterisation of metabolism of the mutant strains in presence of 
NaNO2 
4.2.5.1 Rationale and methods 
To test the functional inactivation of the newly generated ∆aniA/∆norB, ∆nsrR/∆norB and 
∆aniA/∆norB/∆nsrR strains, a batch culture growth curve was performed in Mueller Hinton 
Broth (MHB) supplemented with 5 mM NaNO2
 in microaerobic condition. This condition has 
been used for examining meningococcal denitrification (Anjum et al, 2002) (Rock & Moir, 
2005). This experiment enabled us to investigate the comparative NO2
- depletion over time in 
presence of different denitrification gene mutants compared to the Wt MC58. For comparative 
analysis Wt and ∆nsrR/∆aniA (a kind gift from Dr James Moir, our collaborator, University of 
York) strains were also included. In 25 ml tubes, the cultures were normalised to OD600nm = 
0.05 in 25 ml MHB with 5 mM NaNO2 supplementation. The cultures were grown for 24 hours 
without agitation. Static condition ensured limited oxygen diffusion in the media. In a separate 
tube, 25 ml MHB with 5 mM NaNO2 was incubated without any bacteria. This condition served 
as positive control. Viable counts were performed at 0, 2, 4, 8, 12 and 24 hour time points by 
dilutional plating. A volume of 1 ml of culture from each condition was collected for 
absorbance reading. At the specified time points, 1 ml of each sample was transferred to sterile 
1.5 ml microcentrifuge tube. The samples were centrifuged at 13000 rpm for 5 minutes and 
supernatants were collected.  Bacteria free supernatants were used to measure nitrite (NO2
-) by 
Griess Assay (Section 2.10.1). In this calorimetric assay nitrite is converted to diazonium salt 
following the reaction with acidified sulphanilamide. This salt reacts with NED solution to 
generate an azo dye, which is spectrophotometrically quantified on the basis of absorbance at 
540 nm.  
4.2.5.2 Results 
As can be seen from Figure 4.11 A, there was no significant difference in the amount of NO2
-
detected in the presence of different bacterial strains at 0, 2, and 4 hour time points. At 8, 12 
and 24 hour time points NO2
- depletion by Wt was significantly higher compared to all other 
mutant strains. Area under curve analysis using the viable count data showed that growth of 
Wt and ∆nsrR/∆aniA are significantly higher than that of ∆nsrR/∆norB (**p<0.01, One way 
ANOVA with Tukey’s multiple comparison) (Figure 4.11 B). The absorbance detected with 
Wt infected media at 12 and 24 hour time points were significantly higher compared to other 
strains (Figure 4.11 C) (p < 0.05). Compared to ∆nsrR/∆norB, absorbance readings from other 
strains were significantly higher at 12 and 24 hour time points (p < 0.01). Importantly, there 
 Bacterial nitric oxide metabolism in the pathogenesis of meningococcal sepsis 
154 
 
was no significant difference in the amount of NO2
- detected from ∆aniA/∆norB, 
∆aniA/∆norB/∆nsrR infected media in comparison with the positive control media (with 5 mM 
NaNO2
 supplementation only) at any of the time points studied (Figure 4.11 A). In the first 
replicate, Wt MC58 started depleting NO2
- at the 8 hour timepoint (Figure 4.12 A) whereas in 
the second (Figure 4.12 B) and third replicate NO2
- (Figure 4.12 C) depletion started after 12 
hour. However, in the final replicate NO2
- depletion was apparent at the 24 hour timepoint 
(Figure 4.12 D). In all four replicates NO2
- depletion coincided with an increase in absorbance. 
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Figure 4.11 Characterisation of the functional inactivation of the newly generated mutant 
strains in the presence of 5 mM NaNO2. 
Wt, ∆aniA/∆norB, ∆nsrR/∆norB, ∆nsrR/∆aniA, ∆aniA/∆norB/∆nsrR were grown in the 25 ml 
MHB containing 5 mM NaNO2
 in 50 ml tubes without agitation. Media was collected at 0, 2, 
4, 8, 12 and 24 hour timepoints to take viable count readings. 1 ml of sample from each 
condition was stored for later A) [NO2
-] measurement by Griess Assay (Section 2.10.1)  B) 30 
µl of sample from each timepoint was serially diluted and plated on CBA plate for measuring 
viable count (cfu/ml) next day, C) 1 ml of sample was used for measuring absorbance OD600nm. 
Bars denote means ± SEM. n = 4, *p<0.05, ***p<0.0001, Two way ANOVA with Tukey’s 
multiple comparison test. Apart from ∆nsrR/∆aniA (A kind gift from Moir group, York), other 
mutant strains (∆aniA/∆norB, ∆nsrR/∆norB, ∆aniA/∆norB/∆nsrR) were generated by the 
author. 
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Figure 4.12 Transition from oxidative respiration to denitrification in four identical 
cultures of N. meningitidis Wt MC58. 
All the cultures were incubated in 25 ml MHB with an initial OD600nm of 0.05 in the presence 
of 5 mM NaNO2 under microaerobic condition at 37°C, 5% CO2. Media was collected at 0, 2, 
4, 8, 12 and 24 hour timepoints. 1 ml of sample from each condition was stored for later [NO2
-
] measurement by Griess Assay (Section 2.10.1) and another 1 ml was used for measuring 
absorbance at OD600nm. 
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4.2.6 Characterisation of metabolism by mutant strains in the presence of 
an NO donor, Spermine NONOate 
 
4.2.6.1 Rationale and methods 
A second batch culture growth curve in the presence of an NO donor, 50 µM Spermine 
NONOate (further referred as SperNO) was performed to metabolically characterise the newly 
created mutant strains. This was done to check the functional inactivation of norB. NO from 
media inoculated with different strains will be measured as NO2
-, one of the stable break down 
products of NO. SperNO spontaneously dissociates to donate 1.5 molecules of NO per 
molecule. Therefore, the bacteria had high NO supplementation in the media from the onset of 
the growth curve. Wt, ∆aniA/∆norB, ∆nsrR/∆aniA and ∆aniA/∆norB/∆nsrR were grown in 
Mueller Hinton Broth in the presence of 50 µM SperNO for 24 hours. All the strains were 
normalised to an OD600nm ~ 0.03 in 50 tubes containing 25 ml MHB supplemented with freshly 
prepared 50 µM SperNO. Cultures were agitated at 320 rev/minute for 24 hours. In parallel, as 
a positive control, media containing 50 µM SperNO without any bacteria was added to the 
growth conditions. Samples were collected at 0, 2, 4, 6, 8, 12 and 24 hour time points. From 
each condition 1 ml culture was used for measuring bacterial viable counts by dilutional 
plating. Another 1 ml of culture was centrifuged at 13000 rpm for 5 minutes and bacteria free 
supernatant was stored at -80°C. NO2
- was measured by Griess assay. NO2
- is detected after 
formation of an azo dye following the reaction with acidified sulphanilamide and NED solution 
(Section 2.10.1). Due to lack of an NO electrode, we could not directly measure NO present in 
these samples. 
4.2.6.2 Results 
There was rapid depletion of NO (detected in the form of NO2
- by Griess assay) (Figure 4.13 
A) from 2 hour and later time points with the ∆nsrR/∆aniA infected media compared to other 
strains. This statistically significant decrease in NO2
- was evident at all the time points studied. 
However, at the 6 hour time point the number of viable bacteria recovered from ∆nsrR/∆aniA 
media was significantly higher than the recovery from media infected with other strains 
(Figure 4.13 B). Interestingly, there was no significant difference between NO2
- (Figure 4.13 
A) output from ∆nsrR/∆aniA and Wt infected media at 8, 12 and 24 hour time points. This 
observation was not influenced by the number of bacteria as there was no significant difference 
in viable bacteria recovered from Wt and ∆nsrR/∆aniA stimulated media at these time points 
(Figure 4.13 B and Figure 4.13 C). 
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At 8, 12 and 24 hour time points, the amount of detected NO2
- (Figure 4.13 A) from the Wt 
infected media was significantly lower than the media stimulated with ∆aniA/∆norB, 
∆aniA/∆norB/∆nsrR strains and positive control (50 µM SperNO).  
It was noteworthy that at none of the time points studied there was any significant difference 
in the measured NO2
- (Figure 4.13 A) from the ∆aniA/∆norB, ∆aniA/∆norB/∆nsrR infected 
media in comparison to that of positive control (50 µM SperNO supplementation in the media). 
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Figure 4.13 Characterisation of the functional inactivation of the newly generated mutant 
strains in the presence of 50 µM SpermineNONOate. 
Wt, ∆aniA/∆norB, ∆nsrR/∆aniA, ∆aniA/∆norB/∆nsrR were grown in 25 ml MHB containing 
50 ml tubes in the presence of  50 µM SpermineNONOate at 37°C, 5% CO2. Media was 
collected at 0, 2, 4, 6, 8, 12 and 24 hour timepoints to take viable count readings. Supernatant 
from 1 ml of sample from each condition was stored for later A) [NO2
-] measurement by Griess 
assay  (Section 2.10.1) B) 30 µl of sample from each timepoint was plated on CBA plate for 
measuring viable count next day C) 1 ml of sample was  taken at each timepoint to measure 
absorbance at OD600nm. Positive control, 50 µM SperNO. Bars denote means ± SEM. n = 3, 
*p<0.05, **p<0.01, Two way ANOVA with Tukey’s multiple comparison test. Apart from 
∆nsrR/∆aniA (A kind gift from Moir group, York), other mutant strains (∆aniA/∆norB, 
∆aniA/∆norB/∆nsrR) were generated by the author. 
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4.3 Discussion 
This chapter reports the first creation and characterisation of ∆aniA/∆norB and 
∆aniA/∆norB/∆nsrR mutants for studying the roles of multiple genes of the denitrification 
pathway of N. meningitidis in pathogenesis. ISA (Figure 4.1) was used to generate the 
Kanamycin containing norB cassette which was transformed into ∆nsrR/∆aniA to get the final 
∆aniA/∆norB/∆nsrR mutant. The ISA cloning offers several advantages over traditional 
cloning by restriction digest. Firstly, it allows the user to join multiple fragments (up to 5) in a 
single reaction without having to use multiple restriction enzymes. Secondly, the fragments to 
be cloned are just added to the ISA mix which can be simply prepared and stored in aliquots 
for long term use (Section 2.11.4). So, the process is simple and reliable. In addition, it is less 
error prone as a viable plasmid is only generated if all the participating fragments are ligated. 
Therefore, it eases the painstaking step of screening a positive clone submerged in a lawn of 
often false positive colonies. However, it is to be noted that the success of ISA cloning is largely 
dependent on designing the right set of primers with overlapping end regions of participating 
components (Figure 4.1 A). Therefore, care has to be taken for choosing optimal primer for 
the subsequent PCR reaction condition.  
PCR amplification confirmed the inactivation of aniA, norB and nsrR in the ∆Triple 
(∆aniA/∆norB/∆nsrR) strain (Figure 4.6). Primer pairs were designed to amplify 1.3 Kb, 2.0 
Kb and 1.4 Kb products from aniA, norB and nsrR regions respectively. Expected products 
were seen with Wt GD amplification. Similar sized bands were not seen with ∆Triple PCR 
indicating the inactivation of aniA, norB and nsrR. In lanes 2-3, the approximate 3.2 Kb band 
represents the 2.0 Kb spectinomycin cassette flanked by disrupted aniA sequence ; in lanes 5-
6, the approximate 2.6 Kb band represents the 1.4 Kb kanamycin cassette flanked by disrupted 
norB sequence; in lanes 8-9, the approximate 4.0 Kb band represents the 2.5 Kb tetracycline 
cassette flanked by disrupted nsrR region. PCR reaction by nsrR primers produced an 
unexpected 1 Kb band with Wt, ∆nsrR and ∆Triple GD (Lanes 8 -10, Figure 4.6). This could 
be due to non-specific binding of primers to elsewhere in the genome. These non-specific 
products apparent on the gel could have been gel extracted and sequenced after cloning into a 
suitable plasmid vector to identify the region of genome that has been amplified. However, it 
was deemed not be essential as later metabolic characterisation confirmed the functional 
inactivation of the genes (Section 4.2.5 and Section 4.2.6). Confirmatory PCR for gene 
inactivation in ∆aniA/∆norB and ∆nsrR/∆norB were performed by the same sets of aniA, norB 
and nsrR primers. Inactivation of the genes was confirmed by the similar evident bands (Figure 
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4.7 and Figure 4.8) where the expected products were found with the Wt GD template but not 
with the mutant GD templates.  
Downstream polar effects of the norB deletion were examined by measuring GpxA (NMB 
1621) activity (Figure 4.9). In the newly created strain ∆aniA/∆norB/∆nsrR where norB was 
inactivated there was no defect in GpxA activity compared to Wt and ∆norB. However, it is to 
be noted that one of the three replicates for Wt GpxA activity showed a large variation in output 
compared to the other two replicates. Therefore, the inclusion of this replicate rendered the p 
value to a small amount (p = 0.06) which was close to being statistically significant. Therefore, 
more replicates have to be performed to establish that norB deletion did not cause any polar 
effect in ∆aniA/∆norB/∆nsrR. 
Isogenic single mutants (∆aniA, ∆norB, ∆nsrR) were grown alongside the newly generated 
strains (∆aniA/∆norB, ∆nsrR/∆norB and ∆aniA/∆norB/∆nsrR) in an aerobic growth condition 
(Figure 4.10). No difference was seen in the measured absorbance and viable count across the 
strains. 
 Batch culture growth curves were performed to test the functional inactivation genes in 
∆aniA/∆norB, ∆nsrR/∆norB and ∆aniA/∆norB/∆nsrR strains in the presence of 5 mM NaNO2 
and 50 µM SperNO (Figure 4.11 and Figure 4.13). 
Observations with the Wt strain from batch culture growth curve in the presence of 5 mM 
NaNO2 was concomitant with the respiration by denitrification (Figure 4.11 and Figure 4.12). 
Initially, there could have been a small amount of NO produced by minimal activity of AniA 
mediated by FNR in the presence of oxygen. This could have been detoxified by constitutively 
expressed cytochrome c'. When all the available oxygen was utilised, the bacteria switched 
from aerobic growth to denitrification. This caused increased aniA activity by association of 
FNR with its promoter. As NO produced by aniA reached ~ 1 µM concentration threshold, 
nsrR mediated repression of aniA and norB were relieved and expression of these genes were 
increased. Thus, Wt strain was able to produce enough norB to detoxify high amounts of NO 
produced by aniA and grow rapidly in oxygen depleted condition (Figure 4.11). It has been 
demonstrated that N. meningitidis prefers denitrification over oxygen respiration in the 
presence of high amounts of intermediate NO accumulation as such in presence of 5 mM 
NaNO2  (Rock et al, 2005). However, in microaerobic condition, as the concentrations of NO 
becomes exceedingly high (> 1 µM) it reduces the expression of aniA. This could be due to 
inactivation of FNR by dinitrosyl-iron-cysteine complex which is formed when NO binds to 
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the [4Fe - 4S]2+ cluster of FNR (Cruz-Ramos et al, 2002). Subsequently FNR dissociates from 
the aniA promoter resulting in diminished NO2
- reduction as FNR binding is mandatory for 
aniA expression (Lissenden et al, 2000). However, expression of other denitrification genes 
such as norB, dnrN remain highly activated to counteract toxicity by accumulation of excessive 
NO. Therefore, N. meningitidis tightly regulates AniA activity by dual functions of NsrR and 
FNR in response to varying concentrations of NO to prevent toxicity induced by NO 
accumulation and also to support growth by denitrification in parallel. 
Media extracted from the newly created strains, ∆aniA/∆norB and ∆aniA/∆norB/∆nsrR had the 
similar amount of NO2
- (Figure 4.11 A) as found with the positive control at any monitored 
time point. The viable counts of these strains also remained steady over the course of 24 hour 
growth curve. However, the growth was significantly lower than the Wt at 8, 12 and 24 hour 
time points (Figure 4.11 C). This was due to the fact that when the oxygen in the media was 
consumed by the organism, the mutants could not switch to denitrification due lack of 
functional aniA. If both the strains had the functional denitrification genes aniA and norB, high 
levels of NO produced by the activity of aniA would have been detoxified by norB and their 
growth pattern would have been similar to that of wild type. In contrast, ∆nsrR/∆norB was not 
able to deplete NO2
- to level of Wt despite the presence of a functional aniA and an inactivated 
nsrR at 8, 12 and 24 hour time points (Figure 4.11 A). This was due to the rapid reduction of 
viable cells from ∆nsrR/∆norB at these time points (Figure 4.11 B and Figure 4.11 C).  An 
isogenic single ∆norB grows poorly compared to Wt in the presence of 5 mM NO2- (Anjum et 
al, 2002). For ∆nsrR/∆norB, activity of a functional aniA resulted in overproduction of NO in 
absence of nsrR, which could not be detoxified due the inactivated norB. Accumulated NO if 
not detoxified can damage mitochondrial respiration by forming iron-NO complex with iron 
group from cytochrome oxidase (Brown, 2001). NO can reversibly inhibit cyctochrome c 
oxidase, the terminal enzyme of mitochondrial respiratory chain, leading to the inhibition of 
cellular respiration (Cleeter et al, 1994). The only oxidase of the meningococcal respiratory 
chain, cytochrome cbb3 type oxidase is also inhibited by NO (Rock et al, 2005). Therefore, in 
the presence of 5 mM NO2
-, ∆nsrR/∆norB did not grow from 8 hour time point due to toxicity 
exerted by aniA activity derived NO.  
It is noteworthy that in all four growth curves performed in presence of 5 mM NaNO2
 without 
agitation, Wt MC58 made a successful transition from oxidative respiration to denitrification 
(Figure 4.12). This was evidenced by the increase in growth (absorbance) coinciding with the 
depletion of NO2
- (Figure 4.12 A, B, C, D) and thereby confirming the AniA activity. 
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However, there have been several studies that reported mutations in aniA sequence in isolates 
of N. meningitidis which is conserved across other Neisseria spp (Barth et al, 2009; Ku et al, 
2009; Stefanelli et al, 2008). In other Neisseria spp., AniA can receive electrons from 
cytochrome C5 and via a second route via the CcoP domain of cytochrome cbb3. However, 
AniA of N. meningitidis only receives electrons from cytochrome C5  (Figure 1.7) as the second 
route of electron transfer from cbb3 oxidase to aniA is non functional due to a single nucleotide 
polymorphism in the ccoP domain of cbb3 which is a meningococci specific adaptation 
(Aspholm et al, 2010). This indicates that there could be an evolutionary pressure on N. 
meningitidis to remove aniA. Another study reported that transition from oxidation to 
denitrification is unstable and inconsistent in meningococci. AniA activity was observed in 
four out of six identical microaerobic cultures of N. meningitidis (Moir, 2011). According to 
the data presented in this chapter the denitrification occurred at different times in four identical 
cultures (Figure 4.12 A, B, C and D). This observation further verified that transition from 
oxidation to denitrification is sophisticated and variable. Variable transient accumulation of 
NO by aniA activity could account for the variable transition from aerobic growth to 
denitrification (Rock et al, 2005).   
SperNO donates NO rapidly into the media.  NO2
- was detected as the breakdown product of 
NO (Figure 4.13 A), ∆nsrR/∆aniA began NO2- depletion early at 2 hour and similar trend 
continued until 24 hour (Figure 4.13 A). This observation was not unexpected given that norB 
from ∆nsrR/∆aniA can start metabolising NO early in the absence of nsrR. There was a 
significant increase in growth of this strain at 6 hour time point which could be due to rapid 
removal of NO mediated toxicity by functional norB (Figure 4.13 B). NO2
- depletion by Wt 
was significantly higher compared to ∆aniA/∆norB and ∆aniA/∆norB/∆nsrR at 8, 12 and 24 
hour timepoints.  However, amount of NO detected in form of NO2
- from ∆aniA/∆norB and 
∆aniA/∆norB/∆nsrR was not significantly different compared to the media with only 50 µM 
SperNO supplementation (Figure 4.13 A).  
Taken together all the observations from two batch culture growth curves, we provide evidence 
for functional inactivation of the aniA, norB and nsrR genes in the mutant strains, 
∆aniA/∆norB, ∆nsrR/∆norB and ∆aniA/∆norB/∆nsrR. nsrR is an NO sensitive negative 
regulator of  meningococcal denitrification genes (Rock et al, 2005). Unlike E. coli nsrR, where 
it regulates as many as 40 genes (Filenko et al, 2007), nsrR of N. meningitidis regulates a 
compact set of five genes. Alongside AniA and NorB, it represses the activity of DnrN, a 
putative protein for repairing iron-sulfur cluster in nitrosative damage and NirV, a putative 
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nitrite reductase assembly protein (Heurlier et al, 2008). It was noteworthy in none of the 
growth curves analysed (Figure 4.11 and Figure 4.13), there was any statistically significant 
difference in the NO2
- and viable count output between ∆aniA/∆norB and ∆aniA/∆norB/∆nsrR. 
This observation indicates that in batch culture growth conditions supplemented with NO or 
NO2
-, inactivation of nsrR does not differentially regulate the NO metabolic output in the 
presence of DnrN and NirV. 
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5 Chapter 5: Effect of meningococcal NO metabolism on 
the regulation of barrier function and innate immune 
response in human primary bronchial airway epithelial 
cells 
5.1 Introduction 
As an exclusive coloniser of the human nasopharynx, N. meningitidis has to withstand high 
concentrations of NO present in that environment (Busch et al, 2000). It can use its 
denitrification pathway to supplement its growth under oxygen limited condition (Rock & 
Moir, 2005). Previously our group has shown that the NO detoxification pathway of N. 
meningitidis helps the bacteria to survive inside human MDMs and nasopharyngeal mucosa 
(Stevanin et al, 2005). The organism is an accidental pathogen and in unknown circumstances, 
known to be influenced by the particular meningococcal strain, environmental factors and 
human genetic predispositions to disease, can go on to become a deadly pathogen. To cause 
pathology, bacteria have to cross the nasopharyngeal barrier and enter into systemic circulation 
via the bloodstream. In order to gain access to the bloodstream following acquisition at the 
nasopharynx, meningococci have to interact with the nasopharyngeal epithelial barrier. This 
layer consists of polarised and differentiated columnar epithelial cells, which are joined by tight 
junctions controlling the entry of pathogens and other noxious substances. Although various 
types of cells such as mucus secreting goblet cells are present, the majority of the cells at this 
layer are ciliated forming a brush border (Chevillard et al, 1993). Differentiated, human 
primary bronchial airway epithelial cells, cultured at the air-liquid interphase (HPEC-ALI) 
constitutes a closely representative model of this barrier, as they consist of columnar and 
polarised epithelial cells with tight junctions and also contain mucus producing goblet cells. 
Although the cell line is developed following bronchoscopy from human bronchial epithelium, 
it is an ideal model for studying the biology of meningococcal interaction since the respiratory 
tract is covered by a differentiated columnar epithelium from the posterior nostrils down to 
bronchioles. Furthermore, NO is an important mediator of inflammation (Neri et al, 2010) and 
barrier function of airway epithelium (Olson et al, 2009). Multiple studies have demonstrated 
that increased NO detected from airway epithelium, in the form of its oxidation and reactive 
products, NO2
-, NO3
- correlate positively with the high level of airway inflammation 
(Fitzpatrick et al, 2009; Kharitonov & Barnes, 2006; Sittipunt et al, 2001). 
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Our group has previously established that meningococcal NO detoxification differentially 
regulates the cytokine TNFα release from human MDMs (Stevanin et al, 2007). To date 
there is no information on the interaction of N. meningitidis with HPEC-ALI. An ability 
to alter the barrier function and immune response by bacterial NO metabolism could 
modulate the interaction of meningococci with the epithelium and facilitate the 
colonisation and invasion process. Therefore, it was decided to use the newly generated 
and characterised ∆aniA/∆norB and ∆aniA/∆norB/∆nsrR strains (Chapter 4) to infect the 
HPEC-ALIs to test the hypothesis that the meningococcal NO metabolism affects the 
barrier function and the immune response of the HPEC-ALIs. This study will also shed 
light on the role of genes (dnrN and nirV) (Section 1.13.3) other than the meningococcal 
denitrification pathway (aniA and norB) regulated by nsrR on the barrier function and 
cytokine profile of the HPEC-ALIs.   
5.2 Differentiated, human primary bronchial airway epithelial cell at air-
liquid interface (HPEC-ALI) 
The epithelial surface of the airway is continuously exposed to inhaled noxious particles such 
as dust and microbes. Secretions made from the airway act as the first line of defence against 
the foreign particles.  In this way, the epithelial barrier functions to protect the internal milieu 
of the lung from the external environment. HPEC-ALI culture represents a physiologically 
relevant model for studying the interaction of bacteria with the epithelial cell. Although once 
perceived as only a physical barrier, the epithelium plays a pivotal role in the maintenance of 
airway homeostasis. Now it is well established that the barrier function of HPEC-ALI can be 
split into three types: chemical, immunological and physical (Swindle et al, 2009). Epithelial 
cells can be cultured at the air-liquid interface (ALI), using defined media that helps to develop 
the differentiated phenotype. This cell model is typified by a pseudostratified and polarised 
phenotype, and contains ciliated and goblet cells with high transepithelial resistance (TER) 
(Section 5.2.1).  Goblet cells produce mucus secreting mucin for the clearance of dust particles 
and microbes. In addition, neuro-endocrine and clara cells are also present. Details on how the 
HPEC-ALI cells were cultured and maintained are described in Chapter 2 (Section 2.9) and 
Figure 5.1 is a cartoon representing the tight junction complex of the differentiated HPEC-
ALI. 
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5.2.1 HPEC-ALI as physical barrier 
Epithelial cells make adhesive contact with adjacent cells and form sheets. This characteristic 
gives rise to a ‘cobblestone’ pattern (Boublil et al, 2013). Tight junctions (TJ) and adherent 
junctions (AJ) make up the ‘apical junction complex’ located closed to the airway lumen 
(Figure 5.1). TJs are pivotal for maintaining the function of epithelium as a selectively 
permeable barrier. They control the passage of ions and solutes via the paracellular pathway 
and define epithelial cell polarity by separating apical and basolateral compartment (Sawada et 
al, 2003). Transmembrane proteins such as claudins (Krause et al, 2008) and occludins (Furuse 
et al, 1993) make up TJs. These proteins are linked to the actin filament network by zona 
occludens (ZO) proteins such as ZO-1, ZO-2 and ZO-3 (Fanning & Anderson, 2009; Fanning 
et al,1998; Fanning et al,2012). Secreted mucus from epithelium is a part of the chemical 
barrier function and plays a crucial role in protecting the epithelium from toxic agents and 
pathogens. Mucus is highly proteinaceous and is comprised mainly of mucins. Mucins (MUC2, 
MUC5AC, MUC5B, MUC6) are large and highly charged proteins responsible for forming the 
mucus layer (Loxham et al, 2014). This layer protects the epithelium against a range of particles 
of different morphologies and sizes.  NO is an important molecule in the maintenance of 
epithelial barrier function (Bove et al, 2007; Rose et al, 2002). Using both an endotoxemic 
murine model and Calu-3 human respiratory epithelial cell line, it was demonstrated that 
increased iNOS activity is responsible for altered tight junction protein expression (Han et al, 
2004). TER is an indirect marker of tight junction formation and barrier function 
integrity (Pedemonte, 1995). The first use of TER to check cellular integrity of a cell 
monolayer was reported by von Bonsdorff and colleagues in 1985 (von Bonsdorff et al, 1985). 
During TER measurement, ohmic resistance of the barrier forming layer is determined using 
an EVOM Voltohmmeter (World precision instruments) with chopstick electrodes (Section 
2.10.3). It is used as an indicator of barrier function permeability and a marker of disruption of 
the epithelial layer.  In order to examine whether the NO detoxification machinery of the 
meningococcus is able to modulate the physical barrier functions of the epithelium, 
similar to the way in which the same process acts remotely to modulate the host cell 
burden of S-nitrosothiol in iNOS-expressing macrophage cells (Laver et al, 2010), TER 
measurement of Neisseria–infected, differentiated, human primary bronchial airway 
epithelial cell at the air-liquid interphase (HPEC-ALI) was performed using a 
voltohmmeter.  
 Bacterial nitric oxide metabolism in the pathogenesis of meningococcal sepsis 
168 
 
 
Figure 5.1 Differentiated bronchial airway epithelial cells with tight junction complex. 
The primary epithelium acts as a selective barrier against the invading pathogen. This action is 
achieved by the activity of adhesion molecules such as tight junction (T) and adherent junction 
(A) present in the apical junction complex and lateral desmosomes (D), basolateral 
hemidesmosomes (H) anchoring cells to the basal membrane. Detail structure of the junctional 
complex is depicted in Figure B. 
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5.2.2 HPEC-ALI as chemical barrier 
NO produced from epithelium is the part of the chemical barrier. All three types of NOS 
(eNOS, iNOS and nNOS) have been detected in human airway epithelium (Sherman et al, 
1999). NO plays a pivotal role in lungs and has been linked with inflammatory lung disease 
such as asthma where high levels of exhaled NO are found (Barnes & Liew, 1995; Kharitonov 
et al, 1994). iNOS is continuously expressed in human lungs in vivo both at the mRNA and 
protein levels (Kobzik et al, 1993). Although basal levels of NO are detected from 
differentiated human airway epithelium, iNOS expression is upregulated following exposure 
to TNFα and IL1β. Both these factors are likely to be encountered in the aftermath of 
meningococcal infection. NO in airway epithelium has been implicated in the modulation of 
numerous functions such as epithelial ion transport (Hardiman et al, 2004; Helms et al, 2005), 
ciliary beat frequency (Li et al, 2000), antimicrobial and antiviral host defence (Darling & 
Evans, 2003; Zheng et al, 2003) and mucus secretion (Branka et al, 1997).  All these 
observations make NO a marker and modulator of the infection and inflammation of the 
airway epithelium. 
5.2.3 HPEC-ALI as an immunological barrier 
Although most inhaled substances are cleared without an inflammatory response, the airway 
epithelium plays an important role in the immune defence against infection. Different PRR 
(pattern recognition receptor) present in the epithelium recognise pathogen associated 
molecular patterns (PAMP). Activation of toll-like receptors results in the activation of 
multiple pro-inflammatory cytokines and chemokines. Chemokine IL-8 is an important player 
of the immune regulation of the epithelium. A study demonstrated that NO increases IL-8 
expression in lung epithelial cells (Sparkman & Boggaram, 2004). Increased IL-8 has been 
detected from the serum and CSF of the patients with meningococcal disease (Halstensen et al, 
1993). A positive correlation between increased IL-8 release and meningococcal infection has 
been reported from the patients with fulminant meningococcal sepsis (Møller et al, 2005). 
TNFα cytokine is a marker of airway inflammation and it can also regulate TJ permeability 
(Steed et al, 2010). NO can activate Tumor Necrosis Factor-α-Converting Enzyme (TACE) by 
nitrosation which releases membrane bound cytokines such as TNFα (Zhang et al, 2000). 
Endogenous TNFα induces NO release from the murine retinal epithelial cell (Goureau et al, 
1997). Although our group has established that NO denitrification of N. meningitidis 
differentially regulates the production of TNFα from human MDMs (Stevanin et al, 2007), 
there is no information on the role of meningococcal denitrification machinery on cytokine 
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release from the HPEC-ALIs. Therefore, IL-8 and TNFα were measured following 
infection with the newly created ∆aniA/∆norB and ∆aniA/∆norB/∆nsrR (Chapter 4) 
strains in this study to test the hypothesis that NO metabolism can differentially modulate 
the cytokine (TNFα) and chemokine (IL-8) release from the HPEC-ALIs.  
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5.3 Results 
5.3.1 Infection of HPEC-ALI with N. meningitidis results in a decreased 
TER and increased cytokine release but meningococcal NO 
metabolism does not differentially regulate the TER and cytokine 
release  
5.3.1.1 Rationale and methods  
N. meningitidis has to penetrate the nasopharyngeal or microvascular epithelium to enter the 
bloodstream. Differentiated HPEC-ALI mimics the human nasopharyngeal epithelial cells by 
having similar mucociliary and polarised properties (Section 5.2). Since NO is an important 
mediator of barrier function and modulator of the immune response in airway epithelium 
(Section 5.2.1, 5.2.2 and 5.2.3), it was decided to examine the effect of meningococcal NO 
metabolism on the TER and cytokine release of HPEC-ALIs. 
HPECs were obtained from the healthy volunteers by epithelial brushing (Section 2.9.4.1). The 
cells were seeded onto collagen coated transwell (Section 2.9.4.3). Each transwell containing 
plate was incubated overnight (at 37°C, 5% CO2) to allow the formation of a confluent 
monolayer. After reaching confluence, apical media was removed to take the cells to the air-
liquid interphase (ALI) (Section 2.9.4.4). Media from the basal compartment was removed and 
replaced with ALI media (Section 2.9.3.6) which contained high concentration of retinoic acid 
and growth factor containing BEGM media. Retinoic acid and other growth factors promoted 
the differentiation of the HPEC-ALI. The TER reading was checked after 7, 14 and 21 days to 
confirm the differentiation state (Section 2.9.4.7). After roughly 21 days the cells were 
observed by microscopy for the presence of cobblestone type phenotype. In addition, TER 
reading was checked to examine if it fell within the range of 1.0 Ω - 3.0 Ω, which is a marker 
of differentiated HPEC. Ciliated cells were observed by microscopy after 18-21 days. These 
characteristics confirmed the differentiated state of the HPEC-ALI (Figure 2.1).  
Penicillin/streptavidin antibiotics in the ALI media were normally used for the maintenance of 
ALI cultures to avoid contamination (Section 2.9.4.6) but were removed on the day before the 
experiment to avoid interference with bacterial growth during infection. Cells from one 
transwell were trypsinised and the cell number was counted using a hemocytometer (Section 
2.9.4.8). The cell count was used to calculate the amount of bacterial cells required for each 
Multiplicity of Infection (MOI). Approximately 0.2 - 0.7 x 106 cells were found from one 
transwell and this count was used to determine the required multiplicity of infection (MOI). 
TER reading was taken using an EVOM voltohmmeter prior to infection. After washing in IMS 
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and HBSS solutions, the dried electrodes were positioned at 90° angle to the base of the plate, 
with the longest electrode on the outside (basal) and shortest electrode on the inside (apical) 
side of the transwell insert and TER reading was noted (Section 2.10.3). Wild type Neisseria 
meningitidis strain MC58 and the ∆aniA/∆norB and ∆aniA/∆norB/∆nsrR mutant derivatives 
thereof were grown up in MHB to mid log phase. Bacteria were pelleted, washed and then 
resuspended into 100 µl HBSS at the appropriate MOI (1 to 100).  Infected HBSS was added 
to the apical compartment. To minimise disruption to the air-liquid interface, and to roughly 
simulate in vivo conditions (whereby potentially colonising meningococci are introduced to the 
epithelium via respiratory fomites), it was decided to keep the period of infection to a minimum 
(1 hour). In addition, preliminary experiments showed that the presence of infection bolus in 
apical compartment longer than 1 hour significantly reduces the viability of the HPEC-ALIs 
(data not shown). After 1 hour, the infected HBSS was carefully aspirated from the apical 
compartment. The HPEC-ALIs were then incubated at 37°C, 5% CO2 for a further 24 hour. 
After 24 hour, 100 µl of HBSS was added to the apical compartment of each well and incubated 
for 15 minutes to extract apical secretions. Subsequently TER was measured by EVOM 
Voltohmmeter (Section 2.10.3). Bacterial viability on the apical surface was determined by 
tenfold serial dilution and plating on Columbia Blood agar, retrospectively adjusting for 
dilution factor and volume of the apical supernatant. The remainder of the apical and 
basolateral secretions were collected in microcentrifuge tubes and supernatants were stored in 
the freezer after centrifugation. The supernatants were later used to measure the concentrations 
of IL-8 and TNFα by ELISA (Section 2.8.1). IL-8 released from both the basal and apical 
compartments were measured, however detectable levels of TNFα were only measurable in the 
supernatant derived from the basal compartment (data not shown). A generic overview of the 
experimental procedures in presented in Figure 5.2. 
5.3.1.2 Results  
As can be seen from Figure 5.3 A, bacterial infection with MOI 1-100 lowers TER readings 
of HPECs compared to control.  However, only infection with MOI 100 of Wt (0.35 Ω ± 0.08), 
∆aniA/∆norB (0.31 Ω ± 0.07) and ∆aniA/∆norB/∆nsrR (0.41 Ω ± 0.12) were found to be 
statistically significant compared to control TER (1) (p< 0.05).  Importantly, a negative 
correlation between bacterial load and TER (Spearman correlation test. p = 0.01) was found 
(Figure 5.3 B). Mutant bacteria with disrupted denitrification pathways, ∆aniA/∆norB and 
∆aniA/∆norB/∆nsrR, did not differentially modulate the TER response. 
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TNFα from the apical compartment was below the limits of detection (data not shown). There 
was an increase in TNFα output from the basolateral compartment when cells were infected at 
MOI 100 of Wt MC58 (131.7 pmol/µl ± 27.29), ∆aniA/∆norB (181.2 pmol/µl ± 53.53) and 
∆aniA/∆norB/∆nsrR (138.1 pmol/µl ± 33.88), as compared to control (13.88 pmol/µl ± 5.78) 
(Figure 5.4 A). However, the increase was only significant in the case of ∆aniA/∆norB (p < 
0.05). A positive correlation between bacterial load and TNFα (Spearman correlation test, p = 
0.01) was also found (Figure 5.4 B). 
Figure 5.5 shows that infection of cells at MOI 100 led to a significant increase in the 
concentration of IL-8 in the apical compartment, Wt (6.81 x 104 pmol/µl ± 2.34 x 104), 
∆aniA/∆norB/∆nsrR (6.49 x 104 pmol/µl ± 1.43 x 104), as compared to the uninfected control 
(3.68 x 103 pmol/µl ± 704.3) (p < 0.05). A similar pattern was noticed in the basolateral 
compartment (Figure 5.6). Compared to the control (3.86 x 103 pmol/µl ± 1.21 x 103), infection 
of epithelial cells at an MOI 100 of Wt (6.93 x 104 pmol/µl ± 1.85 x 104), ∆aniA/∆norB (7.65 
x 104 pmol/µl ± 3.52 x 104) and ∆aniA/∆norB/∆nsrR (7.66 x 104 pmol/µl ± 3.23 x 104), 
significantly increased basal IL-8 release from HPECs-ALI (p < 0.05). 
However, neither of the cytokines examined was differentially altered by the newly created 
strains ∆aniA/∆norB and ∆aniA/∆norB/∆nsrR compared to Wt infection.  
As can be seen from Tables 5.1 and 5.2, there was no significant difference in the number of 
viable bacteria used to inoculate the epithelial cells (Table 5.1) (Figure 5.7 A), or in the output 
supernatant collected after the infection period (Table 5.2) (Figure 5.7 B). Interestingly, the 
number of output viable bacteria recovered for MOI 1-100 infections were not significantly 
different, indicating our bacterial population had in each case grown up to the highest levels 
sustainable by the HPEC-ALI model.  
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Table 5.1 Input viable count 
Strain Cfu/ml 
Wt 1.45 x 108 cfu/ml ± 
2.78 x 107 
∆aniA/∆norB 1.64 x 108 cfu/ml ± 
4.28 x 107 
∆aniA/∆norB/∆nsrR 1.66 x 108 cfu/ml ± 
5.26 x 107 
 
Table 5.2 Output viable count 
Strain MOI Cfu/ml 
Wt 1 4.83 x 106 cfu/ml ± 3.27 x 
106 
10 2.67 x 106 cfu/ml ± 2.20 x 
106 
100 3.38 x 106 cfu/ml ± 2.74 x 
106 
∆aniA/∆norB 1 1.22 x 107 cfu/ml ± 4.00 x 
106 
10 1.37 x 107 cfu/ml ± 8.85 x 
106 
100 2.08 x 107 cfu/ml ± 6.07 x 
106 
∆aniA/∆norB/∆nsrR 1 2.28 x 106 cfu/ml ± 1.34 x 
106 
10 3.88 x 106 cfu/ml ± 1.42 x 
106 
100 1.88 x 107 cfu/ml ± 6.64 x 
106 
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Figure 5.2 Methods for measuring TER, TNFα and IL-8 after infecting the HPEC-ALI 
culture with denitrification mutants of N. meningitidis. 
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Figure 5.3 Measurement of A) TER and B) Correlation graph for TER vs Output viable 
count of the differentiated HPEC-ALI infected with Wt, ∆aniA/∆norB, 
∆aniA/∆norB/∆nsrR (MOI 1-100). 
Bacteria grown up to logarithmic phase were used to infect the HPEC-ALIs for 1 hour 
suspended in 100 µl HBSS after measuring the A) TER (Section 2.10.3). Then after removing 
the bacteria, plate was incubated for 24 hours at air-liquid interphase. Following day 100 µl 
HBSS was added to the transwells and incubated for 15 minutes. Then TER was measured by 
Voltohmmeter. TER reading before and after the experiments were used to calculate the final 
TER and normalised to the control (No bacteria) condition.  Data represents mean ± SEM * p< 
0.05, One way ANOVA with Dunn’s multiple comparison test, n= 6. B) Statistically 
significant negative correlation between recovered output bacterial burden and TER 
reading. Spearman’s rank correlation test, graphpad prism. 
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Figure 5.4 Measurement of A) TNFα and B) Correlation graph for TNFα vs Output viable 
count of the differentiated HPEC-ALI infected with Wt, ∆aniA/∆norB, 
∆aniA/∆norB/∆nsrR (MOI 1-100). 
Bacteria grown up to logarithmic phase were used to infect HPECs for 1 hour suspended in 
100 µl HBSS after measuring the TER (Section 2.10.3). Then after removing the bacteria, plate 
was incubated for 24 hours at air-liquid interphase. Following day 100 µl HBSS was added to 
the transwells and incubated for 15 minutes. Basal supernatant was collected and TNFα was 
measured by ELISA in duplicates (Section 2.8.1). Data represents mean ± SEM * p< 0.05, One 
way ANOVA with Tukey’s multiple comparison test, n= 6. B) Statistically significant 
positive correlation between recovered output bacterial burden and basal TNFα release. 
Spearman’s rank correlation test, graphpad prism. 
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Figure 5.5 Measurement of IL-8 release from the apical compartment of the 
differentiated HPEC-ALIs infected with Wt, ∆aniA/∆norB, ∆aniA/∆norB/∆nsrR (MOI 1-
100). 
Cells were infected for an hour with logarithmic phase bacteria (Wt, ∆aniA/∆norB, 
∆aniA/∆norB/∆nsrR) suspended in 100 µl HBSS. After removing bacteria, HPECs were 
incubated further at air-liquid interphase for 24 hours. After 24 hour 100 µl HBSS was added 
to the apical compartment and supernatant was collected after centrifugation. IL-8 
concentration was determined by ELISA in duplicates (Section 2.8.1). Data represents mean ± 
SEM. *p<0.05, One way ANOVA with Tukey’s multiple comparison test. n = 6. 
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Figure 5.6 Measurement of IL-8 release from the basolateral compartment of the 
differentiated HPEC-ALIs infected with Wt, ∆aniA/∆norB, ∆aniA/∆norB/∆nsrR (MOI 1-
100). 
Cells were infected for an hour with logarithmic phase bacteria (Wt, ∆aniA/∆norB, 
∆aniA/∆norB/∆nsrR) suspended in 100 µl HBSS. After removing bacteria, HPECs were 
incubated further at air-liquid interphase for 24 hours. After 24 hour 100 µl HBSS was added 
to the apical compartment and supernatant was collected after centrifugation. Basolateral 
supernatant was also collected from basal compartment after centrifugation. Basal IL-8 
concentration was determined by ELISA in duplicates (Section 2.8.1). Data represents mean ± 
SEM. *p<0.05, **p<0.01, Kruskal Wallis test, n = 6. 
 
 
 
 
 
  
 Bacterial nitric oxide metabolism in the pathogenesis of meningococcal sepsis 
180 
 
W
t M
O
I 1
0 0

a n
iA
/ 
n o
rB
 M
O
I 1
0 0

a n
iA
/ 
n o
rB
/ 
n s
rR
 M
O
I 1
0 0
1 0 7
1 0 8
1 0 9
In p u t v ia b le  c o u n t
C
FU
 m
l-1
W
t M
O
I 1
W
t M
O
I 1
0
W
t M
O
I 1
0 0

a n
iA
/ 
n o
rB
 M
O
I 1

a n
iA
/ 
n o
rB
 M
O
I 1
0

a n
iA
/ 
n o
rB
 M
O
I 1
0 0

a n
iA
/ 
n o
rB
/ 
n s
rR
 M
O
I 1

a n
iA
/ 
n o
rB
/ 
n s
rR
 M
O
I 1
0

a n
iA
/ 
n o
rB
/ 
n s
rR
 M
O
I 1
0 0
1 0 2
1 0 3
1 0 4
1 0 5
1 0 6
1 0 7
1 0 8
1 0 9
O u tp u t v ia b le  c o u n t
C
FU
 m
l-1
A .
B .
  
Figure 5.7 A) Input and B) Output viable count from the differentiated HPEC-ALI 
infected with Wt, ∆aniA/∆norB, ∆aniA/∆norB/∆nsrR at MOI 1-100. 
A) Bacteria were grown up to logarithmic phase. Appropriate number of bacterial pellet was 
resuspended in HBSS to give MOI 1- 100 and was used to infect the HPEC-ALIs. Triplicates 
of 10 µl aliquots of each dilution were separately spotted on Columbia blood agar plates. 
Following overnight incubation at 37°C, 5% CO2, the mean number of colonies for each 
dilution were counted and corrected for the dilution factor and volume. B) After 24 hour 100 
µl HBSS was added to the apical compartment and an aliquot of this was used to determine the 
number of viable bacteria post incubation. Data represents mean ± SEM. Kruskal Wallis test, 
n =6 
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5.3.2 Induction of HPEC-ALI with a slow releasing NO donor SNAP (S-
Nitroso-N-acetyl-DL-Penicillamine) does not affect the TER and 
cytokine profile of HPEC-ALI in relation to meningococcal NO 
denitrification pathway 
5.3.2.1 Rationale and methods 
Infection of epithelial cells with the newly created meningococcal denitrification mutants did 
not differentially modulate the TER and cytokine release from HPEC-ALIs in the presence of 
de novo synthesised NO (Section 5.3.1). Although human airway inflammation is reported to 
be an NO rich environment (Bove & van der Vliet, 2006), it is conceivable that the lack of any 
measurable impact of the meningococcal partial denitrification pathway on the epithelial 
barrier parameters was due to an insufficiency in the overall levels of NO in each well. Given 
the chemistry of NO, including its high partition coefficient and freely diffusible nature, it is 
likely that the NO concentration present in the airway is much higher than a small number of 
infected epithelial cells can generate de novo. Concentrations of NO in exhaled breath represent 
the accumulated synthesis of NO from thousands of epithelial cells, in addition to iNOS-
mediated responses by cellular mediators of innate immunity such as macrophages.  It is 
plausible therefore, given their location on the respiratory surface; that the aggregative, ‘cloud’ 
effect of NO generation results in exposure of HPEC-ALI cells in situ to much higher 
concentrations of NO than they are able to generate themselves in vitro.  The NO insufficiency 
in this model might in turn mean that the critical threshold concentration of NO required to de-
repress NsrR-regulated promoters in N. meningitidis is not reached, with the result that the 
genetic differences between the strains used in this study do not translate into phenotypic 
differences. To ensure that the partial denitrification pathway of our strains is being de-
repressed by NO, it was decided to supplement the HPEC-ALI model with media containing a 
slow releasing NO donor, SNAP. This was done for two main reasons. Firstly, SNAP is a slow 
releasing NO donor which has a half-life of 5 hour in aqueous solution (Ignarro et al, 1981). 
So the bacterial strains and HPEC-ALIs will be exposed to NO over a longer period of time for 
relieving the nsrR mediated repression of the meningococcal denitrification. Secondly, a 
concentration of 500 µM SNAP differentially regulates the chemokine and cytokine profile of 
human MDMs (Stevanin et al, 2007) and lowers the IL-8 release of the human bronchial 
epithelial (HBEC) cells (Neri et al, 2010). However, there is no information on the effects of 
SNAP and meningococcal denitrification machinery on HPEC-ALI. The HPEC-ALIs were 
infected with MOI 100 of Wt, ∆aniA/∆norB and ∆aniA/∆norB/∆nsrR in the presence of 500 
 Bacterial nitric oxide metabolism in the pathogenesis of meningococcal sepsis 
182 
 
µM SNAP in the basal compartment.  The rest of the experimental procedures were carried out 
as mentioned in Section 5.3.1.1.  
5.3.2.2 Results 
Figure 5.8 demonstrates that infection with meningococcal infection significantly reduced the 
TER (Wt MOI 100, 0.55 Ω ± 0.04; ∆aniA/∆norB MOI 100, 0.66 Ω ± 0.01 ; ∆aniA/∆norB/∆nsrR 
MOI 100, 0.66 Ω ± 0.14) of HPEC-ALIs compared to control ( 1 Ω) (p < 0.05). However, 
meningococcal denitrification pathway did not differentially regulate the TER response of 
HPEC-ALI.  
There was a statistically non-significant increase in TNFα release with bacterial infection (Wt 
MOI 100, 239.5 pmol/µl ± 103.3; ∆aniA/∆norB MOI 100, 99.22 pmol/µl ± 77.34; 
∆aniA/∆norB/∆nsrR MOI 100, 109.6 pmol/µl ± 82.32) compared to control (32.31 pmol/µl ± 
29.52) and 500 µM SNAP (84.58 pmol/µl ± 73.80) (p = 0.46) (Figure 5.9) 
Similar non-significant increase was noticed for apical IL-8 secretion with meningococcal 
infection (Wt MOI 100, 6.99 x 104 pmol/µl ± 7.01 x 103, ∆aniA/∆norB MOI 100, 7.35 x 104  
pmol/µl ± 9.03 x 103; ∆aniA/∆norB/∆nsrR MOI 100, 8.18 x 104 pmol/µl ± 1.64 x 104) 
compared to control (3.21 x 104 pmol/µl ± 3.0 x 104) and 500 µM SNAP (3.6 x 104 pmol/µl ± 
2.35 x 104) (p = 0.29) (Figure 5.10) and also from basal IL-8 secretion (Wt MOI 100, 6.74 x 
104 pmol/µl ± 2.31 x 104; ∆aniA/∆norB MOI 100, 5.72 x 104 pmol/µl ± 2.95 x 104; 
∆aniA/∆norB/∆nsrR MOI 100, 6.98 x 104 pmol/µl ± 2.01 x 104) compared to control (3.75 x 
104 pmol/µl ± 2.4 x 104) and 500 µM SNAP (3.66 x 104 pmol/µl  ± 2.43 x 104) (p = 0.79) 
(Figure 5.11). But meningococcal denitrification machinery did not significantly alter the 
release of IL-8 from neither apical nor the basal compartment. 
It was important to note that there was no statistically significant difference in input viable 
count of any of the strains (Wt MOI 100, 1.58 x 108 cfu/ml ± 3.21 x 107;  ∆aniA/∆norB MOI 
100, 1.75 x 108  ± 3.94 x 107; ∆aniA/∆norB/∆nsrR MOI 100, 1.9 x 108 cfu/ml ± 3.79 x 107) (p 
= 0.83) (Figure 5.12 A). Non-significant difference was also observed in output viable count 
after infection (Wt MOI 100, 3.80 x 106 cfu/ml ± 3.75 x 106;  ∆aniA/∆norB MOI 100, 3.07 x 
107  ± 2.96 x 107; ∆aniA/∆norB/∆nsrR MOI 100, 5.24 x 106 cfu/ml ± 5.23 x 106) (p = 0.51) 
(Figure 5.12 B).  
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Figure 5.8 Measurement of TER of the differentiated HPEC-ALI infected with Wt, 
∆aniA/∆norB, ∆aniA/∆norB/∆nsrR (MOI 100) in the presence of 500 µM SNAP. 
Bacteria grown up to logarithmic phase were used to infect HPECs for an hour suspended in 
100 µl HBSS containing 500 µM SNAP after measuring TER (Section 2.10.3). In addition, 
500 µM SNAP was also added to the basal compartment. Then after removing the HBSS after 
1 hour, HPEC-ALIs were incubated further for 24 hours. Following day 100 µl HBSS was 
added to the transwells and incubated for 15 minutes. Then TER was measured by 
Voltohmmeter. TER reading before and after the experiments were used to calculate the final 
TER and normalised to the control (No bacteria) condition.   Data represents mean ± SEM * 
p< 0.05, One way ANOVA with Tukey’s multiple comparison test, n= 3. 
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Figure 5.9 Measurement of TNFα of the differentiated HPEC-ALIs infected with Wt, 
∆aniA/∆norB, ∆aniA/∆norB/∆nsrR (MOI 100) in the presence of 500 µM SNAP. 
Bacteria grown up to logarithmic phase were used to infect HPECs for an hour suspended in 
100 µl HBSS containing 500 µM SNAP after measuring TER (Section 2.10.3). In addition, 
500 µM SNAP was also added to the basal compartment. Then after removing the HBSS after 
1 hour, HPEC-ALIs were incubated further for 24 hours. Following day 100 µl HBSS was 
added to the transwells and incubated for 15 minutes. Basal supernatant was collected and 
TNFα was measured by ELISA in duplicates (Section 2.8.1). Data represents mean ± SEM 
One way ANOVA with Tukey’s multiple comparison test, n= 3. 
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Figure 5.10 Measurement of IL-8 release from apical supernatants of the differentiated 
HPEC-ALIs infected with Wt, ∆aniA/∆norB, ∆aniA/∆norB/∆nsrR (MOI 100) in the 
presence of 500 µM SNAP. 
Cells were infected for an hour with logarithmic phase bacteria (Wt, ∆aniA/∆norB, 
∆aniA/∆norB/∆nsrR) suspended in 100 µl HBSS containing 500 µM SNAP. In addition, 500 
µM SNAP was also added to the basal compartment. After removing bacteria after 1 hour, 
HPEC-ALIs were incubated further for 24 hours. 100 µl HBSS was added to the apical 
compartment and supernatant was collected after centrifugation. IL-8 concentration was 
determined by ELISA in duplicates (Section 2.8.1). Data represents mean ± SEM. One way 
ANOVA with Tukey’s multiple comparison test, n = 3. 
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Figure 5.11 Measurement of IL-8 release from basal supernatants of the differentiated 
HPEC-ALIs infected with Wt, ∆aniA/∆norB, ∆aniA/∆norB/∆nsrR (MOI 100) in the 
presence of 500 µM SNAP. 
Cells were infected for an hour with logarithmic phase bacteria (Wt, ∆aniA/∆norB, 
∆aniA/∆norB/∆nsrR) suspended in 100 µl HBSS containing 500 µM SNAP. In addition, 500 
µM SNAP was also added to the basal compartment. After removing bacteria after 1 hour, 
HPEC-ALIs were incubated further for 24 hours. 100 µl HBSS was added to the apical 
compartment and supernatant was collected after centrifugation. Basolateral supernatant was 
also collected from basal compartment after centrifugation. IL-8 concentration was determined 
by ELISA in duplicates (Section 2.8.1). Data represents mean ± SEM. One way ANOVA with 
Tukey’s multiple comparison test, n = 3. 
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Figure 5.12 A) Input and B) Output viable count from the differentiated HPEC-ALI 
infected with Wt, ∆aniA/∆norB, ∆aniA/∆norB/∆nsrR at MOI 100 in the presence of 500 
µM SNAP. 
A) Bacteria were grown up to logarithmic phase. Appropriate number of bacterial pellet was 
resuspended in HBSS to give MOI 1 - 100. Triplicate of 10 µl aliquots of each dilution were 
separately spotted on Columbia blood agar plates. Following overnight incubation at 37°C, 5% 
CO2, the mean number of colonies for each dilution were counted and corrected for the dilution 
factor and volume. B) After 24 hour, 100 µl HBSS was added to the apical compartment and 
an aliquot of this was used to determine the number of viable bacteria post incubation. Data 
represents mean ± SEM. One way ANOVA with Tukey’s multiple comparison test, n = 3. 
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5.4 Discussion 
There have been numerous studies on the interaction of N. meningitidis with epithelial cell 
lines. Unlike other studies where immortalised epithelial cells such as T84 (colonic epithelial 
cell) (Pujol et al, 1997) (Merz et al, 1996) or Calu-3 (human bronchial epithelial cell) 
(Sutherland et al, 2010)  have been used for studying the interaction of meningococci with 
epithelial cells, the HPEC-ALI used in this study constitutes a closer representation of the in 
vivo, nasopharyngeal environment. This chapter reports the first investigation of the effect of 
the meningococcal partial denitrification pathway on the barrier function and immune response 
of HPEC-ALI. However, despite our best efforts to mimic the in vivo environment of these 
cells, including supplementation of the system with NO donor compounds, our investigation 
shows that meningococcal denitrification machinery does not modulate the barrier function and 
immunological profile of HPEC-ALIs. 
There have been contradictory findings on the route meningococci take to traverse the 
epithelium. Using a bilayer model consisting of endometrial and epithelial-endothelial cells, it 
was demonstrated that meningococci use both para and transcellular routes for the traversal of 
epithelium (Birkness et al, 1995). In contrast, the meningococcus crosses the brain 
microvascular endothelium using a paracellular route, as evidenced by the depletion of junction 
proteins (Coureuil et al, 2009). Another study using T84, a human polarised colonic epithelial 
cell, demonstrated that meningococci can cross the epithelial monolayer without altering the 
tight junctions (Merz et al, 1996). More investigations have demonstrated that the 
meningococcus traverses the T84 human polarised colonic epithelial cell and the Calu-3 
respiratory epithelial using a transcellular route, without disrupting the TER (Pujol et al, 1997; 
Sutherland et al, 2010). In contrast to studies with these immortalised and non-contextual cell 
lines, where TER is unperturbed by meningococcal infection; the current study reports a 
decrease in TER of a primary HPEC monolayer.  This dose-dependent phenomenon shows a 
positive correlation between bacterial load and a decrease in TER (Figure 5.3 B). Infection 
with any of our bacterial strains at MOI 100 significantly reduced the TER in all conditions 
(Figure 5.3 and 5.8). A reduction in TER following bacterial infection has been reported for 
other bacterial species. Infection with enteropathogenic E.coli also causes a significant 
reduction in TER of Caco-2 and MDCK epithelial cells without disrupting the tight junction 
protein  (Canil et al, 1993). Progressive decreases in TER with modification of tight junction 
structures was noticed with Salmonella typhimurium infection of MDCK epithelium (Jepson 
et al, 1995). Infection of T84 with Campylobacter jejuni significantly reduces TER and disrupts 
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the tight junction complex (Wine et al, 2008). Tight junction function could be altered due to 
the infection with a high number of bacteria present at the entry site. There could have been an 
increased availability of TNFα, LPS and IFNɣ in the epithelium due to the meningococcal 
infection. Indeed, an abundance of TNFα, LPS and IFNɣ has been shown to be responsible for 
a reduction in TER from rat retinal pigment epithelium (Zech et al, 1998). 
NO has both stimulatory and inhibitory effects on IL-8 release. In response to incubation with 
NO donors such as 1 mM SNP and 500 µM SNAP for 24 hours, the IL-8 output from human 
bronchial epithelial cell was shown to be reduced (Neri et al, 2010). The reduction was 
diminished by preincubating the cells with NOS inhibitor L-NAME. In contrast, the level of 
IL-8 release from human MDMs is increased in the presence of 500 µM SNAP (Stevanin et al, 
2007). However, this alteration in IL-8 release was not seen in the case of HPEC-ALIs where 
500 µM SNAP was present compared to control infection with only HBSS media (Figure 5.10 
and 5.11).  
Increased IL-8 (Figure 5.5, 5.6, 5.10 and 5.11) and TNFα (Figure 5.4 A and 5.9) release were 
observed with meningococcal infection (at MOI 100) of HPEC-ALIs compared to the 
uninfected control cells. This is not unexpected given that TNFα and IL-8 are pro-inflammatory 
signalling molecules, released in response to bacterial infection. This is in keeping with the 
observation where bacterial infection caused by Salmonella and Listeria monocytogenes result 
in an increased IL-8 release from intestinal and cervical epithelial cell (Eckmann et al, 1993).  
A positive correlation between increased IL-8 release from plasma and meningococcal LPS 
has been reported for the patients with fulminant meningococcal septicaemia (Møller et al, 
2005). However, it is noteworthy that during the infection of HPEC-ALI with meningococcal 
strains at MOI 100, the TNFα release (Figure 5.4 A and 5.9) was lower than the IL-8 release 
(Figure 5.5, 5.6, 5.10 and 5.11) in all conditions. This is in agreement with the previous finding 
where increased IL-8 release but undetectable levels of TNFα release was found after infection 
of epithelial cells with Helicobacter pylori  (Huang et al, 1995). This would make sense as a 
decreased TNFα response would help the meningococci to survive better in the epithelium as 
it is likely to induce a weak proinflammatory response against the bacteria. High 
meningococcal viable count output (Figure 5.7 A, B and 5.12 A, B) from HPEC-ALI points 
to this possibility. 
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Multiple explanations could account for meningococcal NO metabolism not differentially 
altering the barrier function and immune response of the HPEC-ALIs. Firstly, since HEPC-
ALI is a primary cell line cultured from different volunteers, there is most probably a much 
higher degree of interdonor variation in the development of the immune response to bacterial 
infection.  In the event that modulation of the barrier functions and immunological chemistry 
of these cells by the partial denitrification pathway is nuanced or extremely subtle, we might 
lose our signal amongst the experimental ‘noise’.  This could of course be counteracted with 
further repetition of the experiment, but the culture of HPEC-ALIs is both extremely time 
consuming and expensive.  Our initial findings suggest there may be limited gains in carrying 
out this work. Secondly, low levels of TNFα (Figure 5.4 A and 5.9) release following 
meningococcal infection points to the possibility of a reduced NO activity as it has been 
suggested that TNFα acts as an inducer of NOS expression from endothelial and epithelial cells 
(Donnelly & Barnes, 2002; Robbins et al, 1997; Yan et al, 1997) . Another study demonstrated 
that NO can activate the TNF-converting enzyme (TACE) responsible for releasing the 
membrane bound TNFα (Zhang et al, 2000). Thirdly, NOS bioactivity during airway 
inflammation following infection of HPEC-ALI with meningococci could have been reduced 
by the increased arginase activity (Figure 5.3 – 5.7). Arginase is the magnesium containing 
final enzyme of the urea cycle that converts L-arginine to urea (Christianson, 2005). 
Availability of L-arginine is one of the key factors that determine the NO activity in cellular 
environment given that L-arginine is a substrate for NOS activity (Section 1.9). Two distinct 
types of mammalian arginases, arginase I and arginase II are detected in the human airway 
epithelium (Wu & Morris, 1998). Dramatic induction of arginase I and II have been observed 
during the airway inflammatory condition such as asthma (Meurs et al, 2003; Zimmermann et 
al, 2003). Increased arginase activity would reduce the available arginine to a suboptimal level 
for any NO related activity. Therefore, it might have inhibited the NOS expression and limit 
NO production required for observing any meningococcal NO metabolism mediated impact on 
barrier function or immune response of the HPEC-ALI (Figure 5.3 – 5.7). To circumvent this 
possibility an exogenous NO donor was added for the later experiment. However, any alteration 
in immune response and barrier function was still unapparent (Figure 5.8 – 5.12). Therefore it 
could be possible that meningococcal NO metabolism does not differentially regulate the TER 
and cytokine release of the HPEC-ALIs. 
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6 Chapter 6: Effect of meningococcal denitrification on 
biofilm formation in vitro 
6.1 Introduction 
As an obligate commensal, N. meningitidis has to withstand the immune response mediated by 
the innate and adaptive immune defence mechanism of the nasopharynx. This indicates the 
adaptation of a special lifestyle to resist clearance by the immune system. Indeed, IgA antibody 
in saliva and increased serum bactericidal antibody response have been detected from the 
meningococcal carriage population (Caugant et al, 2007). Formation of biofilm could be one 
of the strategies employed by the meningococci to maintain the carriage stage and avoid 
immune mediated killing in nasopharynx. Although there is no definitive evidence to date for 
meningococcal biofilm formation in vivo, histological studies on carrier population have 
reported the presence of microcolonies on tonsillar tissue indicating the presence of a biofilm 
type phenotype in the carriage state (Neil & Apicella, 2009). There is evidence for 
meningococcal biofilm formation in vitro from multiple studies (Lappann et al, 2006; Neil et 
al, 2009; Yi et al, 2004). Since the nasopharynx is an oxygen poor environment and rich 
in NO (Andersson et al, 2002; Lundberg & Weitzberg, 1999), an ability to denitrify could 
confer an additional survival advantage to the N. meningitidis to form biofilm and 
maintain colonisation. Therefore, it was decided to examine if meningococcal 
denitrification pathway has an impact on biofilm formation in vitro by using the newly 
created and characterised ∆aniA/∆norB strain (Chapter 4). 
6.2 Bacterial biofilm formation and NO 
Presence of biofilm like structure dates back to the early record in fossil found from the 
hydrothermal environment. Bacterial microcolonies have been identified from 3.3 - 3.4 billion 
year old South African Korngberg formation and 3.2 billion year old hydrothermal rocks of 
Australia in the deep sea (Rasmussen, 2000; Westall et al, 2001). A biofilm is a group of 
microorganisms attached to a surface by forming extracellular polymeric substance (EPS) 
which facilitates the attachment and matrix formation (Donlan, 2001). Organisms in biofilm 
population have distinct growth rate and gene expression, metabolic and proteomic profile 
compared to the single species in planktonic form. In the model organism for biofilm study 
Pseudomonas aeruginosa, biofilm formation can be divided into five stages; 1) weak 
attachment to the surface, 2) transcriptional changes and tight binding to the surface for 
environmental adaptation, 3) bacterial aggregation and microcolony formation, 4) mature 
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biofilm development and 5) detachment of biofilm from the surface to move to a separate 
location (Hall-Stoodley et al, 2004). Formation of biofilm offers the organism protection from 
numerous environmental stress such as acid exposure (Welin-Neilands & Svensäter, 2007), 
metal toxicity (Teitzel & Parsek, 2003), phagocytosis (Leid et al, 2002), antibiotics (Stewart & 
Costerton, 2001), antimicrobial (Mah & O'Toole, 2001) agents and immune response 
(Domenech et al, 2013).  
Studies have demonstrated that  non capsulated N. meningitidis can form biofilm in vitro both 
on plastic tubing  (Yi et al, 2004) and continuous flow chambers (Lappann et al, 2006). 
However, encapsulated meningococci can also form biofilm as evidenced by a study performed 
on SV-40 transformed human bronchial epithelial (HBE) cell (Neil et al, 2009).  
NO have both positive and negative impacts on bacterial biofilm formation. The effect is 
dependent on multiple factors such as the concentration of NO present in the biofilm 
environment. Pseudomonas aeruginosa is a pathogen in cystic fibrosis (Davies, 2002) and its 
pathogenicity has been linked to the ability to form biofilm (Costerton et al, 1999). In 
Pseudomonas aeruginosa, high concentrations (µM level) of NO induce biofilm formation 
whereas sublethal concentrations (~25 to 500 nM) cause the sessile bacterial population to 
disperse (Barraud et al, 2006). In contrast, high concentrations (~125 -1000 µM) of NO reduce 
biofilm formation by Staphylococcus aureus but low concentrations (0.9 – 2 µM) of NO 
increase  biofilm biomass (Jardeleza et al, 2011).  One of the mechanisms by which NO forms 
biofilm is by controlling the level of c-di-GMP molecule which is an inducer for biofilm 
formation (Plate & Marletta, 2012).  
It is well established that the closely related pathogenic species, Neisseria gonorrhoeae, 
forms biofilm both in vitro and in vivo (Greiner et al, 2005; Steichen et al, 2008). There 
have been several studies that confirmed a link between denitrification pathway and 
biofilm formation by N. gonorrhoeae (Falsetta et al, 2009; Falsetta et al, 2010). These 
studies demonstrated the importance of aniA and norB in gonococcal biofilm formation. 
However, there has not been any study investigating the effect of meningococcal 
denitrification pathway on biofilm formation in vitro.  Therefore it was decided to 
examine if meningococcal NO denitrification has an impact on biofilm formation in vitro.  
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6.3 Results 
6.3.1 The absence of denitrification pathway affects meningococcal biofilm 
formation in vitro 
6.3.1.1 Rationale and methods 
As a coloniser of nasopharynx, meningococci are likely to compete with other commensal 
species for the available nutrients. Initial experiments in our laboratory condition showed that 
a 50% strength growth media (MHB and TSB) induces meningococcal biofilm formation in 
vitro (Data not shown) in microaerobic condition. A range of concentrations of TSB media has 
been titrated and successfully used for inducing biofilm formation of Pseudomonas, 
Streptococcus and N. lactamica (personal communication with Sara Hughes, NHS 
Southampton). In the closely related species N. gonorrhoeae, it has been demonstrated both 
aniA and norB are important for biofilm formation (Falsetta et al, 2009; Falsetta et al, 2010). 
A comparative proteomic analysis revealed that the glyceraldehyde-3-phosphate 
dehydrogenase, one of the enzymes of oxygen independent glycolytic pathway is upregulated 
in biofilm layer compared to the planktonic cells of N. meningitidis (van Alen et al, 2010). To 
examine the impact of meningococcal denitrification genes, biofilm formation was induced by 
nutrient starving and a comparative biofilm formation analysis was performed between Wt and 
the newly created ∆aniA/∆norB (Chapter 4) strain in microaerobic condition. 
Biofilm was quantified by Crystal Violet (CV) staining. CV staining has been repeatedly used 
to study the static biofilm from a number of bacterial species for years (Favre-Bonté et al, 2003; 
Merritt et al, 2005) including N. meningitidis (Lappann et al, 2006; Yi et al, 2004). In the 
aqueous solution CV dissociates into CV+ and OH- ions. The CV+ component can penetrate the 
bacterial cell wall and stain the bacteria purple by interacting with the negatively charged 
component of bacteria. The intensity of this purple dye is quantified using a spectrophotometer 
(Jenway 7315). This reading provides an estimation of the biomass in biofilm.  
Ten colonies of N. meningitidis strain (Wt and ∆aniA/∆norB) were grown in the presence of 
50 µM SpermineNONOate containing MHB and were normalised to an OD600nm = 0.5.  Multiple 
colonies were chosen to account for the phase variable properties of N. meningitidis. The cells 
were resuspended in fresh 2 ml of full strength MHB media, after discarding the old media 
following centrifugation. Bacterial cultures were seeded onto 6 well polystyrene plates (Biolite, 
Thermo). The plates had an electrostatic surface treatment on the polystyrene to promote 
attachment. To induce biofilm formation by nutrient starving, 2 ml of reduced strength MHB 
broth (50% MHB+ 50% PBS) which we termed as ‘starvation media’ was added to the 2 ml of 
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bacteria containing full strength media. This gave a total media strength of 75%. Another set 
of duplicate wells were used for growing biofilm for 48 hours in parallel. On this plate, 2 ml 
of media from the biofilm seeding plate was removed after 24 hours and replaced with 2 ml of 
fresh starvation media. Therefore, the plates for 48 hour biofilm formation which started with 
a 75% media strength had a media strength of 62.5% after 24 hours. Special care was taken to 
keep the working hood sterile while setting up the biofilm plates. All the media and PBS was 
filter sterilised through a 0.22 µm MillexR filter using syringe. Each bacterial strain was seeded 
in duplicates; one well was used for crystal violet staining whereas the other well was used for 
counting the number of viable bacteria in biofilm layer. The plates were incubated at 37°C, 5% 
CO2. After 24 hour the media above the biofilm was removed and centrifuged to pellet the 
planktonic bacteria. The pellet was resuspended in PBS and the number of viable bacteria was 
counted by dilutional plating. After removing the planktonic bacteria containing media, the 
biofilm was washed twice with 4 ml sterile PBS. Pipetting had to be carried out gently from 
one particular corner of the well so that the biofilm was not dislodged. Following the wash step 
2 ml of 0.1% crystal violet solution was added to the biofilm and left for 20 minutes at room 
temperature. The CV was removed and washed twice with 2 ml PBS by very gentle pipetting. 
Then 1.2 ml of 100% ethanol was applied on top of the biofilm to elute the crystal violet. After 
20 minutes CV containing ethanol from biofilm containing wells was removed to fresh 1.5 ml 
tubes and centrifuged for 5 minutes at 13000 rpm. The supernatant from each tube was 
transferred to cuvette and absorbance was measured at 600nm using a spectrophotometer 
(Jenway 7315). Another well from the duplicate well was used to count the number of viable 
bacteria present in the biofilm layer. All the media from this well was removed and biofilm 
was washed twice with PBS. All the residual PBS was removed and 1 ml of fresh PBS was 
applied to the well. The cells in the biofilm were scraped into PBS using a cell scraper and the 
cell containing PBS was transferred to a fresh 1.5 ml microcentrifuge tube. The tubes were 
centrifuged at 13000 rpm for 5 minutes to pellet the bacteria present in biofilm. The PBS was 
removed and bacteria was resuspended in 1 ml fresh PBS. Using 30 µl of this mix, viable count 
was performed with a dilutional counting method. 
6.3.1.2 Results 
CV staining data shows that ∆aniA/∆norB (OD600nm 0.07 ± 0.01) showed a significantly 
reduced biofilm forming ability compared to Wt MC58 (OD600nm 0.44 ± 0.06) after 24 hours 
(p < 0.01) (Figure 6.1 A). There was no significant difference in the input inocula of the strains 
(Wt, 4.99 x 108  cfu/ml ± 1.03 x 108, ∆aniA/∆norB, 3.17 x 108 cfu/ml ± 6.2 x 107) (p = 0.24) 
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(Figure 6.1 B). After 24 hours the viable biofilm biomass from Wt  (4.21 x 108 cfu/ml ± 1.97 
x 108) was significantly higher than that of ∆aniA/∆norB (2.09  x 106 cfu/ml ± 1.27 x 106) (p < 
0.05) (Figure 6.1 C). However there was no statistically significant difference in the number 
of viable planktonic bacteria between Wt (4.0  x 108 cfu/ml ± 2.63 x 108) and ∆aniA/∆norB 
(4.63 x 108 cfu/ml ± 1.47 x 108) (p = 0.47) (Figure 6.1 D). Viable planktonic bacteria and 
viable biofilm biomass were combined to get the total viable biomass. There was no statistically 
significant difference in the total viable biomass in any of the conditions studied after 24 hours 
(Wt, 8.21 x 108 cfu/ml ± 2.4 x 108 and ∆aniA/∆norB, 4.65 x 108 cfu/ml ± 1.48 x 108) (p = 0.39) 
(Figure 6.1 E). 
As can be seen from Figure 6.2 A, Wt MC58 (OD600nm, 0.40  ± 0.09) showed significantly 
higher biofilm forming ability compared to ∆aniA/∆norB (OD600nm, 0.08 ± 0.008) after 48 
hours (p < 0.05). The viable biofilm biomass recovered from Wt (2.47 x 107 cfu/ml ± 1.17 x 
107) was significantly higher than ∆aniA/∆norB (9.35 x 104 cfu/ml ± 6.62 x 104) (p < 0.01) 
(Figure 6.2 C). There was no statistically significant difference across the strains in viable 
planktonic biomass recovery (Wt, 3.14 x 107 cfu/ml ± 2.77 x 107, ∆aniA/∆norB, 3.34 x 107 
cfu/ml ± 2.69 x 107) (p = 0.47) (Figure 6.2 D). Similarly, there was no statistically significant 
difference in the total viable biomass recovered from any of the conditions (Wt, 5.61 x 107 
cfu/ml ± 3.18 x 107 and ∆aniA/∆norB, 3.35 x 107 cfu/ml ± 2.7  x 107)  (p = 0.39) (Figure 6.2 
E).  
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Figure 6.1 Role of meningococcal denitrification on biofilm formation in vitro (24 hour) 
Wt MC58, ∆aniA/∆norB strains were grown in Mueller-hinton broth (MHB) in the presence 
of 50 µM SpermineNONOate and normalised to an OD600nm = 0.5 in the full strength media. 
The old media was discarded after centrifugation and cells were resuspended in fresh media. 
Bacteria were seeded onto 6 well plates (Biolite, Thermo) in 4 ml of reduced strength MHB 
broth (50% MHB+ 50% PBS) and incubated at 37°C, 5% CO2. 30 µl of this culture was serially 
diluted and plated on CBA plates for input viable count (B), Each condition was performed in 
4 wells (2 for 24 hour and 2 for 48 hour). After 24 hour, 2 of the wells were processed for CV 
(Crystal Violet) staining A), viable biomass in biofilm C) and viable count from the planktonic 
media above biofilm D) were determined after cell scrapping. Total viable biomass in well was 
calculated by combining viable biofilm and planktonic biomass E), *p< 0.05, ** p < 0.01, 
Mann-Whitney test, n = 6. Data represents mean ± SEM. 
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Figure 6.2 Role of meningococcal denitrification on biofilm formation in vitro (48 hour). 
Wt MC58, ∆aniA/∆norB strains were grown in Mueller-hinton broth (MHB) in the presence 
of 50 µM SpermineNONOate and normalised to an OD600nm = 0.5 in full strength media. The 
old media was discarded and cells were resuspended in fresh media after centrifugation. 
Bacteria were seeded onto 6 well plates (Biolite, Thermo) in 4 ml of reduced strength MHB 
broth (50% MHB+ 50% PBS) and incubated at 37°C, 5% CO2. 30 µl of this culture was serially 
diluted and plated on CBA plates for input viable count (B).  Each condition was performed in 
4 wells (2 for 24 hour and 2 for 48 hour). After 48 hour, 2 of the wells were processed for CV 
staining A) viable biomass in biofilm C) and viable count from the planktonic media above 
biofilm D) were determined after cell scrapping. Total viable biomass in well was calculated 
by combining viable biofilm and planktonic biomass E). **p < 0.01 Mann-Whitney test, n = 
6. Data represents mean ± SEM. 
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6.3.2 Reverse complementation of ∆aniA under the control of an IPTG 
inducible promoter  
6.3.2.1 Rationale and methods 
In N. gonorrhoeae both aniA and norB have been found to be upregulated in biofilms (Falsetta 
et al, 2009). Although a significant difference in biofilm formation was found with 
∆aniA/∆norB compared to the Wt strain (Section 6.3.1), the individual role of aniA and norB 
was not conclusive from the observation. Since biofilm represents a high population of bacteria, 
there would be less availability of oxygen for aerobic respiration due to competition. The 
biofilm formation was induced by nutrient starvation in microaerobic (static) condition in our 
laboratory (Figure 6.1 - 6.2). Therefore, an ability to switch from oxidative to microaerobic 
respiration would have been pivotal in enabling the meningococci to form biofilm. 
Meningococci initiate the alternative respiratory pathway of denitrification by using the nitrite 
reductase (aniA) in oxygen limited conditions (explained in Section 1.14). Using gfp 
transcriptional fusion it has been demonstrated that aniA is expressed predominantly in the 
substratum of the gonococcal biofilm (Falsetta et al, 2010). Proteomic analysis also showed an 
upregulation of AniA in gonococcal biofilm (Phillips et al, 2012). To test the hypothesis that 
aniA plays a similar role in the meningococcal biofilm formation in vitro, it was decided to 
construct a reverse complemented strain of ∆aniA (referred as ∆aniA/aniAIPTG+ here after) 
which would enable us to perform similar biofilm experiment as mentioned before (Section 
6.3.1) in the presence of Wt, ∆aniA and ∆aniA/aniAIPTG+  strains.  
For reverse complementing aniA under the control of an IPTG inducible promoter, the pGCC4 
plasmid was selected (Mehr et al, 2000; Mehr & Seifert, 1998). It has been successfully used 
for reverse complementing genes in N. meningitidis (Hung et al, 2013; Kumar et al, 2011). 
The plasmid enables to insert meningococcal gene under the transcriptional control of lac 
regulatory elements between aspC and lctP region by using the restriction enzymes from the 
multiple cloning sites (Figure 6.3). Avoiding a native promoter and regulatory region, 1.173 
Kb coding sequence of aniA (NMB1623) was PCR amplified from the Wt MC58 genomic 
DNA. To achieve this primers (Ampli_aniA_Comp_Forward, with PacI restriction site and 
Ampli_aniA_Comp_Reverse, with FseI restriction site, Table 2.6) were used following the Q5 
polymerase protocol (Section 2.11.15.5).  The selected PacI and FseI enzymes do not have any 
overlapping cut sites within the coding region of aniA. Following PCR purification (Section 
2.11.7), the product was digested along with the pGCC4 vector plasmid using PacI and FseI 
restriction digest enzymes (NEB) (Section 2.11.9). After digestion the pGCC4 was treated with 
 Bacterial nitric oxide metabolism in the pathogenesis of meningococcal sepsis 
199 
 
Antarctic phosphatase (NEB) (Section 2.11.11) which acts to minimise the re-circularisation 
of vector plasmid. The phosphatase treatment catalyses the removal of 5' phosphate termini 
from the DNA and thereby minimising the possibility of vector recircularisation by ligase 
during the ligation step. After heat-inactivation of the enzymes, the double digested PCR 
fragment and pGCC4 were ligated using the NEB’s ligation kit (Section 2.11.10). The ligation 
product was transformed into the DH5α competent cells (Section 2.11.2) and the positive 
plasmids were selected on kanamycin and erythromycin containing LB agar plates (Section 
2.4.4). Integration of aniA into pGCC4 was confirmed by sequencing (Sequencing Primers 1 
and 2, Table 2.6 and see the attached CD-ROM for sequencing data) and diagnostic PCR 
(Figure 6.4). The resulting plasmid which was chosen for subsequent cloning application was 
termed as pGCC4:: aniAIPTG3+, KanR, EryR. Then approximately an 8.1 Kb fragment from this 
plasmid was PCR amplified along with the aniA gene cloned between aspC and lctP using the 
phusion polymerase protocol (Figure 6.5) (Section 2.11.15.4). This fragment was transformed 
into the ∆aniA strain using the broth culture transformation protocol (Section 2.11.12) and 
selected on spectinomycin/erythromycin containing plates (Section 2.4.2). Then after GD 
extraction (Section 2.11.6), integration of the correct sequence was tested by sequencing 
primers (Table 2.6) (See the attached CD-ROM for sequencing data). After sequencing 
confirmation the positive colonies were combined. The resulting strain was termed as 
∆aniA/aniAIPTG+ and stored in 60% glycerol containing solution at - 80°C for future usage. 
6.3.2.2 Results 
For confirming restoration of aniA, GD were extracted from Wt, ∆aniA and ∆aniA/aniAIPTG+. 
Primers (aniA_Fwd_start and aniA_Rev_end) (Table 2.6) were designed as such that they 
amplified the 1.173 Kb aniA coding sequence region from Wt GD (Figure 6.6) (Section 
2.11.3). A similar band was apparent with GD extracted from ∆aniA/aniAIPTG+ but not from 
the GD extracted from ∆aniA.  
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Figure 6.3 Testing of pGCC4 plasmid for reverse complementing ∆aniA under the control 
of an IPTG inducible promoter. 
A) A functional copy of the gene to be complemented is ectopically inserted at an unlinked 
chromosomal locus between the lctP (L-lactate permease) and aspC (Aspartate 
aminotransferase) genes of Neisseria genome under the control of IPTG inducible lac 
regulatory elements (lac P and LacI), linked to an Erm (Erythromycin) resistant cassette. 
Multiple cloning site is located after the lacP which harbours multiple restriction enzymes for 
cloning. For reverse complementing aniA under the control of an IPTG inducible promoter 
(lacP), PacI and FseI enzymes were chosen (highlighted in red) as the aniA gene does have any 
cut site for these enzymes (Figure adapted from Addgene website) B) After receiving the 
pGCC4 plasmid from our collaborator (Prof Chris Tang, Oxford), it was tested by restriction 
digest. PacI, ClaI digested (Section 2.11.9) pGCC4 were run on the 1% agarose gel (Section 
2.11.14) to test the plasmid. PacI is an enzyme from the MCS (A) which linearises pGCC4 and 
produces a band length of 9.268 Kb (Lane 1, Figure B). As can be seen from Figure A, 
approximately 2.3 Kb sequence of pGCC4 is flanked by ClaI restriction site. Therefore, ClaI 
digestion of pGCC4 yields two bands which are of approximately 6.968 Kb and 2.3 Kb length 
(Lane 2, Figure B)  
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Figure 6.4 Diagnostic PCR for the selection of pGCC4::aniAIPTG+ plasmid containing aniA 
coding region under the control of lac promoter 
Integration of aniA into pGCC4 was confirmed by designing primers (pGCC4_diagnostic_Fwd 
and pGCC4_diagnostic_Rev) (Section 2.11.3) which amplified 2.397 Kb region containing 
aniA coding sequence under lac promoter using pGCC4::aniA+, KanR, EryR  plasmids as 
template (Lanes 1-7). NEB phusion protocol was used (2.11.15.4). Similar PCR amplification 
was performed using pGCC4 as a template (Lanes 8-12). Details of the amplified products are 
mentioned in the cartoon above the gel. Colony number 3 (Lane 3) was selected as later cloning 
application after sequencing confirmation and was named as pGCC4 :: aniAIPTG3+, KanR, EryR. 
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Figure 6.5 Amplification of aspC to lctP region along with aniA coding sequence under 
lac promoter from pGCC4::aniAIPTG3+ for transforming into ∆aniA. 
Integration of aniA into pGCC4::aniAIPTG3+ was confirmed by designing primers (Ampli-
pGCC4Forward and Ampli-pGCC4Reverse) (Section 2.11.3) which amplified the entire 
region from aspC to lctP using pGCC4::aniAIPTG3+, KanR, EryR  plasmid as template (Lane 1). 
Similar PCR amplification was performed using pGCC4 as a template (Lane 2). Details of the 
amplified products are mentioned in the cartoon above the gel. The correct size of band (8.141 
Kb) was found with the PCR reaction using pGCC4::aniAIPTG3+, KanR, EryR as template. The 
product was transformed into ∆aniA for generating ∆aniA/aniAIPTG+ strain. 
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Figure 6.6 PCR confirmation of aniA restoration in ∆aniA/aniAIPTG+ 
Genomic DNA (GD) (Section 2.11.6) was extracted from the ∆aniA/aniAIPTG+ in which aniA 
was cloned after the IPTG inducible promoter. In parallel, GD was extracted from Wt, ∆aniA. 
PCR was performed using the Q5 polymerase (Section 2.11.15.5) and the PCR products were 
run in 1% agarose gel (Section 2.11.14) to separate the products according to their size. The 
primers (Ampli_aniA_Comp_Forward and Ampli_aniA_Comp_Reverse) covering aniA coding 
region in chromosome showed a 1.173 Kb band from the Wt GD (Lane 1). Same size band was 
absent in ∆aniA GD (Lane 2) but present in ∆aniA/aniAIPTG+ GD (Lane 3). The approximately 
3.2 Kb band with ∆aniA GD amplification product (Lane 2) represents the 2.0 Kb 
spectinomycin cassette flanked by disrupted aniA sequence. 
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6.3.3 aniA activity is not restored in the newly created IPTG inducible 
∆aniA/aniAIPTG+ strain 
6.3.3.1 Rationale and methods 
The newly generated ∆aniA/aniAIPTG+ (Section 6.3.2) had to be characterised for the 
restoration of aniA activity. To achieve this ∆aniA/aniAIPTG+ was grown alongside the Wt 
MC58 and ∆aniA in  batch culture growth curve performed in MHB supplemented with 5 mM 
NaNO2
 in microaerobic condition. This condition has been used for examining meningococcal 
denitrification (Anjum et al, 2002; Rock et al, 2005). This experiment enabled us to investigate 
the comparative NO2
- depletion over time. In 25 ml tubes, the cultures were normalised to 
OD600nm = 0.05 in 25 ml MHB with 5 mM NaNO2 and where appropriate with 1 mM IPTG 
(Sigma-Aldrich, UK)  supplementation. The cultures were grown for 24 hours without agitation 
at 37°C, 5% CO2. Static condition ensured limited oxygen diffusion in the media. In a separate 
tube, 25 ml MHB with 5 mM NaNO2 was incubated without any bacteria. This condition served 
as positive control.  Similar batch culture growth curves were also performed in the presence 
of 1 mM IPTG in aerobic condition at 320 rev/minute. This was done to examine if agitation 
can induce aniA activity triggered by IPTG. Viable counts were performed at 0, 4, 8, 12 and 
24 hour time points by dilutional plating. At the specified time points, 1 ml of each sample was 
transferred to sterile 1.5 ml microcentrifuge tube. The samples were centrifuged at 13000 rpm 
for 5 minutes and supernatants were collected.  Bacteria free supernatants were used to measure 
nitrite (NO2
-) by Griess Assay (Section 2.10.1).  
6.3.3.2 Results 
As can be seen from Figure 6.7 A, there was a statistically significant difference in NO2
- 
reduction by the Wt strain in the presence of IPTG at 12, 24 hour and at 8, 12 and 24 hour 
without IPTG compared to all other strains including ∆aniA/aniAIPTG+ (p < 0.05). There was 
no difference in viable count output (Figure 6.7 B). In the case of aerobic batch culture growth 
curve in the presence of IPTG, there was no significant difference in the NO2
-, viable count 
readings from any of the strains including ∆aniA/aniAIPTG+ (Figure 6.8). 
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Figure 6.7 Functional characterisation of the newly generated IPTG inducible 
∆aniA/aniAIPTG+ in the presence of NaNO2 in microaerobic condition. 
Wt, ∆aniA, ∆aniA/aniAIPTG+ were grown in 25 ml MHB containing 5 mM NaNO2 in 50 ml 
tubes with or without 1 mM IPTG. Cultures were grown at 37°C, 5% CO2 and media were 
collected at 0, 4, 8, 12 and 24 hour timepoints to take viable count readings. 1 ml of sample 
from each condition was stored for later A) [NO2
-] measurement by Griess Assay (Section 
2.10.1),  B) 30 µl of sample from each timepoint was serially diluted and plated on CBA plate 
for measuring viable count (cfu/ml) next day. Bars denote means ± SEM. n = 4, Two way 
ANOVA with Tukey’s multiple comparison test.  
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Figure 6.8 Functional characterisation of the newly generated IPTG inducible 
∆aniA/aniAIPTG+ in the presence of NaNO2 in aerobic condition. 
Wt, ∆aniA, ∆aniA/aniAIPTG+ were grown in 25 ml MHB containing 5 mM NaNO2 and 1 mM 
IPTG in 50 ml tubes with agitation at 320 rev/minutes. The cultures were incubated at 37°C, 
5% CO2. Media were collected at 0, 4, 8, 12 and 24 hour timepoints to take viable count 
readings. A volume of 1 ml of sample from each condition was stored for later A) [NO2
-] 
measurement by Griess Assay (Section 2.10.1),  B) 30 µl of sample from each timepoint was 
serially diluted and plated on CBA plate for measuring viable count (cfu/ml) next day. Bars 
denote means ± SEM. n = 3, Two way ANOVA with Tukey’s multiple comparison test. 
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6.3.4 Reverse complementation of aniA under the control of its endogenous 
promoter  
6.3.4.1 Rationale and methods 
In the newly created ∆aniA/aniAIPTG+, 1.173 Kb aniA coding sequence starting from ‘ATG’ 
start codon to ‘TAA’ stop codon was cloned without the upstream regulatory elements. The 
regulation of aniA is a complex process and is dependent on the co-ordination of multiple 
factors such as FNR (Edwards et al, 2010; Rock et al, 2005), NsrR (Heurlier et al, 2008; Rock 
et al, 2007), FUR (Delany et al, 2004) and NarQ/NarP (Rock et al, 2005) which all have 
binding sites upstream of aniA coding region (for details see Section 1.13- 1.14). Therefore, 
the absence of regulatory region in the upstream of aniA could have been one of the reasons 
aniA activity was not restored in ∆aniA/aniAIPTG+ (Section 6.3.2, 6.3.3). So, it was decided to 
reverse complement aniA along with the upstream essential regulatory sequences. Alongside 
the promoter binding sites, the selected region contained the binding sites for the regulatory 
proteins such FNR, NarP, NsrR, FUR (Figure 6.10). For reverse complementing aniA under 
its endogenous promoter, pGCC5 plasmid (Addgene) was used (Figure 6.9). It enables to 
complement the desired gene under the control of its endogenous promoter at an unlinked 
chromosomal locus between aspC and lctP region linked to a chloramphenicol resistant 
cassette (Figure 6.9). It has been used to successfully reverse complement mutant strain of N. 
gonorrhoeae (Stohl et al, 2005). 
The selected Forward primer (AniA_compl_RUH8_FWD) and reverse primer 
(AniA_compl_RUH8_REV) contained AatII and NsiI restriction enzyme sites respectively and 
were designed to PCR amplify aniA coding sequence along with its 300 bp upstream 
endogenous regulatory elements (1.6 Kb) (Figure 6.10). Approximately 1.6 Kb long PCR 
product was bulked up, PCR purified (Section 2.11.7) and verified by running on 1% Agarose 
gel. PCR purified aniA along with its upstream regulatory region (using Phusion polymerase) 
(Section 2.11.15.4) and vector plasmid pGCC5 were double digested first with NsiI (with low 
salt buffer) and then sequentially with AatII (high salt buffer) (Section 2.11.9). After heat 
inactivating the enzymes, restriction digest products were run on 1% Agarose gel for 
confirmation (Section 2.11.14). Subsequently, ligation was performed at vector to insert ratios 
of 1:1, 1:3 and 1:5 using NEB’s T4 DNA ligase (Section 2.11.10). Following day products 
from ligation was transformed into DH5α competent cells (Section 2.11.2). The resulting 
colonies were selected on Kanamycin containing plates. Plasmid DNA was extracted from the 
selected positive colonies (Section 2.11.8) and positive colonies were verified by diagnostic 
PCR (Figure 6.11). The selected pGCC5::aniA2+ was verified by the sequencing primers 
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(Comp_check_RUH19_aniA1 and Comp_check_RUH20_aniA2) (See the attached CD ROM 
for sequencing data). A primer pair was designed for pGCC5 as such that forward primer 
(Comp1_check_RUH14_lctP/aspC_FWD) was complementary to the beginning of lctP and 
reverse primer (Comp1_check_RUH14_lctP/aspC_REV) was complementary to the end of 
aspC. These primer pairs were used to PCR amplify aniA along with its native promoter from 
the newly created pGCC5::aniA2+ using NEB’s phusion polymerase (Figure 6.12) (Section 
2.11.15.4). PCR product was bulked up and purified (Section 2.11.7). After qualitative and 
quantitative assessment of PCR product by NanoDrop (Section 2.11.5), PCR product was 
transformed into the ∆aniA by spot transformation (Section 2.11.13). Resulting colonies were 
selected on spectinomycin/chloramphenicol containing plates (Section 2.4.2). Positive 
colonies were selected by colony PCR (Section 2.11.15.1) using AniA_compl_RUH8_FWD 
and AniA_compl_RUH8_REV primers which amplified the aniA containing 1.6 Kb region 
(Figure 6.13). The confirmed ∆aniA/aniA+ was stored in 60% glycerol containing solution in 
-80°C for future usage. 
 
6.3.4.2 Results 
GD were extracted from Wt, ∆aniA and ∆aniA/aniA+ strains (Section 2.11.6). PCR amplication 
was carried out with AniA_compl_RUH8_FWD and AniA_compl_RUH8_REV primers using 
My TaqTM Red Mix  polymerase (Section 2.11.15.2). Primers amplified the 1.6 Kb aniA region 
along with its endogenous promoter. With Wt and ∆aniA/aniA+  PCR products, approximately 
a 1.6 Kb band representing the aniA region along with its upstream regulatory elements was 
evident (Figure 6.14). However, the similar band was not seen with ∆aniA GD PCR. An 
approximately 3.6 Kb long band was seen with both the ∆aniA and ∆aniA/aniA+ GD 
amplification products (Lanes 2-3).  
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Figure 6.9 Testing of pGCC5 plasmid for complementing ∆aniA under the control of its 
endogenous promoter. 
A) pGCC5 is used to complement mutation under the control of its endogenous promoter.  A 
functional copy of the gene to be complemented is ectopically inserted at an unlinked 
chromosomal locus between the lctP and aspC genes under the control of its endogenous 
promoter and linked to a Cam (Chloramphenicol) resistance cassette. (Figure adapted from 
Addgene website) Multiple cloning site harbours multiple restriction enzymes for cloning. For 
aniA complementation under its endogenous promoter along with the regulatory sequences, 
AatII and NsiI enzymes were chosen (highlighted in red) B) After receiving the plasmid from 
Addgene, restriction digest reactions were performed to test the plasmid. ClaI, AatII digested 
(Section 2.11.9) pGCC5 were run on the 1% agarose gel (Section 2.11.14). As can be seen 
from Figure A, approximately 2.3 Kb sequence is flanked by ClaI. Therefore, ClaI digestion 
of pGCC5 yields two bands which are of 5.0 Kb and 2.3 Kb length (Lane 1, Figure B). AatII 
is an enzyme from the MCS which linearises pGCC5 and produces a band length of 
approximately 7.3 Kb (Lane 2, Figure B), Lane 3 represents the uncut pGCC5. Image captured 
by Biorad gel imager  
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Figure 6.10 Sequence selected for reverse complementation of aniA along with its 
endogenous promoter and upstream regulatory protein (FNR, NsrR, FUR, NarP) binding 
sites. 
The cartoon represents the selected 300 basepair upstream region of aniA coding regions (in 
the bracket) plus 100 bp downstream region of the aniA gene. aniA coding region is highlighted 
in yellow. All the four regulators directly or indirectly affect the aniA activity and therefore are 
important for denitrification (for details on these regulators the readers are referred to (Section 
1.12 - 1.14). The sequences highlighted in green represents the selected regions for primer 
design with the selected restriction enzymes (AatII and NsiI) from the MCS of pGCC5 (Figure 
6.9) which do not have any overlapping cut sites within the aniA region.  
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Figure 6.11 Diagnostic restriction digest for selecting positive pGCC5::aniA plasmid. 
After cloning aniA with upstream endogenous promoter region into AatII and NsiI restriction 
sites of pGCC5 plasmid (as shown in Figure A), positive clones were selected on Kanamycin 
containing plates. After plasmid extraction selected colonies were double digested (Section 
2.11.9) with NsiI and AatII restriction enzymes. Digested product was run on 1% agarose gel 
(Section 2.11.14) to separate the products according to their size. As can be seen from the 
Figure B, pGCC5::aniA (2) and pGCC5::aniA (3) plasmids contained the expected 1.6 Kb aniA 
region and 7.3 Kb part of the remaining pGCC5 plasmid (Figure A). pGCC5::aniA (2) was 
selected for subsequent cloning application after sequencing confirmation (See the attached 
CD ROM for sequencing data) and termed as pGCC5::aniA2+. Image captured by Biorad gel 
imager. 
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Figure 6.12 Amplification of aspC to lctP region containing aniA with its upstream 
promoter region using pGCC5 :: aniA2+ as template for transforming into ∆aniA. 
Integration of aniA into pGCC5:: aniA2+ was confirmed by designing primers (Ampli-pGCC4 
Forward and Ampli-pGCC4Reverse) (Section 2.11.3) which amplified the entire region from 
aspC to lctP containing aniA with upstream promoter region using pGCC5 :: aniA2+, KanR, 
CamR  plasmid as template. Details of the amplified products are mentioned in the cartoon 
above the gel. The correct size of band (6.6 Kb) was found with the PCR reaction using pGCC5 
:: aniA2+, KanR, CamR  as template. NEB’s phusion polymerase was used for PCR (Section 
2.11.15.3). After gel confirmation the 6.6 Kb fragment was transformed into the ∆aniA strain. 
Image captured by Biorad gel imager. 
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Figure 6.13 Confirmation of positive colonies from the reverse complemented 
∆aniA/aniA+ under its native promoter by colony PCR. 
Colony PCR (Section 2.11.15.1) was performed on the putative ∆aniA/aniA+ colonies selected 
on Spectinomycin/Chloramphenicol containing plates using My Taq polymerase (Section 
2.11.15.2).  AniA_compl_RUH8_FWD and AniA_compl_RUH8_REV primers (Section 2.11.3) 
were used to amplify 1.6 Kb sequence containing aniA along with its 300 bp upstream 
regulatory region. PCR products were run on 1% agarose gel (Section 2.11.14). Colony 5 and 
Colony 10 contained the expected 1.6 Kb band similar to the Wt MC58 GD and were used for 
subsequent characterisation. Image captured by Biorad gel imager.    
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Figure 6.14 PCR confirmation of the reverse complementation of ∆aniA/aniA+ under its 
endogenous promoter region. 
 Genomic DNA (GD) (Section 2.11.6) was isolated from Wt, ∆aniA and ∆aniA/aniA+ colonies. 
PCR was performed using My Taq polymerase (Bioline) (Section 2.11.15.2) with 
AniA_compl_RUH8_FWD and AniA_compl_RUH8_REV primers and the PCR products were 
run in 1% agarose gel (Section 2.11.14) to separate the products according to their size. The 
primers covering aniA along with its endogenous promoter in chromosome showed a 1.6 Kb 
band from the Wt GD (Lane 1). Same size band was absent in ∆aniA (Lane 2) but present in 
∆aniA/aniA+ (Lane 3). Lanes 2 and 3 represent a band of approximately 3.6 Kb in size from 
PCR products with ∆aniA and ∆aniA/aniA+ GD templates. This represents 2.0 Kb 
spectinomycin cassette flanked by disrupted aniA region. Therefore, PCR product with 
∆aniA/aniA+ GD  showed two bands; one representing the newly integrated aniA along with its 
upstream regulatory elements (1.6 Kb) and the other band representing spectinomycin cassette 
flanked by disrupted aniA region (3.6 Kb). These observations confirmed the successful 
integration of aniA along with its upstream promoter region into ∆aniA/aniA+. Image taken by 
BioRad gel imager. 
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6.3.5 aniA activity is restored in the ∆aniA/aniA+ strain where aniA was 
complemented along with its endogenous promoter and upstream 
regulatory elements 
6.3.5.1  Rationale and methods 
The newly created ∆aniA/aniA+ had to be characterised for the restoration of NO2- metabolism.  
To test the functional restoration of aniA in the newly generated ∆aniA/aniA+, a batch culture 
growth curve was performed in MHB supplemented with 5 mM NaNO2. The newly created 
∆aniA/aniA+ was grown alongside the Wt and ∆aniA strains for comparison. The cultures were 
grown for 24 hours with mild agitation at 90 rev/minute. In 50 ml tubes, the cultures were 
normalised to OD600nm = 0.05 in 25 ml MHB with 5 mM NaNO2
 supplementation before 
incubating the cultures at 37°C, 5% CO2 incubator. In a separate tube, 25 ml MHB with 5 mM 
NaNO2 was incubated without any bacteria. This condition served as positive control. Viable 
counts were performed at 0, 2, 4, 8, 12 and 24 hour time points by dilutional plating. At the 
specified time points, 1 ml of each sample was transferred to sterile 1.5 ml microcentrifuge 
tube. The samples were centrifuged at 13000 rpm for 5 minutes and supernatants were 
collected.  Bacteria free supernatants were used to measure nitrite (NO2
-) by Griess Assay 
(Section 2.10.1).  
6.3.5.2 Results 
Figure 6.15 demonstrates that there was a statistically significant reduction in NO2
- with the 
∆aniA/aniA+ containing media compared to Wt and ∆aniA at 12 and 24 hour timepoints (p < 
0.05). The bacterial viable count for ∆aniA/aniA+ was statistically significantly higher at 12 
and 24 hour timepoints compared to the Wt and ∆aniA (p < 0.05). In four identical replicates 
of ∆aniA/aniA+, the first three replicates (1, 2 and 3) demonstrated an obvious transition from 
oxidative respiration to denitrification but for the last replicate the transition was not apparent. 
(Figure 6.16) 
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Figure 6.15 Functional characterisation of the newly generated complemented strain 
∆aniA/aniA+ in the presence of 5 mM NaNO2 in microaerobic condition. 
Wt, ∆aniA, ∆aniA/aniA+ were grown in 25 ml MHB containing 5 mM NaNO2 in 50 ml tubes 
at 90 rev/minute agitation. The cultures were incubated at 37°C, 5% CO2. Media were collected 
at 0, 2, 4, 8, 12 and 24 hour timepoints to take viable count readings. 1 ml of sample from each 
condition was stored for later A) [NO2
-] was measured by Griess Assay (Section 2.10.1),  B) 
30 µl of sample from each timepoint was serially diluted and plated on CBA plate for 
measuring viable count (cfu/ml) next day. Bars denote means ± SEM. n = 4, *p<0.05, Two 
way ANOVA with Tukey’s multiple comparison test. 
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Figure 6.16 Transition from oxidative respiration to denitrification in the three out of 
four identical cultures of ∆aniA/aniA+. 
All the cultures were incubated in 25 ml MHB with an initial OD600nm of 0.05 in the presence 
of 5 mM NaNO2 with mild agitation at 90 rev/minute. Media were collected at 0, 2, 4, 8, 12 
and 24 hour timepoints. 1 ml of sample from each condition was stored for later [NO2
-] 
measurement by Griess Assay (Section 2.10.1) and another 1 ml was used for doing viable 
count using dilutional plating. 
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6.4 Discussion 
This chapter presents preliminary data that the meningococcal denitrification pathway has a 
role in differential biofilm formation in vitro (Figure 6.1 - 6.2). Given that presence of 
exopolysaccharides (EPS) is feature of a true biofilm structure (Hall-Stoodley et al, 2004), 
microscopic analysis has to be performed after staining the biofilm to confirm this. Congo red 
staining helps to detect the β-glucan component of EPS (Yi et al, 2004). Interestingly, 
meningococci formed biofilm with 50 µM SpermineNONOate supplementation in starvation 
media in static condition. SpermineNONOate is a rapid acting NO donor which was added to 
induce removal of the nsrR mediated repression of the meningococcal denitrification pathway 
(Heurlier et al, 2008; Rock et al, 2007). Some of the NO released by SpermineNO would have 
been converted to NO2
- over time. This would have induced the expression of denitrification 
genes in a starved media as the competition amongst the bacteria to exploit the scarce 
alternative energy resources would have been intense. 
 For testing the role of aniA in biofilm formation, a reverse complemented strain (∆aniA/aniA+) 
was generated and successfully characterised. This is the first study reporting successful 
reverse complementation of ∆aniA/aniA+ strain (Figure 6.14, 6.15 and 6.16). However, 
essential experiments for investigating the role of aniA in differential biofilm formation using 
the newly characterised ∆aniA/aniA+ alongside the ∆aniA and Wt strains as presented in 
Section 6.3.1 could not be performed due to the time constraints on the project.   
As can be seen from Figure 6.6, a 1.173 Kb aniA was apparent for ∆aniA/aniAIPTG+ strain and 
Wt but not from the ∆aniA as expected. The 1.173 Kb sequence represents the coding sequence 
of aniA. However, the functional characterisation growth curves (Figure 6.7 – 6.8) showed 
that aniA activity was not restored in the ∆aniA/aniAIPTG+ when induced by the addition of 1 
mM IPTG in the growth media.  
Figure 6.14 showed that ∆aniA/aniA+ where aniA was reverse complemented along with its 
upstream regulatory protein (NarP, Fur, NsrR and FNR) binding sites and the endogenous 
promoter (Figure 6.10), it showed the expected 1.6 Kb band after PCR which was also evident 
with the Wt GD amplification PCR product. In addition, another band was apparent with ∆aniA 
and ∆aniA/aniA+ GD PCR amplification products (Figure 6.14). This 3.6 Kb band represented 
the 2.0 Kb spectinomycin cassette flanked by disrupted aniA regions. Therefore the two bands 
(3.6 Kb and 1.6 Kb) with ∆aniA/aniA+ GD PCR template confirmed the presence of disrupted 
version of aniA (3.6 Kb band) as well as a complemented version of aniA along with its 
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endogenous upstream regulatory elements (1.6 Kb) at a different locus. The functional 
characterisation growth curve (Figure 6.15) also provided evidence for the aniA activity 
restoration in ∆aniA/aniA+ as shown by a significant decrease in NO2- (Figure 6.15 A) but a 
significant increase in viable count (Figure 6.15 B) at 8 and 12 hour timepoints compared to 
Wt and ∆aniA conditions. This implies that along with the environmental cues such as the 
absence of oxygen and presence of NO2
-, aniA activity is regulated by a complex set of 
regulatory proteins which have binding sites to the upstream of aniA coding region (Figure 
6.10). 
It is noteworthy that three out of four replicates performed in the presence of 5 mM NaNO2, 
∆ania/aniA+ made a successful transition from oxidative respiration to denitrification (Figure 
6.16). This was evidenced by the increase in growth (viable count) coinciding with the 
depletion of NO2
- (Figure 6.16 A, B, C) and thereby confirming the restored AniA activity in 
the newly created ∆aniA/aniA+. However, NO2- depletion was not apparent in the fourth 
replicate (Figure 6.16 D). It could have been due to an unexpected reduction in the number of 
viable bacteria recovered with ∆aniA/aniA+ at 24 hour timepoint. Unlike other microaerobic 
growth curves performed in this project (Chapter 4, Figure 4.11 and Chapter 6, Figure 6.7), 
obvious transition from aerobic to microaerobic growth was not apparent with the Wt MC 58 
strain in the ∆aniA/aniA+ characterisation growth curve (Figure 6.15). Transition from aerobic 
to microaerobic respiration was apparent only in one out of four identical batch culture growth 
curves of Wt MC58 (separate graph for Wt replicates data not shown). This is not surprising 
given that there have been several studies reporting the presence of polymorphisms in aniA 
activity in the isolates of N. meningitidis which is conserved across other Neisseria spp (Barth 
et al, 2009; Ku et al, 2009; Stefanelli et al, 2008).  Another study reported that transition from 
oxidation to denitrification is unstable and inconsistent in meningococci. AniA activity was 
observed in four out of six identical microaerobic cultures of N. meningitidis (Moir, 2011). In 
other Neisseria spp., AniA can receive electrons from both cytochrome C5 and via the CcoP 
domain of cytochrome cbb3 oxidase. However, AniA of N. meningitidis only receives electrons 
from the cytochrome C5 as one of the CcoP domain of  cytochrome cbb3  oxidase is non 
functional due to a single nucleotide polymorphism which is a meningococci specific 
adaptation (Aspholm et al, 2010). This indicates that there could be an evolutionary pressure 
on N. meningitidis to remove aniA. Variable transient accumulation of NO by aniA activity 
could account for the variable transition from aerobic growth to denitrification (Rock et al, 
2005). A significant reduction in the viable count from Wt MC58 strain in the presence of 5 
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mM NaNO2 (Figure 6.15 B) indicates that there would have been an unexpected NO mediated 
cytotoxicity in the culture.  
It is to be noted that there is limited clinical evidence to date for biofilm formation by N. 
meningitidis in vivo. In the biopsies takes from patients with purpura fulminas, a feature of 
meningococcal sepsis, virulence factors such as capsule, pili and porA were found to be 
expressed in microcolonies (Harrison et al, 2002). Histological studies from rat tissue have 
demonstrated that meningococci can proliferate in microcolony like structures in these brain 
capillaries when the blood flow is temporarily low (Mairey et al, 2006). This observation would 
imply that it is possible for meningococcal biofilm to exist in the bloodstream of septic patients. 
Although biofilm is generally considered to be a feature of chronic infection, these observations 
indicate that meningococcal biofilm formation could occur during a symptomatic infection. 
During another study where tonsils were removed from the carriers of N. meningitidis, 
microcolonies were found below the epithelial surface (Sim et al, 2000). Given that 
microcolonies form the basic unit of bacterial biofilm (Costerton et al, 1995), the tonsillar 
meningococcal aggregate could resemble the actual biofilm structure. Evidence for biofilm 
formation exists in the nasopharynx, the natural niche for the meningococci (Coticchia et al, 
2007). However, microcolonies found from none of the studies mentioned above were followed 
up with high resolution imaging for determining the presence of a biofilm matrix, which would 
have confirmed the presence of a mature biofilm. Therefore a comprehensive study on the 
tissues excised during adenoidectomy, tonsillectomy and subsequent experimental 
characterisation of tissue section for the presence of mature meningococcal biofilm would be 
useful. Since the nasopharynx is an oxygen poor and NO rich environment (Lundberg & 
Weitzberg, 1999), the meningococcal denitrification pathway would play a vital role in  
establishing the mature biofilm. The data presented in this chapter indicated that an inability to 
denitrify results in impaired biofilm formation in vitro (Figure 6.1 - 6.2). Since aniA is essential 
for switching to denitrification from oxidative respiration, the generation and characterisation 
of ∆aniA/aniA+ (Section 6.5- 6.6) will be pivotal in investigating the hypothesis that aniA is  
essential for meningococcal biofilm formation in vitro in future.  
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7 Chapter 7: General Discussion 
Using the pre-existing NO metabolising gene mutants, we demonstrate that meningococcal NO 
metabolism does not differentially regulate the physiologically important regulatory molecules 
such as SNO, NO2
-, NOx in a murine model of early acute meningococcal sepsis (Chapter 3). 
The newly generated strains with the deletion of multiple genes responsible for NO metabolism 
were created and characterised to explore the effect of multiple genes on meningococcal 
pathogenesis (Chapter 4). Barrier function and cytokine profile of the HPEC-ALIs (Chapter 
5), a primary epithelial cell sharing similar properties to nasopharyngeal epithelium were 
unperturbed by meningococcal NO metabolism. Preliminary data showed that NO metabolism 
could be important for meningococcal biofilm formation in vitro which is to be followed up in 
future experiments using the newly generated and characterised reverse complemented strain 
(∆aniA/aniA+) (Chapter 6). 
Previously, our group has shown that bacterial NO detoxification reduces the concentration of 
host-cell S-nitrosothiol (SNO), a vital post-translational modification akin to phosphorylation, 
in murine macrophages in vitro (Laver et al, 2010). Proteomic analysis on the same cell line 
revealed that a number of SNO proteins are differentially regulated in relation to the bacterial 
NO detoxification machinery (Dr Jay Laver, personal communication). In the murine model of 
early fulminant meningococcal septicaemia, we were able to reproducibly detect NO 
metabolites following meningococcal infection (Chapter 3). We showed that bacterial burden 
correlates positively with plasma SNO and hepatic NO2
- but negatively with hepatic NOx. This 
is the first study reporting an abundance of SNO molecules in an early murine model of acute 
sepsis. Inclusion of human holo transferrin made the model more physiologically relevant to 
human as meningococci can only harness iron by binding to human transferrin due to receptor 
compatibility of meningococcal transferrin binding proteins (Gorringe et al, 2005; Renauld-
Mongenie et al, 2004). However, bacterial NO metabolism did not differentially modulate SNO 
and other NO metabolite profile of murine blood and liver tissue. Multiple reasons could 
account for not observing meningococcal NO metabolism mediated effect on SNO depletion 
in vivo contrary to the finding from the in vitro study in the murine J774.2 cell line (Laver et 
al, 2010). As explained in the discussion section of Chapter 3 (Section 3.6), SNO depletion by 
meningococcal NO metabolism could be a localised cell specific (i.e. macrophages) 
phenomenon which is not detectable in vivo at the whole tissue/animal level. Secondly, there 
could have been lack of meningococcal NO metabolism due to the abundance of oxygen and a 
lack of spatiotemporally available NO required for observing any NO mediated effect in vivo. 
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Multiple studies on human septic patients have reported decreased amount of oxygen 
consumption in tissues due to defective mitochondrial oxidative respiration (Adrie et al, 2001; 
Brealey et al, 2002; Garrabou et al, 2012; Yamakawa et al, 2013). Decreased oxygen 
consumption in ileum and liver has been reported in model of septic rat and mouse respectively 
(Carchman et al, 2013; King et al, 1999). As observed with human septic patients 
mitochondrial dysfunction has been attributed for decreased oxidative respiration by host 
tissues in septic model of rodents (Brealey et al, 2004; Singer, 2014). A microarray analysis 
performed on RNA extracted from critically ill acute septic patients at 0, 4, 8, 12, 24 and 48 
hour time points revealed that the expression of genes relating to oxidative phosphorylation 
falls early and continues to decrease throughout the course of  sepsis (Raman et al, 2015). As 
more than 90% of the available oxygen in body is used by mitochondria (Nathan & Singer, 
1999) it could be possible that in our murine model of early acute meningococcal sepsis, there 
was an abundance of oxygen due to inability of the host cells to consume oxygen for ATP 
generation via oxidative respiration. Previous study has demonstrated that norB is essential for 
the survival of meningococci in nasopharyngeal mucosa and human macrophages (Stevanin et 
al, 2005). The viable bacteria recovered from ∆norB infection were significantly lower than 
that of Wt infection. This effect was diminished when the cells were treated with NOS inhibitor, 
NG-Monomethyl-L-arginine (L-NMMA) implying that norB mediated survival is important in 
highly cytotoxic NO environment. In our in vivo murine model there was no statistically 
significant difference between the recovery of number of viable bacteria from Wt and ∆norB 
infected mice (Figure 3.5, 3.9 and 3.14). Therefore, it is possible that generated cytotoxic 
amounts of NO by murine tissues in response to meningococcal infection would have inhibited 
the oxidative respiration of the host cells by interacting with the mitochondrial enzyme 
complexes (Almeida et al, 2005; Brown, 2001; Cleeter et al, 1994) leading to the accumulation 
of unconsumed oxygen. Indeed evidence from multiple studies exist for mitochondrial 
dysfunction mediated by NO overproduction in both human and rodent septic models (Brealey 
et al, 2002; Brealey et al, 2004; Vanasco et al, 2012). An oxygen abundant and 
spatiotemporally NO deficient environment can lead to a number of important ramifications 
for observing any meningococcal NO metabolism mediated activity. Firstly, meningococci 
prefer respiration by O2 reduction over NO2
- reduction as O2 has higher affinity for electron 
compared to NO2
-
.
 This is due to fact that the redox potential of O2/H2O (+820 mV) is higher 
than that of NO2
-/NO (+348 mV) (Conrad, 1990). Furthermore, higher energy is liberated by 
proton translocation by the flow of electrons towards O2 physiologically in comparison to that 
of NO2
-. The translocated protons are used to generate ATP for the organism. In presence of 
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both O2 and NO2
-, reduction of O2 is preferable due to the generation of higher energy in the 
form of more ATPs. Therefore, meningococci would continue aerobic respiration in the 
presence of high oxygen. This would have led to diminished or reduced activity of 
meningococcal denitrification pathway pivotal for observing any NO mediated effect in our 
murine model of early acute sepsis. Secondly, in vitro study showed that meningococcal norB 
mediated SNO depletion was not evident when the J774.2 murine macrophages were co-
infected with bacterial strains in the presence of an iNOS inhibitor (1400W) (Laver et al, 2010). 
This implies that norB precludes SNO formation by degrading the S-nitrosylating substrate, 
NO required for SNO formation instead of degrading the pre-existing SNO molecules. The 
lack of spatiotemporally available NO would also result in the persistence of nsrR mediated 
repression of norB activity as high NO concentration (~1 µM) is a pre-requisite for relieving 
nsrR mediated repression of denitrification regulon (Heurlier et al, 2008; Rock et al, 2007). 
Therefore, an oxygen abundant and spatiotemporally NO deficient environment in vivo would 
imply that there was not enough NO for detecting the impairment of SNO formation by 
meningococcal norB activity as observed in vitro.  
To investigate the effect of multiple meningococcal denitrification genes (aniA and norB) on 
the cellular pathology of meningococcal sepsis, we constructed and characterised a panel of 
NO metabolising gene mutants (∆aniA/∆norB, ∆nsrR/∆norB, ∆aniA/∆norB/∆nsrR) using the 
isocloning method (Chapter 4). Although functional inactivation of the denitrification genes 
were demonstrated in the newly generated mutants (∆aniA/∆norB, ∆nsrR/∆norB, 
∆aniA/∆norB/∆nsrR) (Chapter 4), it will be useful to perform western blot using antibodies 
developed against AniA, NorB and NsrR to check for these protein production. The blots can 
be performed on samples extracted at different timepoints to get an estimation of these protein 
expression over time. It would also be interesting to examine the aniA coding region 
complemented ∆aniA/aniAIPTG+ for any AniA protein production as the functional restoration 
was not observed in the characterisation growth curves (Figure 6.7 - 6.8). Similar AniA 
detection western blot can be performed to test the AniA production in the newly generated 
∆aniA/aniA+ strain where aniA was complemented along with the upstream regulatory 
elements (Figure 6.14 - 6.16). This would inform us about comparative AniA protein activity 
in all the replicates where we and other researchers observed inconsistent aniA activity (Barth 
et al, 2009; Moir, 2011). Pili, opa and opc are essential components of N. meningitidis for 
mediating the interaction with host cells (Section 1.7). Therefore, along with the wild type 
strain, the newly generated strains can be tested for the identical expression of these proteins. 
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This can be achieved by performing western blot using the monoclonal antibodies developed 
against these proteins (Kolb-Mäurer et al, 2001). 
In addition, direct norB mediated NO metabolism was not evident from the growth curves 
presented in Chapter 4 (Figure 4.11 and 4.13).  By using NO electrode it is possible to monitor 
the direct NO consumption by bacteria in batch culture growth curves (Heurlier et al, 2008; 
Rock et al, 2007). Direct detection of NO in identical batch culture growth curves (Figure 4.11 
and Figure 4.13) will provide information on comparative NO consumption by different 
bacterial strains. In parallel with the growth curves in presence of a rapid acting NO donor 
(SpermineNONOate) (Figure 4.13), growth curves in presence of a slow NO releasing donor 
such as NOC-18 can be performed. This will help to measure the comparative NO consumption 
by different bacterial strains over longer period of time as NOC-18 has a half life of 20 hour 
(Keefer et al, 1996). These experiments will help not only to prove the norB inactivation in the 
newly generated strains comprehensively but also will provide a quantitative measurement of 
NO metabolism by different bacterial strains in batch culture growth curve. More replicates 
need to be performed to establish that there is no statistically significant difference in the 
downstream GpxA activity in ∆norB, ∆aniA/∆norB/∆nsrR due to polar effect caused by norB 
deletion in these strains compared to the Wt MC58 (Figure 4.9). Other newly generated norB 
deleted strains (∆aniA/∆norB and ∆nsrR/∆norB) can also be included in the comparative GpxA 
assay for investigating the polar effect of norB deletion in these strains. 
We demonstrated that bacterial burden inversely correlates with the barrier function (TER) but 
positively with the cytokine profile (IL-8, TNFα) of HPEC-ALI, a cell line having similar 
features to nasopharyngeal epithelial cell. However, meningococcal denitrification did not have 
any differential role in the regulation of barrier function and cytokine profile of the HPEC-
ALIs in the experimental system we used (Chapter 5). There could have been a lack of NO 
activity in the HPEC-ALI system. Measurement of NOx by chemiluminescence from the apical 
and basal supernatants of the HPEC-ALIs shows basal level of NOx production (data not 
shown). This is important as NO can activate the TNF-converting enzyme (TACE) responsible 
for releasing the membrane bound TNFα (Zhang et al, 2000). Low levels of TNFα (Figure 5.4 
A and 5.9) release following meningococcal infection points to the possibility of a reduced NO 
activity as TNFα acts as an inducer of NOS expression from endothelial and epithelial cells 
(Donnelly & Barnes, 2002; Robbins et al, 1997; Yan et al, 1997). Although both ∆aniA/∆norB 
and ∆aniA/∆norB/∆nsrR lack NO metabolic capability due to the absence of norB, deletion of 
aniA meant that any present NO2
- in the media would not have been reduced to NO and thereby 
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minimising a route for maximal presence of NO in an infection model of HPEC-ALIs. To 
address this an isogenic ∆norB can be used alongside the wild type strain to investigate any 
effect that may show the biggest difference from the wild type under conditions where NO 
metabolism is important.  
Preliminary data also showed when biofilm formation was induced by nutrient starvation, 
∆aniA/∆norB showed a significantly reduced biofilm forming ability compared to the Wt strain 
measured by the crystal violet staining (Chapter 6). However, microscopic analysis has to be 
performed to confirm the presence of exopolysaccharides (EPS) in biofilm matrix given that 
EPS is an essential characteristic for a true biofilm structure (Hall-Stoodley et al, 2004). Congo 
red stains the β-(1→4)-linked D-glucopyranosyl units or β-(1→3)-D-glucan component of the 
exopolysaccharides in biofilm (Yi et al, 2004). Therefore, if stained positive it would confirm 
the presence of a true biofilm structure in the experimental system we used. Advanced 
microscopic toolkits such as confocal or scanning electron microscopy have to be used to 
examine the biofilm structure with high resolution and magnification (Asahi et al, 2015; 
Mueller et al, 2006). To study the interaction of biofilm with substratum atomic force 
microscopy can be used. It enables to model the biofilm substratum in both qualitative and 
quantitative manner by providing high resolution images at atomic level (Beech et al, 2002). 
This will be particularly important for our experimental system where preliminary data 
(Section 6.3.1) indicated that biofilm formation by bacterial denitrification could be a 
substratum specific phenomenon. 
A previous study demonstrated that deletion of narP, a regulator of denitrification for both N. 
gonorrhoeae (Householder et al, 1999) and N. meningitidis (Barth et al, 2009) results in 
impaired meningococcal biofilm formation (Jamet et al, 2013). For investigating the role of 
aniA in the differential regulation of biofilm formation, a reverse complemented strain 
(∆aniA/aniA+) was created and characterised. This work provides important foundation for 
studying the role of meningococcal denitrification on biofilm formation. The future follow up 
work has the potential to shed light on the process of meningococcal colonisation as biofilm 
formation could be one of the strategies adopted by meningococci to survive and thrive in an 
NO rich environment such as nasopharynx (Lundberg et al, 1995; Lundberg & Weitzberg, 
1999). 
A number of studies (Lappann et al, 2006; Yi et al, 2004) have demonstrated that non-
capsulated meningococcal strains cannot form biofilm which is contradictory to the finding 
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from another study where capsulated meningococci formed biofilm (Neil et al, 2009). 
Although the strains used in this project had capsular background, the presence of capsulated 
meningococci in biofilm has to be verified experimentally given that the expression of capsular 
genes is subject to regulation by phase variation through slipped strand mispairing and 
reversible insertion of mobile elements (Hammerschmidt et al, 1996a; Hammerschmidt et al, 
1996b). Furthermore, the expression of capsule can be switched off/on at a high rate (Swartley 
et al, 1997). Capsule is an essential component of meningococcal adaptation machinery to 
resist complement mediated killing (Jarvis & Vedros, 1987) and for intracellular survival 
(Spinosa et al, 2007). Therefore, the investigation if capsulated meningococci can form biofilm 
is important given that the capsulated population would be better suited to evade host-immune 
clearance and cross the epithelial/endothelial cells (Nikulin et al, 2006; Spinosa et al, 2007). 
For verifying the presence of capsule in biofilm, the bacterial lysates from different 
experimental strains can be tested by PCR for the expression of siaD (polysialyltransferase), a 
gene responsible for coding the sialic acid component of meningococcal capsule or ctrA, an 
exclusive component of the meningococcal capsule biosynthesis locus (Bennett et al, 2004; 
Taha et al, 2005). In addition, ELISA can also be performed on the bacterial lysates for 
identifying capsule measured as immunoglobulins using specific antibodies directed against 
serogroup B capsule (Jordens et al, 2004; Williams et al, 2003). 
Biofilm data presented in Section 6.3.1 were performed in a 50% nutrient content starvation 
media that was altered just at specific timepoints (before the experiment and after 24 hour).  
However a flowsystem can be used to control the influx of nutrients into the media to determine 
the formation of biofilm at different nutrient compositions (Apicella et al, 2012). It will also 
enable us to continually supply NO into the system at a controlled manner which would mimic 
the physiological condition more closely. It will facilitate the investigation of the role of NO 
on biofilm formation over time. The newly constructed and characterised ∆aniA/aniA+ could 
not be used to perform similar experiment as described in Section 6.3.1 due to the time 
constraints on the project. Therefore, ∆aniA/aniA+ will be used along with the Wt and ∆aniA 
in future to test the hypothesis that aniA is necessary for meningococcal biofilm formation in 
vitro. In parallel, ∆norB/norB+ has to be constructed for performing similar experiments to 
examine the role of norB in differential biofilm formation. This future work has the potential 
to shed light on the contribution of meningococcal denitrification pathway on biofilm 
formation, a process which can be exploited by the meningococci to colonise and avoid innate 
immune mediated killing in the nasopharynx. 
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